GLP-1 Market
LLY $1123.00 ▼ -0.1% NVO $44.01 ▼ -1.2% PFE $27.65 ▼ -0.5% VKTX $32.13 ▼ -1.7% KLRA $14.91 ▲ +0.5% GPCR $39.55 ▼ -4.1% RHHBY $53.19 ▼ -0.4% HIMS $27.44 ▼ -1.6% WW $14.78 ▼ -1.1%
Delayed · As of 9:20 AM
About this data Sourced primarily from ClinicalTrials.gov — a listing isn't proof of safety or FDA approval.

Pipeline and clinical trial information here comes primarily from ClinicalTrials.gov. A listing on ClinicalTrials.gov means a study has been registered — not that a treatment is proven safe, effective, or FDA-approved. Investigational treatments may never be approved. Who can join a trial is decided only by that trial's own study team.

Not yet reported

Growth Hormone, Human

Company
Columbia University
Mechanism
Mechanism not yet reported
Route
Route not yet reported
Recruiting trials
41 recruiting

Efficacy results: Not yet reported

Find a Clinical Trial Near Me

41 recruiting studies currently listed on ClinicalTrials.gov.

Data source: ClinicalTrials.gov · trial data as of Sep 11, 2026

Find a Clinical Trial Near Me

See recruiting studies for Growth Hormone, Human and check eligibility with the study team.

Select conditions
Match
Treatment type

"Added to GLP-1" means the investigational treatment is being studied on top of an existing GLP-1-based therapy.

Your ZIP code is only used to calculate distance to trial sites — it isn't stored.

Trial details
  • Recruiting NCT NCT00227253

    Chromosome 18 Clinical Research Center

    The University of Texas Health Science Center at San Antonio 4000 participants Est. completion 2040-12 2 sites
    Other conditions: Chromosome Aberrations, Growth Hormone Deficiency, Hypomyelination
    View official trial listing →
  • Recruiting NCT NCT01604395

    Long-term Safety and Effectiveness of Growth Hormone With GHD, TS, CRF, SGA , ISS and PWS in Children

    LG Chem 6000 participants Est. completion 2032-12-31 1 site
    Other conditions: Growth Hormone Deficiency, Turner Syndrome, Chronic Renal Failure, Small for Gestational Age, Idiopathic Short Stature
    View official trial listing →
  • Recruiting NCT NCT04121780

    Growth Hormone Replacement Therapy for Retried Professional Football Players

    Not yet reported Center for Neurological Studies 42 participants Est. completion 2026-09 1 site
    Other conditions: TBI (Traumatic Brain Injury), Concussion, Brain, Sport Injury, Anterior Pituitary Hyposecretion Syndrome, Hypopituitarism, Growth Hormone Deficiency
    View official trial listing →
  • Recruiting NCT NCT04375657

    Thymus Regeneration, Immunorestoration, and Insulin Mitigation Extension Trial

    Not yet reported Intervene Immune, Inc. 85 participants Est. completion 2025-12 1 site
    Other conditions: Epigenetic Aging, Immunosenescence
    View official trial listing →
  • Recruiting NCT NCT04798690

    Long-term Safety and Effectiveness of Growtropin®-II Treatment in Children With Short Stature

    Dong-A ST Co., Ltd. 5000 participants Est. completion 2035-02 1 site
    Other conditions: Growth Hormone Deficiency, Idiopathic Short Stature, Turner Syndrome, Small for Gestational Age
    View official trial listing →
  • Recruiting NCT NCT04867317

    Growth Hormone Replacement Therapy in Veterans With Mild Traumatic Brain Injury (mTBI) and Adult Growth Hormone Deficiency (AGHD)

    Not yet reported VA Office of Research and Development 172 participants Est. completion 2029-09-30 16 sites
    Other conditions: Adult Growth Hormone Deficiency, Mild Traumatic Brain Injury
    View official trial listing →
  • Recruiting NCT NCT05293366

    LOng COvid COmorbidities: Endocrine,Metabolic,Neuropsychiatric,Muscle,Cardiovascular,Pulmonary,Dermatologic Dysfunctions

    Federico II University 100 participants Est. completion 2027-01-27 1 site
    Other conditions: Long Covid-19
    View official trial listing →
  • Recruiting NCT NCT05355272

    Growth Hormone Replacement in Veterans With GWI and AGHD (GWIT)

    Not yet reported Baylor College of Medicine 20 participants Est. completion 2027-07-01 2 sites
    Other conditions: Gulf War Syndrome, Adult Growth Hormone Deficiency
    View official trial listing →
  • Recruiting NCT NCT05447208

    Effect of GH on the Blastocyst Euploid Rate in AMA Patients

    Not yet reported ShangHai Ji Ai Genetics & IVF Institute 400 participants Est. completion 2026-12-31 1 site
    Other conditions: Preimplantation Genetic Testing, Growth Hormone, Age, Parental
    View official trial listing →
  • Recruiting NCT NCT05470504

    Study of Growth Hormone Inhibition Using Pegvisomant in Severe Insulin Resistance

    Not yet reported National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 25 participants Est. completion 2028-01-30 1 site
    Other conditions: Insulin Receptor Mutation, Partial Lipodystrophy
    View official trial listing →
  • Recruiting NCT NCT05681299

    Effects of GH and Lirglutide on AgRP

    Not yet reported Columbia University 40 participants Est. completion 2028-04-30 1 site
    Other conditions: Healthy, Growth Hormone Deficiency
    View official trial listing →
  • Recruiting NCT NCT05746650

    Improving Tissue Repair After Injury in the Muscle-tendon Interface Muscle Tissue Injury

    Not yet reported Bispebjerg Hospital 40 participants Est. completion 2027-09-01 1 site
    Other conditions: Muscle Injury
    View official trial listing →
  • Recruiting NCT NCT05820672

    A US Non-interventional, Effectiveness and Safety Study of Patients Treated With SKYTROFA

    Ascendis Pharma Endocrinology Division A/S 900 participants Est. completion 2033-03 27 sites
    Other conditions: Growth Hormone Deficiency
    View official trial listing →
  • Recruiting NCT NCT06037473

    The Efficacy and Safety of PEGylated GH for the Treatment of Short Stature in Chinese Children-GLOBE Reg

    Beijing Children's Hospital 2600 participants Est. completion 2029-08-01 1 site
    Other conditions: Growth Hormone Treatment, Growth Disorders
    View official trial listing →
  • Recruiting NCT NCT06110910

    Long-term Efficacy and Safety Evaluation of Growth Hormone in Children in China(CGLS)

    Xiaoping Luo 10000 participants Est. completion 2027-12-31 1 site
    Other conditions: Childhood Short Stature
    View official trial listing →
  • Recruiting NCT NCT06382155

    A Phase 2 Study of Vosoritide in Children With Idiopathic Short Stature

    Not yet reported BioMarin Pharmaceutical 100 participants Est. completion 2036-12 47 sites
    Other conditions: Idiopathic Short Stature
    View official trial listing →
  • Recruiting NCT NCT06554717

    Tesamorelin as an Adjunct to Exercise for Improving Physical Function in HIV

    Not yet reported Massachusetts General Hospital 100 participants Est. completion 2028-12-01 2 sites
    Other conditions: HIV-1-infection, Frailty, Impaired Physical Function, Abdominal Obesity, Aging
    View official trial listing →
  • Recruiting NCT NCT06571487

    Growth Hormone Resistance of Beta-cells A

    University of Missouri-Columbia 30 participants Est. completion 2030-09-01 1 site
    Other conditions: Gestational Diabetes, Obesity, Healthy
    View official trial listing →
  • Recruiting NCT NCT06571500

    Growth Hormone Resistance of Beta-cells in People With a Family History of Type 2 Diabetes

    University of Missouri-Columbia 30 participants Est. completion 2030-09-01 1 site
    Other conditions: Healthy, Obesity
    View official trial listing →
  • Recruiting NCT NCT06587035

    A Study to Learn About Somatrogon in Patients With Pediatric Growth Hormone Deficiency (p GHD) in India.

    Pfizer 50 participants Est. completion 2028-09-05 4 sites
    Other conditions: Dwarfism, Pituitary
    View official trial listing →
  • Recruiting NCT NCT06668805

    A Study of Vosoritide in Children With Noonan Syndrome With Inadequate Growth During or After Human Growth Hormone Treatment

    Not yet reported BioMarin Pharmaceutical 30 participants Est. completion 2041-09 41 sites
    Other conditions: Noonan Syndrome
    View official trial listing →
  • Recruiting NCT NCT06770621

    Longitudinal Study of the GLUcagon REsponse to Hypoglycemia in Children and Adolescents With New-onset Type 1 DIAbetes

    Not yet reported Cliniques universitaires Saint-Luc- Université Catholique de Louvain 1000 participants Est. completion 2025-10-25 1 site
    Other conditions: Severe Hypoglycemia, Type1diabetes
    View official trial listing →
  • Recruiting NCT NCT06803589

    Growth Hormone for the Treatment of Gastroparesis

    Not yet reported Mayo Clinic 10 participants Est. completion 2027-12 2 sites
    Other conditions: Gastroparesis
    View official trial listing →
  • Recruiting NCT NCT06825182

    Current Status of Islet Alpha Cell Function in Patients with Type 2 Diabetes

    Not yet reported Nanjing First Hospital, Nanjing Medical University 1000 participants Est. completion 2025-12-31 1 site
    Type 2 diabetes
    View official trial listing →
  • Recruiting NCT NCT06930625

    A Study to Assess the Efficacy and Safety of Debio 4126 in Participants With Acromegaly Previously Treated With Somatostatin Analogs

    Not yet reported Debiopharm International SA 119 participants Est. completion 2029-03 73 sites
    Other conditions: Acromegaly
    View official trial listing →
  • Recruiting NCT NCT06948214

    Phase 3 Study of LUM-201 in Children With Growth Hormone Deficiency

    Not yet reported Lumos Pharma 150 participants Est. completion 2028-01 51 sites
    Other conditions: Growth Hormone Deficiency (GHD)
    View official trial listing →
  • Recruiting NCT NCT07016802

    A Clinical Study of GenSci134 in Healthy Adults and Adult Growth Hormone Deficiency(AGHD)

    Not yet reported Changchun GeneScience Pharmaceutical Co., Ltd. 64 participants Est. completion 2026-11-25 1 site
    Other conditions: Safety, Tolerability, Adult Growth Hormone Deficiency
    View official trial listing →
  • Recruiting NCT NCT07129382

    A Study to Evaluate the Efficacy and Safety of CS32582 in Participants With Moderate to Severe Plaque Psoriasis

    Not yet reported, Not yet reported Chipscreen Biosciences, Ltd. 220 participants Est. completion 2027-09-18 11 sites
    Other conditions: Plaque Psoriasis
    View official trial listing →
  • Recruiting NCT NCT07171723

    Studying the Influence of LEAP2 on Integrated Endocrine Control of Eating During Semaglutide Treatment

    Not yet reported, Not yet reported University Hospital, Gentofte, Copenhagen 24 participants Est. completion 2026-02-01 1 site
    Other conditions: Obesity &Amp; Overweight
    View official trial listing →
  • Recruiting NCT NCT07221851

    Trial Investigating the Efficacy and Safety of Weekly Lonapegsomatropin Compared to Daily Somatropin in Children and Adolescents With Short Stature or Growth Failure Due to Growth Hormone Sufficient Disorders

    Not yet reported Ascendis Pharma A/S 186 participants Est. completion 2029-03 43 sites
    Other conditions: Turner Syndrome, Short Stature Homeobox Gene Mutation, Idiopathic Short Stature, Small for Gestational Age at Delivery
    View official trial listing →
  • Recruiting NCT NCT07226089

    Comparison of Weekly Somatrogon to Daily Genotropin in Children Born Small for Gestational Age or With Idiopathic Short Stature.

    Not yet reported Rabin Medical Center 254 participants Est. completion 2028-01 32 sites
    Other conditions: ISS, SGA
    View official trial listing →
  • Recruiting NCT NCT07260500

    A Phase II Study of PEG-rhGH Injection for Short Children Born Small for Gestational Age: Efficacy, Safety, and Pharmacokinetics

    Not yet reported Changchun GeneScience Pharmaceutical Co., Ltd. 72 participants Est. completion 2027-04-30 1 site
    Other conditions: Short Stature Children Born Small for Gestational Age (SGA)
    View official trial listing →
  • Recruiting NCT NCT07309562

    The Efficacy and Safety of Inpegsomatropin Injection in Children With Short Stature Born Small for Gestational Age

    Not yet reported Xiamen Amoytop Biotech Co., Ltd. 141 participants Est. completion 2028-05-07 49 sites
    Other conditions: Small for Gestational Age
    View official trial listing →
  • Recruiting NCT NCT07323329

    Growth Hormone and Dehydroepiandrosterone Role in Vitro Fertilization

    Not yet reported, Not yet reported Beni-Suef University 165 participants Est. completion 2026-11-12 1 site
    Other conditions: Infertility, Infertility (IVF Patients)
    View official trial listing →
  • Recruiting NCT NCT07359625

    Effects of Ketone Bodies on Insulin Sensitivity

    Not yet reported University of Aarhus 10 participants Est. completion 2028-04 1 site
    Other conditions: Insulin Resistance, Obesity & Overweight, Energy Metabolism, Ketone Body Metabolism
    View official trial listing →
  • Recruiting NCT NCT07481734

    Tesamorelin for Reduction of Liver Fat in Adults With Fatty Liver Disease (Mock Study)

    Not yet reported Hudson Biotech 120 participants Est. completion 2028-02-17 1 site
    MASH Other conditions: Metabolic Associated Steatotic Liver Disease, Hepatic Steatosis
    View official trial listing →
  • Recruiting NCT NCT07551804

    Safety, Pharmacokinetic (PK) Profile and Efficacy of Inpegsomatropin Injection in Adults With Growth Hormone Deficiency

    Not yet reported Xiamen Amoytop Biotech Co., Ltd. 36 participants Est. completion 2028-06-30 6 sites
    Other conditions: Adult Growth Hormone Deficiency
    View official trial listing →
  • Recruiting NCT NCT07553351

    GB06 Phase III Trial for Pediatric Growth Hormone Deficiency

    Not yet reported Kexing Biopharm Co., Ltd. 192 participants Est. completion 2028-10-24 1 site
    Other conditions: Growth Hormone Deficiency (GHD), Growth Hormone Deficiency in Children, Growth Hormone Deficiency, Pediatric
    View official trial listing →
  • Recruiting NCT NCT07643844

    AAVrh10-PCCA Gene Therapy for Propionic Acidemia

    Not yet reported Mayo Clinic 9 participants Est. completion 2033-12 1 site
    Other conditions: Propionic Acidemia
    View official trial listing →
  • Recruiting NCT NCT07691125

    Phase IV Study of rhGH Injection in Adult Short Bowel Syndrome

    Not yet reported Changchun GeneScience Pharmaceutical Co., Ltd. 100 participants Est. completion 2028-06-10 2 sites
    Other conditions: Short Bowel Syndrome (SBS) in Adults
    View official trial listing →
  • Recruiting NCT NCT07795736

    Charactertizing Growth Hormone Deficiency in Traumatic Brain Injury

    University of Calgary 200 participants Est. completion 2028-11-01 2 sites
    Other conditions: Growth Hormone Deficiency, Traumatic Brain Injury
    View official trial listing →
  • Completed NCT NCT00001221

    Effect of Biosynthetic Growth Hormone and/or Ethinyl Estradiol on Adult Height in Patients With Turner Syndrome

    Not yet reported Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) 160 participants Est. completion 2003-09 1 site
    Other conditions: Gonadal Dysgenesis, Turner's Syndrome
    View official trial listing →
  • Completed NCT NCT00001305

    Growth Hormone Therapy in Osteogenesis Imperfecta

    Not yet reported Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) 42 participants Est. completion 2017-05-19 1 site
    Other conditions: Osteogenesis Imperfecta
    View official trial listing →
  • Completed NCT NCT00001343

    The Effects of Hormones in Growth Hormone-Treated Girls With Turner Syndrome

    Not yet reported Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) 80 participants Est. completion 2007-10-10 2 sites
    Other conditions: Dwarfism, Turner's Syndrome
    View official trial listing →
  • Completed NCT NCT00001860

    Sandostatin LAR Depot vs. Surgery for Treating Acromegaly

    Not yet reported National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 5 participants Est. completion 2002-07 1 site
    Other conditions: Acromegaly, Pituitary Neoplasm
    View official trial listing →
  • Completed NCT NCT00001953

    The Functioning of Immune and Hormonal Systems in Patients With Sjogren's Syndrome and in Healthy Volunteers

    National Institute of Dental and Craniofacial Research (NIDCR) 32 participants Est. completion 2001-12 1 site
    Other conditions: Sjogren's Syndrome
    View official trial listing →
  • Withdrawn NCT NCT00003514

    Antineoplaston Therapy in Treating Patients With Neuroendocrine Tumor That Is Metastatic or Unlikely to Respond to Surgery or Radiation Therapy

    Not yet reported Burzynski Research Institute 1 site
    Other conditions: Merkel Cell Carcinoma, Islet Cell Carcinoma, Neuroendocrine Carcinoma, Pituitary Tumor
    View official trial listing →
  • Completed NCT NCT00004275

    Oxandrolone Compared With a Placebo on Growth Rate in Girls With Growth Hormone-Treated Turner's Syndrome

    Not yet reported National Institute of Neurological Disorders and Stroke (NINDS) 80 participants 1 site
    Other conditions: Turner's Syndrome
    View official trial listing →
  • Completed NCT NCT00004332

    Study of the Effect of Growth Hormone-Releasing Hormone Antagonist on Growth Hormone Release in Acromegaly

    National Center for Research Resources (NCRR) 148 participants
    Other conditions: Acromegaly
    View official trial listing →
  • Completed NCT NCT00004335

    Study of Gonadotropin-Releasing Hormone Pulse Frequency in Sexual Maturation and in the Menstrual Cycle

    National Center for Research Resources (NCRR) 1 site
    Other conditions: Hypogonadism, Precocious Puberty
    View official trial listing →
  • Completed NCT NCT00004340

    Phase II Randomized Study of the Effects of Growth Hormone on Children and Adolescents on Maintenance Dialysis

    Not yet reported National Center for Research Resources (NCRR) 109 participants 1 site
    Other conditions: Renal Osteodystrophy, End Stage Renal Disease
    View official trial listing →
  • Completed NCT NCT00004365

    Study of Pituitary Size and Function in Familial Dwarfism of Sindh

    National Center for Research Resources (NCRR) 4 participants Est. completion 2000-02
    Other conditions: Growth Hormone Deficiency
    View official trial listing →
  • Completed NCT NCT00004429

    Randomized Study of Recombinant Human Growth Hormone in Patients on Chronic Hemodialysis or Peritoneal Dialysis

    Not yet reported FDA Office of Orphan Products Development 25 participants Est. completion 2005-02 1 site
    Other conditions: Kidney Failure, Chronic
    View official trial listing →
  • Completed NCT NCT00004815

    Descriptive Study of Recombinant Human Insulin-Like Growth Factor for Osteoporosis in Werner's Syndrome

    Not yet reported National Center for Research Resources (NCRR) 1 participants
    Other conditions: Werner's Syndrome
    View official trial listing →
  • Completed NCT NCT00005112

    Growth Hormone Use in Cystic Fibrosis - a Multicenter Study

    Not yet reported National Center for Research Resources (NCRR) 2 sites
    Other conditions: Cystic Fibrosis
    View official trial listing →
  • Completed NCT NCT00006143

    Growth Hormone Treatment of Children With HIV-Associated Growth Failure

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 102 participants Est. completion 2002-07 20 sites
    Other conditions: HIV Infections
    View official trial listing →
  • Completed NCT NCT00006368

    Yttrium Y 90 SMT 487 in Treating Patients With Refractory or Recurrent Cancer

    Not yet reported Novartis Pharmaceuticals 60 participants Est. completion 2003-11 1 site
    Other conditions: Brain and Central Nervous System Tumors, Breast Cancer, Gastrointestinal Carcinoid Tumor, Islet Cell Tumor, Lung Cancer, Lymphoma, Melanoma (Skin), Neoplastic Syndrome
    View official trial listing →
  • Completed NCT NCT00006394

    Randomized Study of Growth Hormone on Bone Mineral Density in Patients With Adult Onset Growth Hormone Deficiency

    Not yet reported National Center for Research Resources (NCRR) 72 participants 7 sites
    Other conditions: Osteoporosis, Growth Hormone Deficiency
    View official trial listing →
  • Completed NCT NCT00016445

    Phase II Study of Growth Hormone in Children With Cystic Fibrosis

    Not yet reported University of Utah 40 participants 9 sites
    Other conditions: Cystic Fibrosis
    View official trial listing →
  • Completed NCT NCT00017927

    A Study of the Effects of Pegvisomant on Growth Hormone Excess in McCune-Albright Syndrome

    Not yet reported National Institute of Dental and Craniofacial Research (NIDCR) 10 participants Est. completion 2005-06 1 site
    Other conditions: McCune Albright Syndrome, Polyostotic Fibrous Dysplasia
    View official trial listing →
  • Completed NCT NCT00034060

    The Role of Cytokines on Growth Hormone Suppression in Premenopausal Women With Rheumatoid Arthritis and the Effect of Treatment With Etanercept

    Not yet reported National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) 36 participants Est. completion 2005-12 1 site
    Other conditions: Rheumatoid Arthritis, Healthy
    View official trial listing →
  • Completed NCT NCT00067860

    Diet/Growth Factor Mechanisms of Gut Adaptation

    Not yet reported Emory University 27 participants Est. completion 2006-12 1 site
    Other conditions: Short Bowel Syndrome
    View official trial listing →
  • Completed NCT NCT00071240

    Growth Hormone to Increase Immune Function in People With HIV

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 22 participants Est. completion 2007-09 1 site
    Other conditions: HIV Infections
    View official trial listing →
  • Completed NCT NCT00079742

    A Study to Evaluate Nutropin AQ for the Treatment of Growth Restriction in Children With Cystic Fibrosis

    Not yet reported Genentech, Inc. 68 participants Est. completion 2007-05
    Other conditions: Cystic Fibrosis
    View official trial listing →
  • Completed NCT NCT00080483

    Testosterone and Growth Hormone for Bone Loss in Men

    Not yet reported University of Pennsylvania 35 participants Est. completion 2010-09 1 site
    Other conditions: Hypopituitarism, Hypogonadism, Growth Hormone Deficiency
    View official trial listing →
  • Completed NCT NCT00082628

    Treatment of Abnormal Adipose Tissue Accumulation in Human Immunodeficiency Virus (HIV) Patients

    Not yet reported EMD Serono 326 participants Est. completion 2005-09-28 31 sites
    Other conditions: HIV Infections, Lipodystrophy
    View official trial listing →
  • Completed NCT NCT00088153

    Effects of Anorexia Nervosa on Bone Mass in Adolescents

    Not yet reported, Not yet reported Massachusetts General Hospital 110 participants Est. completion 2011-06 1 site
    Obstructive sleep apnea
    View official trial listing →
  • Completed NCT NCT00097513

    National Cooperative Growth Study (NCGS) of Optimal Nutropin AQ and Nutropin Dosing in Pubertal Growth Hormone-Deficient (GHD) Patients

    Genentech, Inc. Est. completion 2006-06 1 site
    Other conditions: Dwarfism, Pituitary
    View official trial listing →
  • Completed NCT NCT00097526

    Bone Mineral Density (BMD) in Adolescents With Growth Hormone Deficiency (GHD)

    Genentech, Inc. 125 participants Est. completion 2010-07
    Other conditions: Dwarfism, Pituitary, Turner Syndrome
    View official trial listing →
  • Completed NCT NCT00097539

    National Cooperative Growth Study (NCGS): A Post-marketing Surveillance Program for Nutropin, Nutropin AQ, Nutropin Depot, and Protropin

    Genentech, Inc. 65205 participants Est. completion 2010-06
    Other conditions: Growth Disorders
    View official trial listing →
  • Completed NCT NCT00097552

    A Study to Evaluate Subjects With Turner Syndrome Treated With Growth Hormone

    Genentech, Inc. 1696 participants Est. completion 2010-07
    Other conditions: Turner Syndrome
    View official trial listing →
  • Completed NCT NCT00097617

    A Study in Children With Growth Failure Due to Chronic Renal Insufficiency (CRI) or End Stage Renal Disease (ESRD)

    Genentech, Inc. 395 participants Est. completion 2010-07
    Other conditions: Chronic Renal Insufficiency, End-Stage Renal Disease
    View official trial listing →
  • Completed NCT NCT00100698

    Physiologic Growth Hormone Effects in HIV Lipodystrophy

    Not yet reported Massachusetts General Hospital 56 participants Est. completion 2009-04 1 site
    Other conditions: AIDS, HIV Infections
    View official trial listing →
  • Completed NCT NCT00102258

    Role of Nutrition and Hormones in Boys With Disordered Growth

    Not yet reported Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) 20 participants Est. completion 2007-10-02 1 site
    Other conditions: Short Stature, Constitutional Delay of Growth and Development, Dwarfism, Pituitary
    View official trial listing →
  • Completed NCT NCT00102817

    Somatropin (Norditropin) in Insulin-like Growth Factor (IGF) Deficient Children

    Not yet reported Novo Nordisk A/S 149 participants Est. completion 2006-12 27 sites
    Other conditions: Growth Hormone Disorder, Pituitary Dwarfism
    View official trial listing →
  • Completed NCT NCT00108225

    Effect of a High Protein Diet on the 24-hour Profile of Ghrelin, GH (Growth Hormone) and IGF-1 (Insulin-like Growth Factor-1)

    Not yet reported US Department of Veterans Affairs 8 participants Est. completion 2009-05 1 site
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT00109473

    Trial of Growth Hormone Therapy in Pediatric Crohn's Disease

    Not yet reported Children's Hospital Medical Center, Cincinnati 22 participants Est. completion 2009-08 1 site
    Other conditions: Crohn's Disease
    View official trial listing →
  • Completed NCT NCT00109733

    Cool.Click™ Adolescent Transition Study: Study of Saizen® in Subjects With Childhood-onset Growth Hormone Deficiency

    Not yet reported EMD Serono 31 participants Est. completion 2006-07 9 sites
    Other conditions: Childhood-onset Growth Hormone Deficiency, Pituitary Dwarfism
    View official trial listing →
  • Completed NCT NCT00116129

    Efficacy and Safety of an Oral Growth Hormone Drug in the Treatment of Fibromyalgia

    Not yet reported Bennett, Robert, M.D. 64 participants Est. completion 2008-04 1 site
    Other conditions: Fibromyalgia
    View official trial listing →
  • Status unknown NCT NCT00120497

    Study to Examine Insulin Resistance During Growth Hormone Treatment for Short Stature Due to Low Birthweight

    Massachusetts General Hospital 12 participants Est. completion 2011-12 1 site
    Other conditions: Fetal Growth Retardation
    View official trial listing →
  • Terminated NCT NCT00121875

    Study to Identify Markers of Insulin Resistance During Growth Hormone Treatment for Short Stature

    Massachusetts General Hospital 1 participants Est. completion 2008-12 1 site
    Other conditions: Turner Syndrome, Idiopathic Short Stature
    View official trial listing →
  • Completed NCT NCT00130286

    Growth Hormone and/or Rosiglitazone for HIV-Associated Increased Abdominal Fat and Insulin Resistance

    Not yet reported, Not yet reported Weill Medical College of Cornell University 77 participants Est. completion 2010-08 4 sites
    Metabolic syndrome Other conditions: HIV-Associated Lipodystrophy Syndrome, Insulin Resistance, HIV Infections, Body Weight Changes
    View official trial listing →
  • Completed NCT NCT00131378

    Growth Hormone, Cardiovascular Risk, and Visceral Adiposity

    Not yet reported Massachusetts General Hospital 142 participants Est. completion 2013-06 1 site
    Other conditions: Obesity
    View official trial listing →
  • Completed NCT NCT00133354

    Arimidex Multicenter Trial in Growth Hormone (GH) Deficient Boys

    Not yet reported, Not yet reported Nemours Children's Clinic 53 participants Est. completion 2010-08 1 site
    Other conditions: Hypopituitarism
    View official trial listing →
  • Completed NCT NCT00134420

    Growth Hormone and Chromosome 18q- and Abnormal Growth

    Not yet reported The University of Texas Health Science Center at San Antonio 20 participants Est. completion 2005-06 1 site
    Other conditions: Loss of Chromosome 18q, Growth Hormone Deficiency
    View official trial listing →
  • Completed NCT NCT00139945

    Ghrelin, Growth Hormone and Cortisol Interaction in Growth Hormone Deficient Patients

    Not yet reported University of Aarhus 8 participants Est. completion 2007-03 1 site
    Other conditions: Hypopituitarism
    View official trial listing →
  • Completed NCT NCT00140842

    Neuroendocrine Modulation of Metabolic Effects in Overweight Adolescents

    Massachusetts General Hospital 47 participants Est. completion 2007-06 1 site
    Other conditions: Obesity
    View official trial listing →
  • Completed NCT NCT00145340

    Pioglitazone Treatment in Polycystic Ovary Syndrome

    Not yet reported Odense University Hospital 30 participants Est. completion 2007-01 1 site
    Other conditions: Polycystic Ovary Syndrome
    View official trial listing →
  • Completed NCT NCT00145457

    IGF1 Generation Test

    Not yet reported Pfizer 82 participants Est. completion 2005-01 8 sites
    Other conditions: Growth Hormone Deficiency
    View official trial listing →
  • Terminated NCT NCT00145704

    Study of Adults With Low Growth Hormone Who Survived Childhood Cancer Where Treatment Caused Low Bone Density

    Not yet reported State University of New York - Upstate Medical University 6 participants Est. completion 2008-10 1 site
    Other conditions: Osteopenia
    View official trial listing →
  • Completed NCT NCT00149708

    Consequence of Lifetime Isolated Growth Hormone Deficiency

    Not yet reported National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 400 participants Est. completion 2009-12 1 site
    Other conditions: Growth Hormone Deficiency
    View official trial listing →
  • Completed NCT NCT00156143

    Transition Study: Growth Hormone Therapy In Partial Growth Hormone Deficient Adolescents

    Not yet reported Pfizer 90 participants Est. completion 2005-04
    Other conditions: Growth Hormone Deficiency
    View official trial listing →
  • Completed NCT NCT00163189

    Evolution Of Growth Rate In Children With Growth Retardation Due to Glucocorticosteroid Therapy And Treated By Genotonorm

    Not yet reported Pfizer 98 participants Est. completion 2014-12 19 sites
    Other conditions: Growth Hormone Deficiency
    View official trial listing →
  • Completed NCT NCT00163215

    Growth Retardation In Children With Special Pathological Conditions Or Disease

    Not yet reported Pfizer 46 participants Est. completion 2011-10 18 sites
    Other conditions: Endocrine System Diseases
    View official trial listing →
  • Completed NCT NCT00169637

    Evaluation of the Efficacy and Safety of Recombinant Human Growth Hormone (rhGH) in the Treatment of Children With Short Bowel Syndrome

    Not yet reported Hospices Civils de Lyon 14 participants Est. completion 2008-06 1 site
    Other conditions: Short Bowel Syndrome
    View official trial listing →
  • Terminated NCT NCT00174187

    Treatment With Recombinant Human Growth Hormone (GH) in Children With Short Stature Secondary to a Long Term Corticoid Therapy

    Not yet reported Pfizer 30 participants Est. completion 2011-09 2 sites
    Other conditions: Endocrine System Diseases
    View official trial listing →
  • Completed NCT NCT00174252

    Study Aimed At Improving Height With Genotonorm In Children Born Little And/Or Light With Growth Retardation At The Age

    Not yet reported Pfizer 57 participants Est. completion 2009-04 22 sites
    Other conditions: Fetal Growth Retardation
    View official trial listing →
  • Completed NCT NCT00174278

    Treatment With Recombinant Human Growth Hormone Genotonorm (Registered) In Children With Short Stature Secondary

    Not yet reported Pfizer 14 participants Est. completion 2006-10 1 site
    Other conditions: Growth Hormone Deficiency, Growth Retardation
    View official trial listing →
  • Terminated NCT NCT00174291

    Prevention of Growth Retardation by Early Treatment With Growth Hormone (GH) in Children With CJA Treated by Corticosteroid Therapy

    Not yet reported Pfizer 21 participants Est. completion 2011-10 1 site
    Other conditions: Endocrine System Diseases
    View official trial listing →
  • Completed NCT NCT00174408

    Treatment Of Children With Short Stature At An Age Of 3-7 Years Who Were Born Small For Gestational Age

    Not yet reported Pfizer 110 participants Est. completion 2005-02
    Other conditions: Growth Disorders
    View official trial listing →
  • Completed NCT NCT00174421

    Treatment Of Short Stature With Genotropin In Children Born Small For Gestational Age Until Final Height

    Not yet reported Pfizer 36 participants Est. completion 2005-08
    Other conditions: Growth Disorder
    View official trial listing →
  • Completed NCT NCT00174460

    Somatropin Therapy In Children Born Preterm But Appropriate For Gestational Age

    Not yet reported Pfizer 33 participants Est. completion 2010-03 8 sites
    Other conditions: Growth Hormone Therapy, Infant, Very Low Birth Weight
    View official trial listing →
  • Completed NCT NCT00182091

    Effects of Growth Hormone Administration on Cardiovascular Risk in Cured Acromegalics With Growth Hormone Deficiency

    Not yet reported Massachusetts General Hospital 75 participants Est. completion 2010-12 1 site
    Other conditions: Acromegaly, Growth Hormone Deficiency, Pituitary Disease
    View official trial listing →
  • Completed NCT NCT00182169

    Evaluation of the Effect of Human Recombinant Growth Hormone in Patients With Advanced Heart Failure

    Not yet reported Hamilton Health Sciences Corporation 80 participants Est. completion 2005-06 1 site
    Heart failure
    View official trial listing →
  • Completed NCT NCT00184652

    Growth Hormone Treatment in Adult Patients With Chronic Kidney Disease

    Not yet reported Novo Nordisk A/S 140 participants Est. completion 2005-09 26 sites
    Chronic kidney disease Other conditions: End-Stage Renal Disease
    View official trial listing →
  • Completed NCT NCT00184678

    Effect of Growth Hormone on Bone Mineral Density in Young Adults With Child-hood Onset Growth Hormone Deficiency

    Not yet reported Novo Nordisk A/S 161 participants Est. completion 2006-07 30 sites
    Other conditions: Growth Hormone Disorder, Adult Growth Hormone Deficiency
    View official trial listing →
  • Completed NCT NCT00184691

    Growth Hormone Treatment of Children Born With Retarded Intrauterine Growth at Age 2-5 Years

    Not yet reported Novo Nordisk A/S 78 participants Est. completion 2005-06 13 sites
    Other conditions: Foetal Growth Problem, Small for Gestational Age
    View official trial listing →
  • Completed NCT NCT00184717

    Growth Hormone Treatment in Children Born Small for Gestational Age (SGA)

    Not yet reported Novo Nordisk A/S 98 participants Est. completion 2009-12-28 1 site
    Other conditions: Foetal Growth Problem, Small for Gestational Age
    View official trial listing →
  • Completed NCT NCT00184730

    Long-term Trial on Growth Hormone Deficiency in Adults (GHDA)

    Not yet reported Novo Nordisk A/S 86 participants Est. completion 2006-09 1 site
    Other conditions: Growth Hormone Disorder, Adult Growth Hormone Deficiency
    View official trial listing →
  • Completed NCT NCT00184743

    Long-term Trial on Growth Hormone Deficiency in Adults (GHDA)

    Not yet reported Novo Nordisk A/S 112 participants Est. completion 2005-12-28 1 site
    Other conditions: Growth Hormone Disorder, Adult Growth Hormone Deficiency
    View official trial listing →
  • Completed NCT NCT00184769

    Growth Hormone Treatment in Infants Aged 1 to 2 Years With Chronic Renal Insufficiency (CRI) and Growth Retardation.

    Not yet reported Novo Nordisk A/S 16 participants Est. completion 2005-12-21 20 sites
    Chronic kidney disease Other conditions: Chronic Renal Insufficiency
    View official trial listing →
  • Status unknown NCT NCT00187993

    Growth Hormone Treatment of Young Growth Hormone-Deficient Adults

    University Hospital, Angers 30 participants Est. completion 2005-08 6 sites
    Other conditions: Growth Hormone Deficiency
    View official trial listing →
  • Completed NCT NCT00190658

    Somatropin Treatment in Patients With SHOX Deficiency and Turner Syndrome

    Not yet reported Eli Lilly and Company 75 participants Est. completion 2010-09 1 site
    Other conditions: Failure to Thrive
    View official trial listing →
  • Completed NCT NCT00191113

    Somatropin Treatment to Final Height in Turner Syndrome

    Not yet reported Eli Lilly and Company 154 participants Est. completion 2007-12 14 sites
    Other conditions: Turner Syndrome
    View official trial listing →
  • Completed NCT NCT00191165

    Efficacy and Safety of a High Dosage Compared to the Label Dosage of Somatropin in Early Pubertal Stage Children With Growth Hormone Deficiency

    Not yet reported Eli Lilly and Company 27 participants Est. completion 2008-04 10 sites
    Other conditions: Growth Hormone Deficiency
    View official trial listing →
  • Completed NCT NCT00191360

    Extension Study on Safety of Long-Term Growth Hormone Replacement in Adult Patients With Growth Hormone Deficiency

    Not yet reported Eli Lilly and Company 68 participants Est. completion 2006-05 14 sites
    Other conditions: Adult Growth Hormone Deficiency
    View official trial listing →
  • Completed NCT NCT00191529

    Growth Hormone Treatment in Short Children Born Small for Gestational Age

    Not yet reported Eli Lilly and Company 200 participants Est. completion 2007-06 1 site
    Other conditions: Infant, Small for Gestational Age
    View official trial listing →
  • Suspended NCT NCT00194883

    Effect of Cytokines on Growth of Children With Chronic Kidney Failure

    Not yet reported Weill Medical College of Cornell University 50 participants Est. completion 2003-05 1 site
    Other conditions: Chronic Renal Insufficiency
    View official trial listing →
  • Terminated NCT NCT00194961

    Effect of Growth Hormone on Leptin, Cytokines and Body Composition of Children With Growth Failure Due to Chronic Kidney Disease

    Not yet reported Weill Medical College of Cornell University 15 participants Est. completion 2007-12 1 site
    Chronic kidney disease
    View official trial listing →
  • Terminated NCT NCT00206375

    Growth Hormone and GnRH Agonist in Adolescents With Acquired Hypothyroidism

    Not yet reported Baylor College of Medicine 16 participants Est. completion 2011-11 1 site
    Other conditions: Hypothyroidism
    View official trial listing →
  • Active, not recruiting NCT NCT00209235

    Albright Hereditary Osteodystrophy: Natural History, Growth, and Cognitive/Behavioral Assessments

    Not yet reported Connecticut Children's Medical Center 600 participants Est. completion 2030-12 1 site
    Other conditions: Pseudohypoparathyroidism Type 1A, Albright Hereditary Osteodystrophy, Pseudopseudohypoparathyroidism
    View official trial listing →
  • Completed NCT NCT00212758

    A Study to Optimize Growth Hormone Dosing in Children With Chronic Kidney Disease by Measuring IGF-1 Levels in Blood

    Not yet reported Oregon Health and Science University 17 participants Est. completion 2010-05 8 sites
    Other conditions: Kidney Failure, Chronic, Growth Hormone Deficiency
    View official trial listing →
  • Completed NCT NCT00216398

    Lanreotide Autogel in Patients With Acromegaly Previously Treated With Octreotide LAR

    Not yet reported Ipsen 8 participants Est. completion 2006-06-22 1 site
    Other conditions: Acromegaly
    View official trial listing →
  • Completed NCT NCT00234533

    Study to Define Optimal IGF-1 Monitoring in Children Treated With NutropinAq

    Not yet reported Ipsen 251 participants Est. completion 2008-07 45 sites
    Other conditions: Turner Syndrome, Renal Insufficiency, Chronic, Pituitary Diseases, Dwarfism
    View official trial listing →
  • Completed NCT NCT00235599

    The IGFBP-3 Stimulation Test: A New Tool for the Diagnosis of Growth Hormone Deficiency in Children.

    University of Massachusetts, Worcester 10 participants Est. completion 2006-10 1 site
    Other conditions: Short Stature, Growth Hormone Deficiency
    View official trial listing →
  • Completed NCT NCT00244075

    Effects of Nutritional Supplementation on Protein and Energy Homeostasis in Malnourished Chronic Hemodialysis Patients

    Not yet reported Vanderbilt University 46 participants Est. completion 2006-08 1 site
    Other conditions: End Stage Renal Disease
    View official trial listing →
  • Completed NCT NCT00249821

    Optimization of the Dosage Regimen of Growth Hormone Therapy in Children Born Small for Gestational Age

    Not yet reported Merck KGaA, Darmstadt, Germany 22 participants Est. completion 2007-09-30
    Other conditions: Small Gestational Age (SGA)
    View official trial listing →
  • Completed NCT NCT00250250

    An Open-Label, Multi-centre, Phase III Study of Local Tolerability of ZOMACTON 10MG

    Not yet reported Ferring Pharmaceuticals 27 participants Est. completion 2006-08 6 sites
    Other conditions: Turner's Syndrome
    View official trial listing →
  • Completed NCT NCT00254514

    Controlled Study to Evaluate the Efficacy and Safety of the Treatment With Growth Hormone in Tibia Fractures

    Not yet reported Novo Nordisk A/S 407 participants Est. completion 2003-10 40 sites
    Other conditions: Bone Fracture, Tibia Fractures
    View official trial listing →
  • Completed NCT NCT00255671

    Acute Side Effects in Patients Who Are Undergoing Stereotactic Radiosurgery for Brain Tumors or Other Brain Disorders

    Case Comprehensive Cancer Center 76 participants Est. completion 2012-05 1 site
    Other conditions: Brain and Central Nervous System Tumors, Metastatic Cancer, Radiation Toxicity
    View official trial listing →
  • Withdrawn NCT NCT00256555

    Growth Hormone Treatment Study in Children With Cystic Fibrosis

    Not yet reported, Not yet reported University of Texas Southwestern Medical Center Est. completion 2018-12-12
    Other conditions: Cystic Fibrosis
    View official trial listing →
  • Completed NCT NCT00257712

    SMART: Somatotrophics, Memory, and Aging Research Trial

    Not yet reported University of Washington 151 participants Est. completion 2011-12 1 site
    Other conditions: Aging, Mild Cognitive Impairment
    View official trial listing →
  • Completed NCT NCT00262249

    Effect of Growth Hormone in Children With Growth Hormone Deficiency

    Not yet reported Novo Nordisk A/S 173 participants Est. completion 2004-05 40 sites
    Other conditions: Growth Hormone Disorder, Growth Hormone Deficiency in Children, Growth Disorder, Idiopathic Short Stature
    View official trial listing →
  • Terminated NCT NCT00263445

    Constructing an Insulin-Like Growth Factor-based Prediction Model

    University of California, Los Angeles 30 participants Est. completion 2012-07 1 site
    Other conditions: Growth Hormone Deficiency, Idiopathic Short Stature, Small for Gestational Age
    View official trial listing →
  • Completed NCT NCT00266656

    Long-Term Growth and Skeletal Effects of Early Growth Hormone Treatment in Turner Syndrome

    Not yet reported Eli Lilly and Company 69 participants Est. completion 2015-09 9 sites
    Other conditions: Turner Syndrome
    View official trial listing →
  • Status unknown NCT NCT00271518

    Treatment of Children With Insufficient Secretion of Growth Hormone

    Not yet reported LG Life Sciences 144 participants 1 site
    Other conditions: Growth Hormone Deficiency (GHD)
    View official trial listing →
  • Completed NCT NCT00283595

    Effect of Growth Hormone on Bone Metabolism in Anorexia Nervosa

    Not yet reported Massachusetts General Hospital 21 participants Est. completion 2009-02 1 site
    Obstructive sleep apnea Other conditions: Osteopenia, Osteoporosis, Eating Disorders
    View official trial listing →
  • Withdrawn NCT NCT00286676

    The Use of Nutropin Depot in HIV-infected Adult Males

    Not yet reported, Not yet reported University of Texas Southwestern Medical Center Est. completion 2006-02-01 3 sites
    Other conditions: HIV Infection
    View official trial listing →
  • Withdrawn NCT NCT00286689

    Effects of Growth Hormone in Chronically Ill Children

    Not yet reported University of Texas Southwestern Medical Center Est. completion 2006-02-03 1 site
    Other conditions: Hurler Syndrome, Cerebral Palsy, Juvenile Rheumatoid Arthritis, Crohn Disease, HIV Infections
    View official trial listing →
  • Withdrawn NCT NCT00287430

    Growth Hormone Use in Adolescents and Adults With Cystic Fibrosis

    Not yet reported University of Texas Southwestern Medical Center Est. completion 2006-01
    Other conditions: Cystic Fibrosis
    View official trial listing →
  • Withdrawn NCT NCT00287443

    Metabolic Abnormalities in Hispanic Children With Cystic Fibrosis

    Not yet reported University of Texas Southwestern Medical Center Est. completion 2006-02-02 1 site
    Other conditions: Cystic Fibrosis
    View official trial listing →
  • Completed NCT NCT00287677

    Induction and Expansion of T Cell Repertoire Using Growth Hormone and Vaccination in HIV-1 Infected Patients

    Not yet reported Germans Trias i Pujol Hospital 33 participants Est. completion 2009-07 2 sites
    Other conditions: HIV Infections
    View official trial listing →
  • Completed NCT NCT00294164

    Safety and Efficacy Trial of Serostim® in the Treatment of Subjects With Human Immunodeficiency Virus-associated Adipose Redistribution Syndrome (HARS)

    Not yet reported, Not yet reported EMD Serono 245 participants Est. completion 2002-05
    Other conditions: Human Immunodeficiency Virus-associated Adipose Redistribution Syndrome (HARS), Human Immunodeficiency Virus Infections
    View official trial listing →
  • Completed NCT NCT00294619

    Treatment of Adults With Growth Hormone Deficiency

    Not yet reported LG Life Sciences 147 participants Est. completion 2008-03 1 site
    Other conditions: Pituitary Disorders, Adult Growth Hormone Deficiency
    View official trial listing →
  • Completed NCT NCT00294918

    An Efficacy and Safety Trial of Serostim® in the Maintenance of the Treatment Effect Obtained During the Study of Serostim® in Human Immunodeficiency Virus-associated Adipose Redistribution Syndrome

    Not yet reported, Not yet reported EMD Serono 142 participants Est. completion 2003-02
    Other conditions: Human Immunodeficiency Virus-associated Adipose Redistribution Syndrome (HARS), Human Immunodeficiency Virus Infections
    View official trial listing →
  • Completed NCT NCT00297713

    Study of an Extended-Release, Crystalline Formulation of Recombinant Human Growth Hormone (ALTU-238) in Growth Hormone Deficient Adults to Determine Pharmacokinetics, Pharmacodynamics, and Drug Safety

    Not yet reported Altus Pharmaceuticals 12 participants Est. completion 2006-06 3 sites
    Other conditions: Adult Growth Hormone Deficiency
    View official trial listing →
  • Completed NCT NCT00300664

    A Randomized Trial of Human Growth Hormone (hGH) vs Placebo in Intensively Treated Haemato-Oncology Patients.

    Not yet reported, Not yet reported Royal Marsden NHS Foundation Trust 150 participants Est. completion 2005-04
    Other conditions: Multiple Myeloma, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Myelodysplastic Syndrome
    View official trial listing →
  • Terminated NCT NCT00308464

    A Study To Evaluate The Dose Response And Safety Of PHA-794428 In Adults With Growth Hormone Deficiency

    Not yet reported Pfizer 136 participants Est. completion 2007-12 35 sites
    Other conditions: Growth Hormone Deficiency
    View official trial listing →
  • Completed NCT NCT00309855

    Testosterone-Driven Growth-Hormone (GH) Secretion in Aging Men

    Not yet reported Mayo Clinic 80 participants Est. completion 2008-08 1 site
    Other conditions: Aging
    View official trial listing →
  • Terminated NCT NCT00314938

    A Single Dose Study to Evaluate the PK-PD Response and Safety of PHA-794428 in Children With Growth Hormone Deficiency

    Not yet reported Pfizer 32 participants Est. completion 2007-11 7 sites
    Other conditions: Growth Hormone Deficiency
    View official trial listing →
  • Completed NCT NCT00334945

    Evaluate the Effect of Growth Hormone (GH) Treatment on Fibroblast Growth Factor 23, a Known Phosphaturic Agent

    University of Alabama at Birmingham 35 participants Est. completion 2011-08
    Other conditions: Growth Disorders
    View official trial listing →
  • Completed NCT NCT00352287

    Study to Determine the Effects of Human Growth Hormone and Pioglitazone in Overweight, Prediabetic Adults

    Not yet reported Stanford University 60 participants Est. completion 2005-04 1 site
    Metabolic syndromePrediabetes Other conditions: Obesity
    View official trial listing →
  • Completed NCT NCT00355030

    Somatropin + Leuprorelin vs Somatropin Alone in Pubertal Children With Idiopathic Short Stature

    Not yet reported Eli Lilly and Company 91 participants Est. completion 2015-07 19 sites
    Other conditions: Idiopathic Short Stature (ISS)
    View official trial listing →
  • Completed NCT NCT00355784

    Growth Hormone as a Determinant of Weight Regulation

    Not yet reported University of Michigan 24 participants Est. completion 2015-12 1 site
    Other conditions: Obesity
    View official trial listing →
  • Status unknown NCT NCT00362063

    304-C03/L3301n: Effects of Growth Hormone on Glucose and Protein Metabolism in Children With Growth Hormone Deficiency

    Not yet reported Baylor College of Medicine 20 participants Est. completion 2018-04 1 site
    Other conditions: Growth Hormone Deficiency
    View official trial listing →
  • Completed NCT NCT00368173

    IGF-I/IGFBP-3 Therapy in Children and Adolescents With Growth Hormone Insenitivity Syndrome (GHIS) Such as Laron Syndrome

    Not yet reported, Not yet reported Insmed Incorporated 15 sites
    Other conditions: Growth Hormone Insensitivity Syndrome (GHIS), Laron Syndrome
    View official trial listing →
  • Completed NCT NCT00372125

    Nordic Study on the Effects of Growth Hormone (Norditropin SimpleXx) Treatment in Adults With Prader-Willi Syndrome

    Not yet reported Karolinska University Hospital 46 participants Est. completion 2010-03 3 sites
    Other conditions: Prader-Willi Syndrome
    View official trial listing →
  • Completed NCT NCT00376064

    Efficacy of Octreotide Acetate and Cabergoline in Patients With Acromegaly

    Not yet reported Novartis Pharmaceuticals 20 participants 16 sites
    Other conditions: Acromegaly
    View official trial listing →
  • Completed NCT NCT00395291

    Growth Hormone Secretagogue MK-0677 Effect on IGF-1 Levels in ESRD Patients

    Not yet reported University of Virginia 49 participants Est. completion 2010-05 1 site
    Chronic kidney disease Other conditions: End Stage Renal Disease
    View official trial listing →
  • Completed NCT NCT00396097

    Individualized, Target-Driven Treatment Of Children With Idiopathic Short Stature

    Not yet reported Pfizer 316 participants Est. completion 2012-08 43 sites
    Other conditions: Idiopathic Short Stature
    View official trial listing →
  • Terminated NCT NCT00397319

    Growth Hormone's Effect on the Cardiovascular System

    Vanderbilt University 26 participants Est. completion 2006-12 1 site
    Other conditions: Growth Hormone Deficiency
    View official trial listing →
  • Completed NCT NCT00397592

    Growth Hormone's Effect on Endothelial Progenitor Cells

    Not yet reported Vanderbilt University 18 participants Est. completion 2007-01 1 site
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT00406926

    The Effect of Growth Hormone in Very Young Girls With Turner Syndrome

    Not yet reported Eli Lilly and Company 100 participants Est. completion 2003-08 10 sites
    Other conditions: Turner Syndrome
    View official trial listing →
  • Completed NCT NCT00420654

    Growth Hormone Treatment of Women With Turner Syndrome

    Not yet reported Britta E. Hjerrild 24 participants Est. completion 2011-09 1 site
    Other conditions: Turner Syndrome
    View official trial listing →
  • Withdrawn NCT NCT00432263

    Treatment Of Adult Growth Hormone Deficiency After Traumatic Brain Injury.

    Not yet reported Pfizer
    Other conditions: Brain Injuries
    View official trial listing →
  • Completed NCT NCT00438503

    Glucose in Dialysis Water in Diabetics With Chronic Renal Failure

    Not yet reported Regional Hospital Holstebro 18 participants Est. completion 2007-05 1 site
    Other conditions: Renal Failure, Chronic, Diabetic Nephropathies
    View official trial listing →
  • Completed NCT NCT00443144

    D3-GHR Polymorphism and Turner Syndrome

    University Hospital Tuebingen Est. completion 2007-05 1 site
    Other conditions: Turner Syndrome, Short Stature
    View official trial listing →
  • Completed NCT NCT00444873

    Effect of 120mg Somatuline Autogel at Different Dose Intervals (28, 42 or 56 Days) in Patients With Acromegaly

    Not yet reported Ipsen 38 participants Est. completion 2008-01 1 site
    Other conditions: Acromegaly
    View official trial listing →
  • Completed NCT NCT00444964

    Growth Hormone Use in Adults With Prader-Willi Syndrome

    Not yet reported Children's Mercy Hospital Kansas City 11 participants Est. completion 2012-01-01 1 site
    Other conditions: Prader-Willi Syndrome
    View official trial listing →
  • Completed NCT NCT00448747

    Investigation of a New, Oral Growth Hormone Secretagogue, AEZS-130 as a Growth Hormone Stimulation Test.

    Not yet reported AEterna Zentaris 101 participants Est. completion 2011-07 13 sites
    Other conditions: Diagnosis of Adult Growth Hormone Deficiency (AGDH)
    View official trial listing →
  • Completed NCT NCT00450190

    Saizen® E-Device User Trial

    Not yet reported Merck KGaA, Darmstadt, Germany 20 participants Est. completion 2006-09-30
    Other conditions: Growth Disorders
    View official trial listing →
  • Completed NCT NCT00452725

    Effect of MAXOMAT ® on the Growth of Small Children to NOONAN's Syndrome

    Not yet reported Sanofi 36 participants Est. completion 2010-07 1 site
    Other conditions: Noonan Syndrome
    View official trial listing →
  • Completed NCT NCT00455260

    A Multi-Dose Study to Assess Tolerability, Safety and Pharmacology of hGH-ViaDerm™ System in Adults With GH-Deficiency

    Not yet reported Teva Neuroscience, Inc. 60 participants
    Other conditions: Growth Hormone Deficiency
    View official trial listing →
  • Completed NCT NCT00455728

    A Post Marketing Surveillance Program for NutropinAq® in Paediatric Growth Disorders

    Ipsen 3690 participants Est. completion 2016-12 1 site
    Other conditions: Growth Hormone Disorders
    View official trial listing →
  • Completed NCT NCT00455884

    A Post Marketing Surveillance Study for NutropinAq® in Adults With Growth Hormone Deficiency

    Ipsen 546 participants Est. completion 2011-12 1 site
    Other conditions: Growth Hormone Disorders
    View official trial listing →
  • Completed NCT NCT00458263

    Biochemical Markers of Growth Response to Growth Hormone Treatment in Children With Idiopathic Short Stature

    Not yet reported Rabin Medical Center 21 participants Est. completion 2011-05 1 site
    Other conditions: Idiopathic Short Stature
    View official trial listing →
  • Completed NCT NCT00458991

    rhGH Therapy on Hepatic Drug Metabolism

    University of Louisville 9 participants Est. completion 2008-09 4 sites
    Other conditions: Growth Hormone Deficiency, Dwarfism
    View official trial listing →
  • Completed NCT NCT00461240

    Cardiac and Skeletal Muscle Energy Metabolism in Abnormal Growth Hormone States

    Barts & The London NHS Trust 25 participants Est. completion 2011-12 1 site
    Other conditions: Acromegaly, Growth Hormone Deficiency
    View official trial listing →
  • Completed NCT NCT00462475

    Effect of 5 Years of GH Replacement on Atherosclerosis

    Federico II University 20 participants Est. completion 2006-12 1 site
    Other conditions: Hypopituitarism, Pituitary Tumors, Growth Hormone Deficiency
    View official trial listing →
  • Completed NCT NCT00467909

    Nutrition and Cognition in Indian Children

    Not yet reported St. John's Research Institute 600 participants Est. completion 2007-03-31 1 site
    Other conditions: Healthy
    View official trial listing →
  • Terminated NCT NCT00468624

    Effect of Pegvisomant on GH/IGF-I Relationship in GHD

    Not yet reported The Christie NHS Foundation Trust Est. completion 2005-07 1 site
    Other conditions: Severe Adult Growth Hormone Deficiency
    View official trial listing →
  • Completed NCT NCT00470002

    Effects of Growth Hormone on the Nitric Oxide Pathway

    Not yet reported Hannover Medical School 16 participants Est. completion 2005-01 1 site
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT00474279

    Effects of an Oral GH Secretagogue (MK-677) on Body Composition and Functional Ability of Older Adults

    Not yet reported, Not yet reported University of Virginia 72 participants Est. completion 2004-06 1 site
    Other conditions: Aging
    View official trial listing →
  • Completed NCT NCT00476879

    Growth Hormone During Fasting.Signaltransduktion in Muscle and Adipose Tissue and Changes in Intrahepatic Lipid Content

    Not yet reported University of Aarhus 10 participants Est. completion 2008-06 1 site
    Other conditions: Metabolism, Fatty Liver
    View official trial listing →
  • Completed NCT NCT00486161

    Acylated Ghrelin Response to Acute Exercise in Obesity

    Istituto Auxologico Italiano 16 participants Est. completion 2006-12 1 site
    Other conditions: Obesity
    View official trial listing →
  • Completed NCT NCT00488124

    Growth Response in Short Children Suffering From a Disease With Growth Retardation and Treated With Somatropin

    Not yet reported University of Erlangen-Nürnberg Medical School 120 participants Est. completion 2011-03 13 sites
    Other conditions: Idiopathic Short Stature
    View official trial listing →
  • Completed NCT NCT00489294

    Safety Study of Syntropin (Human Growth Hormone) for the Treatment of Growth Hormone Deficiency

    Not yet reported Phage Pharmaceuticals, Inc. 20 participants Est. completion 2005-06 1 site
    Other conditions: Growth Hormone Deficiency
    View official trial listing →
  • Completed NCT NCT00489528

    Growth Hormone in the Treatment of HIV-Associated Wasting

    Not yet reported EMD Serono Est. completion 2002-03
    Other conditions: HIV Infections, HIV Wasting Syndrome
    View official trial listing →
  • Terminated NCT NCT00490100

    Treatment for Growth Failure in Patients With X-Linked Severe Combined Immunodeficiency: Phase 2 Study of Insulin-Like Growth Factor-1

    Not yet reported, Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 6 participants Est. completion 2012-12 1 site
    Other conditions: Growth Failure, X-linked Severe Combined Immunodeficiency (XSCID), Growth Hormone Resistence
    View official trial listing →
  • Completed NCT NCT00490191

    Comparison of Two Growth Hormone Dosing Methods in Adults With Growth Hormone Deficiency

    Not yet reported Eli Lilly and Company 387 participants Est. completion 2001-07 26 sites
    Other conditions: Hypopituitarism
    View official trial listing →
  • Completed NCT NCT00491582

    The Effects of Growth Hormone (GH) on Lipid Depots

    Not yet reported Insel Gruppe AG, University Hospital Bern 34 participants Est. completion 2013-06 1 site
    Other conditions: Growth Hormone Deficiency
    View official trial listing →
  • Status unknown NCT NCT00497484

    Evaluation of rhGH Replacement Therapy in Patients With Pseudohypoparathyroidism Type Ia (PHP Ia)

    Not yet reported University of Milan 1 site
    Other conditions: Pseudohypoparathyroidism, Growth Hormone Deficiency, Dwarfism
    View official trial listing →
  • Completed NCT NCT00501514

    Effects of Growth Hormone on Exercise Capacity

    Not yet reported Federico II University 22 participants Est. completion 2005-11 1 site
    Heart failure
    View official trial listing →
  • Terminated NCT NCT00511329

    Growth Hormone in Children With Juvenile Rheumatoid Arthritis (JRA) and With Crohn's Disease

    Not yet reported, Not yet reported Nationwide Children's Hospital 10 participants Est. completion 2010-05 1 site
    Other conditions: Arthritis, Juvenile Rheumatoid, Crohn Disease
    View official trial listing →
  • Completed NCT NCT00511927

    Growth Hormone Deficiency in Chronic Heart Failure: an Observational Study

    Federico II University 250 participants Est. completion 2014-02 1 site
    Heart failure Other conditions: Ischemic Heart Disease, Cardiomyopathy, Growth Hormone Deficiency
    View official trial listing →
  • Completed NCT NCT00512473

    Growth Hormone Signaling in Vivo in Humans

    Not yet reported University of Aarhus 8 participants Est. completion 2006-04 1 site
    Other conditions: Intracellular Signaling Peptides and Proteins
    View official trial listing →
  • Completed NCT NCT00517062

    Low Dose Growth Hormone (GH) on Insulin Sensitivity and Cortisol Production Rates

    Not yet reported Oregon Health and Science University 16 participants Est. completion 2012-01 1 site
    Other conditions: Growth Hormone Deficiency
    View official trial listing →
  • Withdrawn NCT NCT00518635

    Low Dose Growth Hormone in Obese PCOS Women

    Not yet reported Oregon Health and Science University Est. completion 2011-10 1 site
    Other conditions: Polycystic Ovary Syndrome
    View official trial listing →
  • Completed NCT NCT00519558

    Growth Hormone Deficiency in Adults (GHDA)

    Not yet reported Novo Nordisk A/S 121 participants Est. completion 2005-01-24 1 site
    Other conditions: Growth Hormone Disorder, Adult Growth Hormone Deficiency
    View official trial listing →
  • Completed NCT NCT00519844

    Growth Hormone Treatment in Children Born Small for Gestational Age: Assessment of Satisfaction

    Not yet reported Novo Nordisk A/S 5 participants Est. completion 2006-01 1 site
    Other conditions: Foetal Growth Problem, Small for Gestational Age
    View official trial listing →
  • Completed NCT NCT00521300

    Preoperative Octreotide Treatment of Acromegaly

    Not yet reported St. Olavs Hospital 62 participants Est. completion 2010-05 5 sites
    Other conditions: Acromegaly
    View official trial listing →
  • Completed NCT NCT00522743

    Growth and Metabolic Response to GH and GnRHa Treatment Versus GH Alone in Boys Born SGA.

    Not yet reported Rabin Medical Center 17 participants Est. completion 2010-07 1 site
    Other conditions: SGA and Growth
    View official trial listing →
  • Terminated NCT NCT00527046

    Effects Of An Oral Growth Hormone Secretagogue In Older Functionally Limited Adults

    Not yet reported Pfizer 396 participants Est. completion 2001-10 12 sites
    Other conditions: Aging, Frail Older Adults
    View official trial listing →
  • Completed NCT NCT00531908

    Physiopathology of Sodium Retention in Acromegaly

    Not yet reported Assistance Publique - Hôpitaux de Paris 12 participants Est. completion 2009-12 1 site
    Other conditions: Acromegaly
    View official trial listing →
  • Completed NCT NCT00533065

    Effects of Donepezil on Deficits Associated With Age-Related Decrease of Growth Hormone

    Not yet reported Ludwig Boltzmann Gesellschaft 80 participants Est. completion 2009-07 1 site
    Other conditions: Elderly
    View official trial listing →
  • Completed NCT NCT00533221

    Pilot Study of Growth Hormon to Treat SMA Typ II and III

    Not yet reported University Hospital Freiburg 20 participants Est. completion 2011-08 6 sites
    Other conditions: Muscular Atrophy, Spinal
    View official trial listing →
  • Completed NCT NCT00537914

    Safety and Efficacy of Omnitrope® (rhGH) in Short Children Born Small for Gestational Age (SGA)

    Not yet reported Sandoz 278 participants Est. completion 2022-03-25 31 sites
    Other conditions: Small for Gestational Age
    View official trial listing →
  • Status unknown NCT NCT00552851

    Changes of Left Ventricular Mass and Cardiac Function in Patients With Active Acromegaly During Treatment With the Growth Hormone Receptor Antagonist Pegvisomant

    Not yet reported University of Wuerzburg 4 participants Est. completion 2010-12 1 site
    Heart failure Other conditions: Acromegaly, Hypertrophy, Left Ventricular
    View official trial listing →
  • Completed NCT NCT00553852

    Replacement GH Therapy After Bariatric Surgery in Patients With Very Severe Obesity

    Not yet reported Federico II University 24 participants Est. completion 2008-03 1 site
    Other conditions: Obesity, GHD
    View official trial listing →
  • Terminated NCT NCT00555009

    Treatment Of Adult Growth Hormone Deficiency After Traumatic Brain Injury

    Not yet reported Pfizer 10 participants Est. completion 2009-01 9 sites
    Other conditions: Brain Injuries, Growth Hormone Deficiency
    View official trial listing →
  • Completed NCT NCT00557336

    Efficacy and Safety of Growth Hormone Treatment in Children Small for Gestational Age

    Not yet reported Novo Nordisk A/S 160 participants Est. completion 2005-06-29 37 sites
    Other conditions: Foetal Growth Problem, Small for Gestational Age
    View official trial listing →
  • Completed NCT NCT00561769

    Luteal Phase Commencing of Growth Hormone

    Gulhane School of Medicine 61 participants Est. completion 2007-11 1 site
    Other conditions: Infertility
    View official trial listing →
  • Completed NCT NCT00562705

    Effects of Growth Hormone (GH) Treatment on Eating Regulation

    Not yet reported Rabin Medical Center 32 participants Est. completion 2012-08 1 site
    Other conditions: Short Stature
    View official trial listing →
  • Completed NCT NCT00562796

    Prevalence and Cardiovascular Effects of Growth Hormone Deficiency in Abdominal Obesity

    Massachusetts General Hospital 149 participants Est. completion 2011-05 1 site
    Other conditions: Obesity, Growth Hormone
    View official trial listing →
  • Completed NCT NCT00567385

    Liquid Somatropin Formulation in Children With Growth Hormone Deficiency

    Not yet reported Novo Nordisk A/S 176 participants Est. completion 2004-03-22 1 site
    Other conditions: Growth Hormone Disorder, Growth Hormone Deficiency in Children
    View official trial listing →
  • Completed NCT NCT00568568

    Metabolic Studies- Interactions Between GH and Insulin in GHDA

    Not yet reported University of Aarhus 8 participants Est. completion 2010-02 1 site
    Other conditions: Insulin Resistance
    View official trial listing →
  • Completed NCT NCT00570011

    Low and Conventional Dose of Somatropin in Growth Hormone Deficient Adult Patients

    Not yet reported Eli Lilly and Company 112 participants Est. completion 1998-12 1 site
    Other conditions: Growth Hormone Deficiency
    View official trial listing →
  • Completed NCT NCT00571727

    Long-Term Treatment With rhIGF-1 in GHIS

    Not yet reported, Not yet reported Ipsen 92 participants Est. completion 2011-12-15 1 site
    Other conditions: Growth Hormone Insensitivity Syndrome
    View official trial listing →
  • Terminated NCT NCT00572156

    rhGH and rhIGF-1 Combination Therapy in Children With Short Stature Associated With IGF-1 Deficiency

    Not yet reported Ipsen 106 participants Est. completion 2012-03 1 site
    Other conditions: Insulin-like Growth Factor-1 Deficiency
    View official trial listing →
  • Completed NCT NCT00591760

    Growth Hormone Deficiency in Chronic Heart Failure: A Preliminary Trial

    Not yet reported Federico II University 56 participants Est. completion 2007-11
    Heart failure Other conditions: Growth Hormone Deficiency, Ischemic Heart Disease
    View official trial listing →
  • Completed NCT NCT00595140

    Acute Application of Pegvisomant and Octreotide in Acromegaly

    Not yet reported Ludwig-Maximilians - University of Munich 10 participants Est. completion 2008-03 1 site
    Other conditions: Acromegaly
    View official trial listing →
  • Completed NCT NCT00596037

    Treatment of Adults With Growth Hormone Deficiency

    Not yet reported LG Life Sciences 136 participants Est. completion 2009-05
    Other conditions: Pituitary Disorders, Adult Growth Hormone Deficiency
    View official trial listing →
  • Terminated NCT NCT00597480

    Study of Growth-promoting and Metabolic Effects of Growth Hormone (rhGH)

    Not yet reported Assistance Publique - Hôpitaux de Paris 10 participants Est. completion 2012-01 1 site
    Other conditions: Small for Gestational Age
    View official trial listing →
  • Completed NCT NCT00600808

    Sustained Release Formulation of Somatropin (rDNA Origin)for Injection

    Not yet reported, Not yet reported BioPartners GmbH 51 participants Est. completion 2006-06
    Other conditions: Growth Hormone Deficiency
    View official trial listing →
  • Completed NCT NCT00600886

    Safety and Efficacy of Pasireotide Long Acting Release (LAR) vs. Octreotide LAR in Patients With Active Acromegaly

    Not yet reported Novartis Pharmaceuticals 358 participants Est. completion 2016-03-11 95 sites
    Other conditions: Acromegaly
    View official trial listing →
  • Withdrawn NCT NCT00601289

    Temozolomide in Treating Patients With Invasive Pituitary Tumors

    Not yet reported Jonsson Comprehensive Cancer Center
    Other conditions: Brain and Central Nervous System Tumors
    View official trial listing →
  • Completed NCT NCT00601419

    Drug Use Investigation of Somatropin for GHD-ADULTS.

    Pfizer 230 participants Est. completion 2012-12
    Other conditions: Dwarfism, Growth Hormone Deficiency
    View official trial listing →
  • Terminated NCT NCT00603109

    Effect of Rimonabant on Weight Gain and Body Composition in Adults With Prader Willi Syndrome

    Not yet reported Weill Medical College of Cornell University 10 participants Est. completion 2009-01 1 site
    Other conditions: Prader-willi Syndrome
    View official trial listing →
  • Completed NCT NCT00608023

    TH9507 Extension Study in Patients With HIV-Associated Lipodystrophy

    Not yet reported Theratechnologies 263 participants Est. completion 2008-10 47 sites
    Other conditions: Lipodystrophy, HIV Infections
    View official trial listing →
  • Completed NCT NCT00616278

    National Cooperative Growth Study in CKD

    University of California, Davis 27 participants Est. completion 2010-02 1 site
    Other conditions: Growth Hormone Deficiency
    View official trial listing →
  • Terminated NCT NCT00625872

    Neuromuscular Changes In Small For Gestational Age Children During Somatropin Therapy

    Not yet reported Pfizer 23 participants Est. completion 2011-03 10 sites
    Other conditions: Growth Hormone Therapy, Infant, Small for Gestational Age
    View official trial listing →
  • Completed NCT NCT00627523

    Genotropin Treatment In Very Young Children Born Small For Gestational Age

    Not yet reported Pfizer 43 participants Est. completion 2013-12 17 sites
    Other conditions: Infant, Small for Gestational Age
    View official trial listing →
  • Completed NCT NCT00635960

    Growth Hormone in Amyotrophic Lateral Sclerosis

    Not yet reported Federico II University 40 participants Est. completion 2010-05 2 sites
    Other conditions: Amyotrophic Lateral Sclerosis
    View official trial listing →
  • Terminated NCT NCT00638053

    A Study to Evaluate the Efficacy of Somatropin in Adults With Growth Hormone Deficiency Caused by Trauma and/or Head Injury

    Not yet reported Pfizer 100 participants Est. completion 2003-11 4 sites
    Other conditions: Brain Injuries, Growth Hormone Deficiency Dwarfism
    View official trial listing →
  • Withdrawn NCT NCT00638287

    Inter-Assay Growth Hormone and IGF-I Variability

    Cedars-Sinai Medical Center 171 participants Est. completion 2011-01
    Other conditions: Acromegaly, Growth Hormone Deficiency
    View official trial listing →
  • Terminated NCT NCT00646308

    Assessment of Cardiovascular Risk Markers in Growth Hormone Deficient Patients With Nonsecreting Pituitary Adenomas

    Columbia University 60 participants Est. completion 2010-03 1 site
    Other conditions: Growth Hormone Deficiency, Pituitary Tumor
    View official trial listing →
  • Completed NCT NCT00646815

    Insulin Sensitivity and Substrate Metabolism Before and After Treatment in Patients With Growth Hormone Deficiency

    Not yet reported University of Aarhus 24 participants Est. completion 2009-09 2 sites
    Other conditions: Growth Hormone Deficiency
    View official trial listing →
  • Completed NCT NCT00647179

    Substrate Metabolism and Insulin Sensitivity in Acromegalic Patients Before and After Treatment

    University of Aarhus 27 participants Est. completion 2016-12-07 1 site
    Other conditions: Acromegaly, Excessive Growth Hormone Secretion, Insulin Resistance
    View official trial listing →
  • Completed NCT NCT00652379

    Co-treatment With Pegvisomant and a Somatostatin Analogue (SA) in SA-responsive Acromegalic Patients

    Not yet reported University of Aarhus 18 participants Est. completion 2011-05 1 site
    Prediabetes Other conditions: Acromegaly, Insulin Resistance
    View official trial listing →
  • Status unknown NCT NCT00662181

    Follow-up on the HIGH: Low Study - the Longterm Effects of Growth Hormone

    Hvidovre University Hospital 46 participants Est. completion 2009-01 1 site
    Other conditions: HIV Infections, HIV-Associated Lipodystrophy Syndrome
    View official trial listing →
  • Completed NCT NCT00663611

    Growth Hormone Administration and the Human Immune System

    Not yet reported National Institute on Aging (NIA) 66 participants Est. completion 2014-10-06 1 site
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Completed NCT NCT00673309

    Assessment of Mechanisms of Improved Wound Healing

    Not yet reported, Not yet reported The University of Texas Medical Branch, Galveston 644 participants Est. completion 2013-04 1 site
    Other conditions: Burns
    View official trial listing →
  • Completed NCT NCT00675506

    Effectiveness of Growth Hormone Releasing Hormone in Reducing Abdominal Fat in People Who Are Obese

    Not yet reported Massachusetts General Hospital 60 participants Est. completion 2012-01 1 site
    Other conditions: Abdominal Obesity, Growth Hormone Deficiency
    View official trial listing →
  • Completed NCT NCT00679692

    Evaluation the Growth Factors(IGF-1,IGFBP-3and HGH)in Patients With Chronic Liver Disease

    Kaohsiung Medical University Chung-Ho Memorial Hospital 210 participants Est. completion 2008-03 1 site
    Other conditions: Hepatitis, Liver Cirrhosis, Hepatocellular Carcinoma
    View official trial listing →
  • Completed NCT NCT00694122

    Comparison of Lantus and Neutral Protamine Hagedorn (NPH) Insulin in the Dawn Phenomenon

    Not yet reported Massachusetts General Hospital 27 participants Est. completion 2010-11 1 site
    Other conditions: Type 1 Diabetes, Dawn Phenomenon
    View official trial listing →
  • Completed NCT NCT00705172

    Retrospective Observational Study on Efficacy and Safety of Norditropin® in Children With Prader-Willi Syndrome

    Novo Nordisk A/S 41 participants Est. completion 2008-11 3 sites
    Other conditions: Genetic Disorder, Prader-Willi Syndrome
    View official trial listing →
  • Completed NCT NCT00715689

    Dose Study in Growth Hormone Deficient Adults Investigating Safety, Pharmacokinetics and Pharmacodynamics of NNC126-0083

    Not yet reported Novo Nordisk A/S 33 participants Est. completion 2009-03 3 sites
    Other conditions: Growth Hormone Disorder, Adult Growth Hormone Deficiency
    View official trial listing →
  • Withdrawn NCT NCT00720616

    Low Dose Growth Hormone Treatment in Subjects With Metabolic Syndrome.

    Not yet reported Oregon Health and Science University Est. completion 2012-12 1 site
    Metabolic syndrome
    View official trial listing →
  • Terminated NCT NCT00720902

    Adult Growth Hormone Deficiency and Cardiovascular Risk

    Not yet reported Columbia University 7 participants Est. completion 2011-05 1 site
    Other conditions: Growth Hormone Deficiency
    View official trial listing →
  • Terminated NCT NCT00742157

    Evaluate the Efficacy and Safety Growth Hormone, Glutamine and Diet in Patients With Short Bowel Syndrome (SBS)

    Not yet reported University of Nebraska 5 participants Est. completion 2008-10-20 1 site
    Other conditions: Short Bowel Syndrome
    View official trial listing →
  • Terminated NCT NCT00747604

    IGFD Registry: A Patient Registry for Monitoring Long-term Safety and Efficacy of Increlex

    Ipsen 1378 participants Est. completion 2014-05 1 site
    Other conditions: Primary Insulin-like Growth Factor-1 Deficiency
    View official trial listing →
  • Completed NCT NCT00757393

    Growth Hormone Therapy and Bone Quality in Pediatric Osteoporosis

    Not yet reported The Hospital for Sick Children 21 participants Est. completion 2015-09 1 site
    Other conditions: Osteoporosis
    View official trial listing →
  • Terminated NCT NCT00765323

    Efficacy and Safety Study of Octreotide Implant in Patients With Acromegaly

    Not yet reported Endo USA Inc., a Keenova Therapeutics Company 169 participants Est. completion 2011-06 47 sites
    Other conditions: Acromegaly
    View official trial listing →
  • Completed NCT NCT00766038

    Recombinant Human Growth Hormone During Rehabilitation From Traumatic Brain Injury.

    Not yet reported University of Pennsylvania 63 participants Est. completion 2013-12 3 sites
    Other conditions: Traumatic Brain Injury
    View official trial listing →
  • Completed NCT NCT00778518

    Safety, Tolerability and PK/PD Study in Young Adult Patients With Childhood Onset Growth Hormone Deficiency (GHD).

    Not yet reported Ambrx, Inc. 36 participants Est. completion 2009-10 1 site
    Other conditions: Growth Hormone Deficiency
    View official trial listing →
  • Completed NCT NCT00781547

    Growth Hormone Treatment in Men With High Risk of Developing Type 2 Diabetes Mellitus

    Not yet reported Göteborg University 40 participants Est. completion 2005-05 1 site
    Metabolic syndrome Other conditions: Abdominal Obesity, Obesity
    View official trial listing →
  • Completed NCT NCT00787878

    Long Term Metabolic Safety of Norditropin® Treatment of Small for Gestational Age (SGA) Subjects

    Novo Nordisk A/S 153 participants Est. completion 2011-01 1 site
    Other conditions: Foetal Growth Problem, Small for Gestational Age
    View official trial listing →
  • Completed NCT NCT00791843

    The Effect of GHRH Therapy on Myocardial Structure and Function in Congestive Heart Failure

    Not yet reported University of Pennsylvania 3 participants Est. completion 2011-08 1 site
    Heart failure
    View official trial listing →
  • Completed NCT NCT00793325

    Long Term Use of Somatropin in Patients Small for Gestational Age

    Pfizer 920 participants Est. completion 2012-12
    Other conditions: Small for Gestational Age
    View official trial listing →
  • Completed NCT NCT00795210

    Effects of Short-term Growth Hormone in HIV-infected Patients

    Not yet reported Massachusetts General Hospital 25 participants Est. completion 2012-11 1 site
    Other conditions: HIV Lipodystrophy
    View official trial listing →
  • Terminated NCT NCT00803179

    Growth Hormone Therapy for Wasting in Cystic Fibrosis

    Not yet reported University of Massachusetts, Worcester 5 participants Est. completion 2012-03 1 site
    Other conditions: Cystic Fibrosis
    View official trial listing →
  • Completed NCT NCT00813189

    Efficacy Study of Recombinant Growth Hormone on Muscle Function in Children Long-term Treated With Glucocorticoid

    Not yet reported Association REMEDE 30 participants Est. completion 2012-05 1 site
    Other conditions: Chronic Disease, Glucocorticoid Therapy, Response to, Growth Retardation
    View official trial listing →
  • Completed NCT NCT00817440

    Effects of Fasting and Exercise on Insulin and GH Signaltransduction in Muscle and Fat

    Not yet reported University of Aarhus 8 participants 1 site
    Other conditions: Healthy
    View official trial listing →
  • Status unknown NCT NCT00840944

    A 4 Year Combination Therapy of Growth Hormone and (GnRH) Agonist in Children With a Short Predicted Height

    Not yet reported Belgian Study Group for Pediatric Endocrinology 44 participants Est. completion 2024-04 6 sites
    Other conditions: Idiopathic Short Stature
    View official trial listing →
  • Completed NCT NCT00850564

    Effect of Short Term Growth Hormone Releasing Hormone in Healthy Men

    Not yet reported Massachusetts General Hospital 15 participants Est. completion 2010-04 1 site
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Terminated NCT NCT00855244

    Metabolic Syndrome in Bone Marrow Transplant Survivors

    Not yet reported Nationwide Children's Hospital 5 participants Est. completion 2010-05 1 site
    Metabolic syndrome
    View official trial listing →
  • Status unknown NCT NCT00867971

    Is Recombinant Growth Hormone Therapy Associated With Increased Intraoccular Pressure?

    Assaf-Harofeh Medical Center 100 participants Est. completion 2010-10 1 site
    Other conditions: Growth Hormone Treatment, Glaucoma
    View official trial listing →
  • Terminated NCT NCT00870220

    Initiating Transdermal Estradiol Therapy in Turner's Syndrome

    Not yet reported University of Chicago 1 participants Est. completion 2011-03 3 sites
    Other conditions: Turner's Syndrome
    View official trial listing →
  • Completed NCT NCT00871455

    Effect of Low-Dose Baclofen Administration on the GH-IGF1 Axis Study

    Not yet reported US Department of Veterans Affairs 20 participants Est. completion 2011-12 1 site
    Other conditions: Spinal Cord Injury
    View official trial listing →
  • Completed NCT NCT00884000

    A Study of Zomacton in Children With Growth Hormone Deficiency

    Not yet reported Ferring Pharmaceuticals 165 participants Est. completion 2012-07 43 sites
    Other conditions: Growth Hormone Deficiency
    View official trial listing →
  • Completed NCT NCT00915954

    Growth Hormone Feedback to Insulin-like Growth Factor-I (IGF-1) and Oral Glucose Tolerance Test (OGTT)

    Not yet reported Cedars-Sinai Medical Center 28 participants Est. completion 2014-06 1 site
    Type 2 diabetes Other conditions: Acromegaly
    View official trial listing →
  • Completed NCT NCT00920738

    Metabolic Syndrome in Childhood Cancer Survivors

    University of Minnesota 512 participants Est. completion 2011-06 1 site
    Metabolic syndrome Other conditions: Brain and Central Nervous System Tumors, Leukemia, Lymphoma, Sarcoma
    View official trial listing →
  • Completed NCT NCT00921609

    Peri-operative Dynamics of the Growth Hormone Axis in Subjects With Acromegaly

    Cedars-Sinai Medical Center 20 participants Est. completion 2025-07 1 site
    Other conditions: Acromegaly
    View official trial listing →
  • Completed NCT NCT00929045

    Growth Hormone and Insulin Growth Factor 1 Deficiencies in Children/Adolescents Following Traumatic Brain Injury: The Impact on Growth and Neuropsychological Development

    Not yet reported University of Virginia 8 participants Est. completion 2010-12
    Other conditions: Traumatic Brain Injury
    View official trial listing →
  • Completed NCT NCT00931476

    A Single Dose Trial in Healthy Caucasians and Japanese Subjects Investigating the Pharmacokinetics of Somatropin

    Not yet reported Novo Nordisk A/S 86 participants Est. completion 2000-06-08 1 site
    Other conditions: Growth Hormone Disorder, Adult Growth Hormone Deficiency, Healthy
    View official trial listing →
  • Completed NCT NCT00932932

    Cortisol Activity in Patients With Prader-Willi Syndrome and Healthy Controls

    Children's Mercy Hospital Kansas City 36 participants Est. completion 2010-08
    Other conditions: Prader-Willi Syndrome
    View official trial listing →
  • Completed NCT NCT00933361

    Individual Dose-escalated Bi-daily Subcutaneously (sc) Ghrelin in Cancer Cachexia: a Phase I/II Study

    Not yet reported, Not yet reported Cantonal Hospital of St. Gallen 21 participants Est. completion 2011-12 1 site
    Other conditions: Advanced Cancer, Cachexia
    View official trial listing →
  • Completed NCT NCT00933686

    Growth Hormone in Neuroendocrine Dysfunction With Severe Fibromyalgia Syndrome

    Not yet reported Merck KGaA, Darmstadt, Germany 113 participants Est. completion 2010-07 1 site
    Other conditions: Fibromyalgia
    View official trial listing →
  • Completed NCT NCT00934063

    An Observational Study Validating a Score That Quantifies the Therapeutic Response to Treatment With Norditropin®

    Novo Nordisk A/S 121 participants Est. completion 2014-06 1 site
    Other conditions: Growth Hormone Disorder, Adult Growth Hormone Deficiency
    View official trial listing →
  • Completed NCT NCT00943995

    Three Times Weekly (TIW) Growth Hormone Therapy in Children on Hemodialysis

    Not yet reported Nationwide Children's Hospital 3 participants Est. completion 2012-08 5 sites
    Other conditions: Kidney Failure, Chronic, Renal Dialysis
    View official trial listing →
  • Terminated NCT NCT00946361

    Impaired Insulin-like Growth Factor-1 (IGF-1) Generation Causes Protein Catabolism and Poor Growth in Children With Crohn Disease

    Nationwide Children's Hospital 1 participants Est. completion 2010-05 1 site
    Other conditions: Crohns Disease
    View official trial listing →
  • Completed NCT NCT00957671

    Anterior Pituitary Hormone Replacement in Traumatic Brain Injury

    Not yet reported The University of Texas Medical Branch, Galveston 15 participants Est. completion 2015-10 2 sites
    Other conditions: Growth Hormone Deficiency, Traumatic Brain Injury
    View official trial listing →
  • Completed NCT NCT00960128

    Observational Prospective Study on Patients Treated With Norditropin®

    Novo Nordisk A/S 21249 participants Est. completion 2016-12-31 23 sites
    Chronic kidney disease Other conditions: Growth Hormone Disorder, Growth Hormone Deficiency in Children, Adult Growth Hormone Deficiency, Genetic Disorder, Turner Syndrome, Foetal Growth Problem, Small for Gestational Age, Chronic Renal Insufficiency, Noonan Syndrome
    View official trial listing →
  • Completed NCT NCT00966134

    Ghrelin, Growth Hormone and Growth Factors at High Altitude

    Medical University of Vienna Est. completion 2005-09
    Other conditions: Healthy, Growth Hormone
    View official trial listing →
  • Status unknown NCT NCT00969644

    The Relationship Between the Growth Hormone (GH)- Insulin Like Growth Factor I (IGF-I) System and the Inflammatory System in Healthy Normal Persons

    Not yet reported Herlev Hospital 12 participants Est. completion 2010-03 1 site
    Other conditions: Interaction Between the GH/IGF-I System and the Immune-system
    View official trial listing →
  • Completed NCT NCT00970463

    Cardiac Function and Morphology Evaluated by Magnetic Resonance Imaging in Growth Hormone Deficiency and Acromegaly

    Herlev Hospital 22 participants Est. completion 2009-05
    Other conditions: Growth Hormone Deficiency, Cardiac Function
    View official trial listing →
  • Terminated NCT NCT00976508

    Figitumumab Combined With Pegvisomant For Advanced Solid Tumors

    Not yet reported Pfizer 24 participants Est. completion 2012-10 5 sites
    Other conditions: Colorectal Neoplasms, Lung Neoplasms, Breast Neoplasms, Prostatic Neoplasms, Sarcoma
    View official trial listing →
  • Completed NCT NCT00990340

    Comparison of a Needle-free Injection Method With a Needle-syringe Injection Method

    Not yet reported Teva Branded Pharmaceutical Products R&D, Inc. 52 participants Est. completion 2010-08
    Other conditions: Growth Hormone Deficiency
    View official trial listing →
  • Completed NCT NCT01007071

    Effects of Growth Hormone on Cognition and Cerebral Metabolism in Adults With Growth Hormone Deficiency

    Not yet reported Stanford University 11 participants Est. completion 2012-12-12 1 site
    Other conditions: Hypopituitarism
    View official trial listing →
  • Completed NCT NCT01009905

    An Observational Study (Registry) Assessing Treatment Outcomes and Safety for Children and Adults Who Are Prescribed Norditropin® (Human Growth Hormone)

    Novo Nordisk A/S 22960 participants Est. completion 2016-09-30 1 site
    Other conditions: Growth Hormone Disorder, Pituitary Dwarfism, Hypopituitarism
    View official trial listing →
  • Completed NCT NCT01010425

    Pharmacokinetics and Pharmacodynamics of ACP-001 (TransCon PEG hGH)

    Not yet reported Ascendis Pharma A/S 44 participants Est. completion 2010-05 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT01020955

    Metabolic Effects of GH and IGF-I in Growth Hormone Deficient(GHD) and Diabetes and Impaired Glucose Tolerance(IGT)

    Not yet reported Karolinska University Hospital 14 participants Est. completion 2011-11 1 site
    Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT01034202

    Dose Study in Healthy Males Investigating Safety, Pharmacokinetics and Pharmacodynamics of NNC126-0083 Compared to Norditropin® SimpleXx®

    Not yet reported Novo Nordisk A/S 56 participants Est. completion 2008-01 1 site
    Other conditions: Growth Hormone Disorder, Healthy
    View official trial listing →
  • Completed NCT NCT01034735

    r-hGH Liquid Multidose Versus Freeze-dried Multidose Bioequivalence Trial

    Not yet reported EMD Serono 30 participants 1 site
    Other conditions: Growth Failure, Growth Hormone Deficiency
    View official trial listing →
  • Completed NCT NCT01060488

    Comparative Validation of the Growth Hormone Releasing Hormone and Arginine Test for the Diagnosis of Adult Growth Hormone Deficiency

    Not yet reported Merck KGaA, Darmstadt, Germany 69 participants 1 site
    Other conditions: Growth Hormone Deficiency
    View official trial listing →
  • Completed NCT NCT01060722

    MOD-4023 Study in Healthy Male Volunteers

    Not yet reported OPKO Health, Inc. 24 participants Est. completion 2010-01 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT01066052

    Growth Hormone Treatment for the Prevention of Short Stature in Young Girls With Turner Syndrome Before the Age of 4 Years

    Not yet reported Merck KGaA, Darmstadt, Germany 115 participants Est. completion 2010-08-31 1 site
    Other conditions: Turner's Syndrome
    View official trial listing →
  • Withdrawn NCT NCT01068639

    An Observational Study on Treatment Compliance by Children Treated With Growth Hormone

    Novo Nordisk A/S Est. completion 2010-04
    Other conditions: Growth Hormone Disorder, Growth Hormone Deficiency in Children
    View official trial listing →
  • Status unknown NCT NCT01070589

    The Effect of Obesity on Growth Hormone Response to Anaerobic Exercise

    Meir Medical Center 24 participants Est. completion 2012-07 1 site
    Other conditions: Obesity
    View official trial listing →
  • Completed NCT NCT01075386

    The Effects of the Endocrine System on Endometrial Cancer

    Queensland Centre for Gynaecological Cancer 75 participants Est. completion 2018-12 1 site
    Other conditions: Endometrial Cancer
    View official trial listing →
  • Completed NCT NCT01080755

    Metabolic Endocrinology and Growth Hormone in Adults

    Merck KGaA, Darmstadt, Germany 90 participants Est. completion 2012-09
    Other conditions: Adult Growth Hormone Deficiency
    View official trial listing →
  • Completed NCT NCT01082354

    A Pharmaco-epidemiological Study of Short Patients Born Small for Gestational Age (SGA), Treated With Saizen® (Recombinant Somatropin)

    Merck KGaA, Darmstadt, Germany 150 participants Est. completion 2015-12 40 sites
    Other conditions: Infant, Small for Gestational Age
    View official trial listing →
  • Completed NCT NCT01088399

    A Prospective Observational Study of Effect of Somatropin on Growth Hormone Deficient Adults

    Eli Lilly and Company 10673 participants Est. completion 2012-12
    Other conditions: Hypopituitarism, Pituitary Insufficiency, Growth Hormone Deficiency, Adult
    View official trial listing →
  • Completed NCT NCT01090778

    Diurnal Variation of Exogenous Peptides (GH Puls/Jurgita I)

    Not yet reported Aarhus University Hospital 8 participants Est. completion 2011-12 2 sites
    Other conditions: Growth Hormone Deficiency
    View official trial listing →
  • Completed NCT NCT01109017

    Observational Study of the Safety and Efficacy of Norditropin® in Adult Patients With Growth Hormone Deficiency

    Novo Nordisk A/S 387 participants Est. completion 2014-12 1 site
    Other conditions: Growth Hormone Disorder, Adult Growth Hormone Deficiency
    View official trial listing →
  • Completed NCT NCT01111019

    Efficacy and Safety Evaluation of Recombinant Human Growth Hormone (r-hGH), Saizen®, on a Population of Children With Hypochondroplasia, Treated at Least 3 Years or Until Near Final Height, When Applicable, in Comparison With a Historic Cohort of Non-treated Children

    Not yet reported Merck KGaA, Darmstadt, Germany 19 participants Est. completion 2017-01-17 1 site
    Other conditions: Hypochondroplasia
    View official trial listing →
  • Completed NCT NCT01112865

    Cross Over Convenience And Preference Study Of New Mark VII Compared To Genotropin Pen In Pediatric And Adult Subjects

    Not yet reported Pfizer 120 participants Est. completion 2011-10 23 sites
    Other conditions: Growth Hormone Deficiency
    View official trial listing →
  • Terminated NCT NCT01130376

    Novel Interventions in HIV-1 Infection

    Not yet reported Imperial College London 12 participants Est. completion 2011-10 1 site
    Other conditions: HIV-1 Infection
    View official trial listing →
  • Completed NCT NCT01137682

    Efficacy and Safety of Pasireotide Long Acting Release (LAR) Versus Octreotide LAR or Lanreotide Autogel (ATG) in Patients With Inadequately Controlled Acromegaly

    Not yet reported Novartis Pharmaceuticals 198 participants Est. completion 2017-02-28 60 sites
    Other conditions: Acromegaly
    View official trial listing →
  • Completed NCT NCT01150955

    Potential Beneficial Effects of Resveratrol

    Not yet reported University of Aarhus 24 participants Est. completion 2011-11 1 site
    Metabolic syndrome Other conditions: Obesity
    View official trial listing →
  • Completed NCT NCT01157793

    A Multicentre, Randomised, Open-label, Controlled Study to Evaluate the Effects of Saizen® on Cardiac Function in Growth Hormone Deficient(GHD) Subjects During the Transition Phase From Childhood to Adulthood

    Not yet reported Merck KGaA, Darmstadt, Germany 34 participants Est. completion 2005-02
    Other conditions: Dwarfism, Growth Hormone Deficiency
    View official trial listing →
  • Completed NCT NCT01158612

    The Effect of Local Injectet GH on the Collagen Synthesis in the Ligamentum Patella

    Not yet reported University of Aarhus 12 participants Est. completion 2011-08 1 site
    Other conditions: Growth Hormone, Elderly
    View official trial listing →
  • Completed NCT NCT01169103

    Effect of Recombinant Human Growth Hormone (rhGH) on Abdominal Fat and Cardiovascular Risk in Obese Girls

    Not yet reported Massachusetts General Hospital 22 participants Est. completion 2014-12 1 site
    Other conditions: Obesity
    View official trial listing →
  • Completed NCT NCT01186796

    Role of Endogenous Estrogen in Growth-Hormone Regulation in Postmenopausal Women

    Not yet reported Mayo Clinic 30 participants Est. completion 2013-06 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT01187550

    Predictive Markers in Chinese Growth Hormone Deficiency (GHD) Children Treated With Saizen®

    Not yet reported Merck KGaA, Darmstadt, Germany 214 participants Est. completion 2009-04
    Other conditions: Dwarfism, Pituitary
    View official trial listing →
  • Completed NCT NCT01196156

    Follow-up to Adult Height of a Cohort of Subjects Born Small for the Gestational Age and Treated With Growth Hormone

    Merck KGaA, Darmstadt, Germany 443 participants Est. completion 2018-12-31 28 sites
    Other conditions: Infant, Small for Gestational Age
    View official trial listing →
  • Completed NCT NCT01200875

    Performance-Enhancing Effects of Platelet-Rich Plasma (PRP) Injections

    Stanford University 25 participants Est. completion 2013-05 1 site
    Other conditions: Tendinopathy, Rheumatic Diseases
    View official trial listing →
  • Completed NCT NCT01225666

    MOD-4023 (Long-Lasting Human Growth Hormone (hGH)) Study in Growth Hormone Deficient Adults (GHDA)

    Not yet reported OPKO Health, Inc. 52 participants Est. completion 2012-04 15 sites
    Other conditions: Adult Growth Hormone Deficiency
    View official trial listing →
  • Terminated NCT NCT01237041

    Free Fatty Acids, Body Weight, and Growth Hormones Secretion in Children

    Not yet reported, Not yet reported Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) 37 participants Est. completion 2017-12-13 1 site
    Other conditions: Obesity, Short Stature, Growth Hormone Deficiency
    View official trial listing →
  • Terminated NCT NCT01237340

    Saizen® Solution for Injection Adult Growth Hormone Deficiency (GHD) Immunogenicity Study

    Not yet reported EMD Serono 59 participants Est. completion 2011-12 1 site
    Other conditions: Growth Hormone Deficiency (GHD)
    View official trial listing →
  • Terminated NCT NCT01243892

    A Study to Evaluate Growth in Participants Treated With Somatropin (Nutropin) Using NuSpin Device

    Genentech, Inc. 18 participants Est. completion 2011-08 14 sites
    Other conditions: Growth Hormone Deficiency
    View official trial listing →
  • Completed NCT NCT01245374

    Norditropin NordiFlex® Device Compared to the Device Previously Used by Patients or Parents

    Not yet reported Novo Nordisk A/S 103 participants Est. completion 2011-04 1 site
    Chronic kidney disease Other conditions: Growth Hormone Disorder, Growth Hormone Deficiency in Children, Foetal Growth Problem, Small for Gestational Age, Genetic Disorder, Turner Syndrome, Chronic Renal Insufficiency, Delivery Systems
    View official trial listing →
  • Completed NCT NCT01246219

    Short Stature Related Distress

    Not yet reported Rabin Medical Center 60 participants Est. completion 2017-11 1 site
    Other conditions: Idiopathic Short Stature, Self Image
    View official trial listing →
  • Completed NCT NCT01247675

    A Safety, Pharmacokinetic and Pharmacodynamic Study of ACP-001 (TransCon hGH) in Adults With Growth Hormone Deficiency

    Not yet reported Ascendis Pharma A/S 37 participants Est. completion 2011-05 4 sites
    Other conditions: Adult Growth Hormone Deficiency
    View official trial listing →
  • Completed NCT NCT01248416

    Aromatase Inhibitors, Alone And In Combination With Growth Hormone In Adolescent Boys With Idiopathic Short Stature

    Not yet reported Nemours Children's Clinic 76 participants Est. completion 2016-09 4 sites
    Other conditions: Idiopathic Short Stature
    View official trial listing →
  • Completed NCT NCT01263457

    To Assess the Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ in the UK

    Merck KGaA, Darmstadt, Germany 191 participants Est. completion 2015-12-31 6 sites
    Other conditions: Growth Disorders
    View official trial listing →
  • Completed NCT NCT01263717

    Effects of Growth Hormone Releasing Hormone in HIV

    Not yet reported Massachusetts General Hospital 54 participants Est. completion 2014-02 1 site
    Other conditions: HIV, HIV Lipodystrophy
    View official trial listing →
  • Completed NCT NCT01267526

    A Canadian, Multi-centre, Observational Registry to Study Adherence and Long Term Outcomes of Therapy in Pediatric Subjects Using SAIZEN® Via Easypod™ Auto-injector for Growth Hormone Treatment

    Merck KGaA, Darmstadt, Germany 205 participants Est. completion 2015-12-31 9 sites
    Other conditions: Growth Disorders
    View official trial listing →
  • Completed NCT NCT01282164

    The Glucagon Stimulation Test for Evaluation of Adult Growth Hormone Deficiency and Adrenocorticotropic Axis

    Not yet reported The Cleveland Clinic 43 participants Est. completion 2014-07 4 sites
    Other conditions: Adult Growth Hormone Deficiency, Hypothalamic-pituitary Disorders
    View official trial listing →
  • Completed NCT NCT01291394

    To Assess the Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ in France

    Merck KGaA, Darmstadt, Germany 223 participants Est. completion 2015-12-31 1 site
    Other conditions: Growth Disorders
    View official trial listing →
  • Completed NCT NCT01296425

    To Assess the Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ in Austria

    Merck KGaA, Darmstadt, Germany 50 participants Est. completion 2015-12-31 1 site
    Other conditions: Growth Disorders
    View official trial listing →
  • Completed NCT NCT01298180

    Is There a Sensibility Increased in the Growth Hormone at Child With Prader-Willi Syndrome?

    Not yet reported University Hospital, Toulouse 111 participants Est. completion 2013-05 26 sites
    Other conditions: Prader-Willi Syndrome, Growth Hormone Deficiency
    View official trial listing →
  • Terminated NCT NCT01298960

    Growth Hormone (GH) in in Vitro Fertilization (IVF) Poor-responder Patients

    Not yet reported Fundacion Dexeus 52 participants Est. completion 2013-06 1 site
    Other conditions: Complications; Artificial Fertilization, Introduction of Embryo in Embryo Transfer
    View official trial listing →
  • Completed NCT NCT01302652

    Effect of Growth Hormone (GH) on Cardiac Echos in GH Deficient Patients After Acromegaly Treatment

    Massachusetts General Hospital 20 participants Est. completion 2015-02 1 site
    Other conditions: Acromegaly
    View official trial listing →
  • Completed NCT NCT01306357

    Evaluation of Overall Compliance and Duration of Zomacton® Treatment With the Zomajet® Needle-free Device

    Ferring Pharmaceuticals 87 participants Est. completion 2011-11 17 sites
    Other conditions: Turner's Syndrome, Human Growth Hormone Deficiency
    View official trial listing →
  • Completed NCT NCT01307059

    To Assess the Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ in Sweden

    Merck KGaA, Darmstadt, Germany 152 participants Est. completion 2015-12-31 3 sites
    Other conditions: Growth Disorders
    View official trial listing →
  • Completed NCT NCT01309555

    To Assess the Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ in Australia

    Merck KGaA, Darmstadt, Germany 33 participants Est. completion 2016-10-31 1 site
    Other conditions: Growth Disorders
    View official trial listing →
  • Withdrawn NCT NCT01314508

    Increlex Treatment of Children With Chronic Liver Disease and Short Stature

    Not yet reported University of California, Los Angeles
    Other conditions: Growth Failure, Chronic Liver Disease
    View official trial listing →
  • Completed NCT NCT01327924

    Usability and Tolerability of the Norditropin NordiFlex® Injection Device in Children Never Previously Treated With Growth Hormone

    Novo Nordisk A/S 77 participants Est. completion 2012-06 1 site
    Chronic kidney disease Other conditions: Growth Hormone Disorder, Growth Hormone Deficiency in Children, Genetic Disorder, Turner Syndrome, Foetal Growth Problem, Small for Gestational Age, Chronic Renal Insufficiency, Delivery Systems
    View official trial listing →
  • Completed NCT NCT01329757

    Efficacy and Safety of Growth Hormone Treatment in Spinal Cord Injury

    Not yet reported Hospital Nacional de Parapléjicos de Toledo 76 participants Est. completion 2015-11 1 site
    Other conditions: Spinal Cord Injury
    View official trial listing →
  • Completed NCT NCT01342146

    Efficiency and Safety Study of Pegylated Somatropin to Treat Growth Hormone Deficiency Children

    Not yet reported Changchun GeneScience Pharmaceutical Co., Ltd. 101 participants Est. completion 2007-02
    Other conditions: Growth Hormone Deficiency
    View official trial listing →
  • Withdrawn NCT NCT01343641

    Growth Hormone Secretagogue MK-0677's Effect on Lean Body Mass in Chronic Kidney Disease Stage 4/5 Subjects

    Not yet reported University of Virginia Est. completion 2010-04 1 site
    Chronic kidney disease Other conditions: Kidney Disease
    View official trial listing →
  • Completed NCT NCT01351818

    Adipocyte Function and Somtropin Deficiency

    Ferring Pharmaceuticals 62 participants Est. completion 2008-03 12 sites
    Other conditions: Growth Hormone Deficiency
    View official trial listing →
  • Completed NCT NCT01359488

    VRS-317 in Adult Subjects With Growth Hormone Deficiency

    Not yet reported Versartis Inc. 50 participants Est. completion 2012-07 1 site
    Other conditions: Growth Hormone Deficiency
    View official trial listing →
  • Completed NCT NCT01363674

    To Assess the Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ in Greece

    Merck KGaA, Darmstadt, Germany 180 participants Est. completion 2015-12-31 1 site
    Other conditions: Growth Disorders
    View official trial listing →
  • Completed NCT NCT01365351

    Online Surveillance of Treatment of Children With Growth Hormone Deficiency With ZOMACTON

    Ferring Pharmaceuticals 1034 participants Est. completion 2016-06 59 sites
    Other conditions: Growth Hormone Deficiency
    View official trial listing →
  • Completed NCT NCT01367834

    Effect of Growth Hormone on Early Brain Development in Girls With Turner Syndrome

    Not yet reported Rebecca Knickmeyer Santelli, PhD 17 participants Est. completion 2014-05 1 site
    Other conditions: Turner Syndrome
    View official trial listing →
  • Status unknown NCT NCT01368133

    The Observational Study of Growth Hormone-secreting Pituitary Tumors

    Huashan Hospital 60 participants Est. completion 2013-12 1 site
    Other conditions: Acromegaly, Pituitary Tumor
    View official trial listing →
  • Withdrawn NCT NCT01371045

    Oral Glucose Tolerance Testing (OGTT) on Patients Taking Somatostatin Analogs

    Cedars-Sinai Medical Center Est. completion 2019-06 1 site
    Other conditions: Acromegaly
    View official trial listing →
  • Completed NCT NCT01376921

    To Assess the Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ in Spain

    Merck KGaA, Darmstadt, Germany 300 participants Est. completion 2015-03-31 1 site
    Other conditions: Growth Disorders
    View official trial listing →
  • Terminated NCT NCT01397500

    Hormone Treatment in Growth Hormone and Testosterone Deficient Patients

    Not yet reported Max-Planck-Institute of Psychiatry 54 participants Est. completion 2015-03 1 site
    Other conditions: Hormone Deficiency
    View official trial listing →
  • Completed NCT NCT01400698

    Saizen in Intra-uterine Growth Retardation

    Not yet reported Merck KGaA, Darmstadt, Germany 91 participants Est. completion 2010-02
    Other conditions: Children Born With Serious Intra-uterine Growth Retardation
    View official trial listing →
  • Completed NCT NCT01400984

    To Assess the Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ in Slovakia

    Merck KGaA, Darmstadt, Germany 92 participants Est. completion 2015-12-31 1 site
    Other conditions: Growth Disorders
    View official trial listing →
  • Completed NCT NCT01400997

    Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ in Czech Republic

    Merck KGaA, Darmstadt, Germany 206 participants Est. completion 2015-12-31 1 site
    Other conditions: Growth Disorders
    View official trial listing →
  • Completed NCT NCT01401244

    Bioequivalence of Two Somatropin Products (Norditropin® Versus Genotropin®) in Healthy Adult Volunteers

    Not yet reported Novo Nordisk A/S 30 participants Est. completion 2011-09-27 1 site
    Other conditions: Genetic Disorder, Prader-Willi Syndrome, Growth Disorder, Idiopathic Short Stature, Healthy
    View official trial listing →
  • Terminated NCT NCT01410799

    Three Month Treatment of Growth Hormone Releasing Hormone (GHRH) in the Elderly

    Not yet reported University of Pennsylvania 13 participants Est. completion 2011-08 1 site
    Other conditions: Hormone Deficiency, Aging
    View official trial listing →
  • Completed NCT NCT01412424

    Efficacy and Safety of Octreotide (MYCAPSSA™ [Formerly Octreolin™]) for Acromegaly

    Not yet reported Chiasma, Inc. 155 participants Est. completion 2014-05 36 sites
    Other conditions: Acromegaly
    View official trial listing →
  • Completed NCT NCT01421589

    Growth Hormone Treatment on Phosphocreatine Recovery in Obesity

    Not yet reported Massachusetts General Hospital 15 participants Est. completion 2013-03 1 site
    Other conditions: Obese, Growth Hormone Secretion Abnormality
    View official trial listing →
  • Completed NCT NCT01435629

    A Survey Collecting Data on Adult Height in Patients With Achondroplasia Treated With Somatropin

    Novo Nordisk A/S 81 participants Est. completion 2015-12-04 1 site
    Other conditions: Genetic Disorder, Achondroplasia
    View official trial listing →
  • Completed NCT NCT01438528

    Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ Electromechanical Device for Growth Hormone Treatment

    Merck KGaA, Darmstadt, Germany 75 participants Est. completion 2015-12-31 1 site
    Other conditions: Growth Disorders
    View official trial listing →
  • Withdrawn NCT NCT01438801

    Predictive Value of the Insulin-like Growth Factor-1 (IGF-1) Generation Test for the Growth Response to Growth Hormone Treatment (PRED-IGF)

    Not yet reported Ipsen Est. completion 2013-05-31
    Other conditions: Idiopathic Short Stature
    View official trial listing →
  • Completed NCT NCT01439061

    To Assess the Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ in Italy

    Merck KGaA, Darmstadt, Germany 220 participants Est. completion 2015-12-31 1 site
    Other conditions: Growth Disorders
    View official trial listing →
  • Completed NCT NCT01440686

    Safety, Pharmacokinetics and Pharmacodynamics Study of HL-032 in Healthy Male Volunteers

    Not yet reported HanAll BioPharma Co., Ltd. 40 participants Est. completion 2012-01 1 site
    Other conditions: Growth Hormone Deficiency
    View official trial listing →
  • Completed NCT NCT01467193

    The Effect of Dietary Fat Load and Physical Exercise on the Flexibility and Partitioning of Ectopic Lipids.

    Insel Gruppe AG, University Hospital Bern 30 participants Est. completion 2014-05 1 site
    Other conditions: Ectopic Lipids, Insulin Sensitivity, Aerobic Exercise, Fat Load, Growth Hormone Deficiency
    View official trial listing →
  • Terminated NCT NCT01491854

    Long-term Safety Follow-up After Growth Hormone Treatment of Short Children Born Small for Gestational Age

    Not yet reported Sandoz 130 participants Est. completion 2018-10-31 23 sites
    Other conditions: Short Children Born Small for Gestational Age (SGA)
    View official trial listing →
  • Status unknown NCT NCT01494779

    Evaluation of Pharmacokinetic and Pharmacodynamic Parameters of Somatropin Produced by Laboratory Blausiegel Indústria e Comércio Ltda., Compared to Saizen® From Laboratory Merck Serono S.A.

    Not yet reported Azidus Brasil 32 participants Est. completion 2013-08 1 site
    Other conditions: GH Deficiency (GHD), Growth Retardation
    View official trial listing →
  • Completed NCT NCT01495468

    Phase III Clinical Study of Pegylated Somatropin (PEG Somatropin) to Treat Growth Hormone Deficiency Children

    Not yet reported Changchun GeneScience Pharmaceutical Co., Ltd. 343 participants Est. completion 2008-03 6 sites
    Other conditions: Growth Hormone Deficiency
    View official trial listing →
  • Completed NCT NCT01500486

    Observational Study of Norditropin NordiFlex® With NordiFlex PenMate™

    Novo Nordisk A/S 84 participants Est. completion 2009-03 4 sites
    Other conditions: Growth Hormone Disorder, Growth Hormone Deficiency in Children, Delivery Systems
    View official trial listing →
  • Completed NCT NCT01502124

    Safety and Efficacy of Somatropin in Children With Growth Hormone Deficiency

    Not yet reported Novo Nordisk A/S 78 participants Est. completion 2003-03-05 21 sites
    Other conditions: Growth Hormone Disorder, Growth Hormone Deficiency in Children
    View official trial listing →
  • Completed NCT NCT01502137

    Pharmacokinetics of Somatropin in Patients With End Stage Renal Disease Receiving Chronic Haemodialysis

    Not yet reported Novo Nordisk A/S 21 participants Est. completion 2005-11 1 site
    Chronic kidney disease Other conditions: End-Stage Renal Disease, Healthy
    View official trial listing →
  • Completed NCT NCT01504802

    Pharmacodynamics of CNP During Growth Hormone Treatment

    Nemours Children's Clinic 22 participants Est. completion 2014-09 2 sites
    Other conditions: Pituitary Dwarfism, Idiopathic Short Stature
    View official trial listing →
  • Withdrawn NCT NCT01512095

    Bioequivalence of Two Products (Norditropin® Versus Nutropin AQ®) in Healthy Adult Volunteers

    Not yet reported Novo Nordisk A/S Est. completion 2013-11
    Other conditions: Growth Disorder, Healthy
    View official trial listing →
  • Completed NCT NCT01512524

    Hormonal Deficiency in the Quality of Life of Patients With Traumatic Brain Injury

    Not yet reported Hospices Civils de Lyon 88 participants Est. completion 2017-05 1 site
    Other conditions: Traumatic Brain Injury (TBI)
    View official trial listing →
  • Completed NCT NCT01516229

    Special Survey for Long Term Application

    Novo Nordisk A/S 395 participants Est. completion 2007-03-31 2 sites
    Other conditions: Genetic Disorder, Achondroplasia
    View official trial listing →
  • Completed NCT NCT01518036

    Use of Somatropin in Turner Syndrome

    Not yet reported Novo Nordisk A/S 57 participants Est. completion 2004-04-11 1 site
    Other conditions: Genetic Disorder, Turner Syndrome
    View official trial listing →
  • Completed NCT NCT01529840

    Somatropin Effect on Linear Growth and Final Height in Subjects With Noonan Syndrome

    Not yet reported Novo Nordisk A/S 24 participants Est. completion 2005-09 1 site
    Other conditions: Genetic Disorder, Noonan Syndrome
    View official trial listing →
  • Completed NCT NCT01529944

    Genetic Testing of Noonan Subjects Previously Treated With Norditropin®. An Extension to Trial GHNOO-1658

    Not yet reported Novo Nordisk A/S 22 participants Est. completion 2008-10 1 site
    Other conditions: Genetic Disorder, Noonan Syndrome
    View official trial listing →
  • Withdrawn NCT NCT01537094

    The Effect of Vitamin C on Growth Hormone Secretion

    Not yet reported Massachusetts General Hospital Est. completion 2013-12 1 site
    Other conditions: Obese, Disorder of Vitamin C, Growth Hormone Secretion Abnormality
    View official trial listing →
  • Completed NCT NCT01540773

    Single Low-Dose of Supplement Amino Acid

    Not yet reported Pennington Biomedical Research Center 16 participants Est. completion 2012-03 1 site
    Other conditions: Growth Hormone, Amino Acid
    View official trial listing →
  • Completed NCT NCT01543867

    Safety and Efficacy of Long-term Somatropin Treatment in Children

    Novo Nordisk A/S 5442 participants Est. completion 2011-12 1 site
    Other conditions: Growth Hormone Disorder, Growth Hormone Deficiency in Children, Foetal Growth Problem, Small for Gestational Age, Genetic Disorder, Turner Syndrome, Growth Disorder, Idiopathic Short Stature
    View official trial listing →
  • Completed NCT NCT01543880

    Safety and Efficacy of Long-term Somatropin Treatment in Adults

    Novo Nordisk A/S 752 participants Est. completion 2014-06 1 site
    Other conditions: Growth Hormone Disorder, Adult Growth Hormone Deficiency
    View official trial listing →
  • Completed NCT NCT01555528

    To Assess the Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ in Mexico

    Merck KGaA, Darmstadt, Germany 193 participants Est. completion 2015-12-31 1 site
    Other conditions: Growth Disorders
    View official trial listing →
  • Completed NCT NCT01562834

    Effect of Somatropin on Left Ventricular Mass in Growth Hormone Deficient Adult Patients

    Not yet reported Novo Nordisk A/S 22 participants Est. completion 2002-12-01 24 sites
    Other conditions: Growth Hormone Disorder, Adult Growth Hormone Deficiency
    View official trial listing →
  • Completed NCT NCT01563926

    Evaluating Acceptance of New Liquid Somatropin Formulation in Children With Growth Hormone Deficiency

    Not yet reported Novo Nordisk A/S 168 participants Est. completion 2002-10-10 6 sites
    Other conditions: Growth Hormone Disorder, Growth Hormone Deficiency in Children, Genetic Disorder, Turner Syndrome
    View official trial listing →
  • Status unknown NCT NCT01572259

    Assessment of the Role of the Growth Hormone (GH) Onthe Intestinal Triglyceride-rich-lipoproteins (TRL) Metabolism

    Not yet reported Assistance Publique Hopitaux De Marseille 40 participants Est. completion 2017-03 1 site
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT01576861

    Long-Term Efficacy and Safety of Growth Hormone Replacement Therapy in Chronic Heart Failure

    Not yet reported Federico II University 28 participants Est. completion 2011-12 1 site
    Heart failure Other conditions: Growth Hormone Deficiency
    View official trial listing →
  • Completed NCT NCT01578135

    French National Registry of Children Born Small for Gestational Age Treated With Somatropin

    Novo Nordisk A/S 291 participants Est. completion 2018-10-09 1 site
    Other conditions: Growth Disorder, Small for Gestational Age
    View official trial listing →
  • Completed NCT NCT01580605

    French National Registry of Adults With Growth Hormone Deficiency Treated With Somatropin

    Novo Nordisk A/S 331 participants Est. completion 2011-11-28 1 site
    Other conditions: Growth Hormone Disorder, Adult Growth Hormone Deficiency
    View official trial listing →
  • Completed NCT NCT01582334

    To Assess the Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ in Argentina

    Merck KGaA, Darmstadt, Germany 68 participants Est. completion 2015-12-31 1 site
    Other conditions: Growth Disorders
    View official trial listing →
  • Completed NCT NCT01592500

    Safety and Efficacy Phase 2 Study of Long-acting hGH (MOD-4023) in Growth Hormone Deficient Children

    Not yet reported OPKO Health, Inc. 56 participants Est. completion 2015-07 4 sites
    Other conditions: Pediatric Growth Hormone Deficiency
    View official trial listing →
  • Completed NCT NCT01604161

    Non-interventional Study of Patients Using Norditropin® for Growth Hormone Deficiency or Turner Syndrome

    Novo Nordisk A/S 2016 participants Est. completion 2015-06 1 site
    Other conditions: Growth Hormone Disorder, Growth Hormone Deficiency in Children, Genetic Disorder, Turner Syndrome
    View official trial listing →
  • Completed NCT NCT01605331

    Safety and Efficacy of SR-hGH (Sustained-release Human Growth Hormone, Declage Inj.)

    Not yet reported LG Life Sciences 132 participants Est. completion 2010-09
    Other conditions: Growth Hormone Deficiency
    View official trial listing →
  • Completed NCT NCT01613573

    Crossover Study to Assess the Safety and Pharmacokinetic of Pegylated Somatropin(PEG Somatropin) in GHD Children

    Not yet reported Changchun GeneScience Pharmaceutical Co., Ltd. 12 participants Est. completion 2010-11
    Other conditions: Growth Hormone Deficiency
    View official trial listing →
  • Withdrawn NCT NCT01614171

    Growth Hormone for Osteoporosis Pseudoglioma Syndrome

    Not yet reported University of Maryland, Baltimore Est. completion 2015-12 1 site
    Other conditions: Osteoporosis Pseudoglioma Syndrome
    View official trial listing →
  • Completed NCT NCT01616095

    Effects of Growth Hormone Supplementation to Adults With Growth Hormone Deficient on Metabolism and Adipose Tissue Molecular Phenotype

    Slovak Academy of Sciences 44 participants Est. completion 2015-08 3 sites
    Other conditions: Growth Hormone Deficiency
    View official trial listing →
  • Terminated NCT NCT01616225

    Growth Hormone in Poor Responders to IVF Trial

    Not yet reported, Not yet reported Pacific Centre for Reproductive Medicine 60 participants Est. completion 2015-08 1 site
    Other conditions: Infertility
    View official trial listing →
  • Completed NCT NCT01626833

    Severe Decrease of Growth Velocity in Children With Anorexia Nervosa.Therapeutic Trial of Growth Hormone

    Not yet reported, Not yet reported Assistance Publique - Hôpitaux de Paris 15 participants Est. completion 2021-03 1 site
    Obstructive sleep apnea Other conditions: Interruption of Growth, Delayed Puberty, Osteopenia With Failure of Acquisition of Bone Mass
    View official trial listing →
  • Withdrawn NCT NCT01632592

    Abdominal Obesity, Cardiovascular Inflammation, and Effects of Growth Hormone Releasing Hormone Analogue

    Not yet reported Massachusetts General Hospital Est. completion 2014-01 1 site
    Other conditions: Abdominal Obesity
    View official trial listing →
  • Withdrawn NCT NCT01647412

    Growth Hormone and Exclusion Diet Therapy in Juvenile Crohn's Disease

    Not yet reported Columbia University 1 site
    Other conditions: Crohn's Disease
    View official trial listing →
  • Completed NCT NCT01699308

    Growth Hormone and Brain Functioning After Traumatic Brain Injury

    Not yet reported Joe Springer 15 participants Est. completion 2014-04-01 1 site
    Other conditions: Traumatic Brain Injury
    View official trial listing →
  • Completed NCT NCT01701973

    Effect of DPP4 Inhibition on Growth Hormone Secretion

    Not yet reported Vanderbilt University 44 participants Est. completion 2017-05 1 site
    Other conditions: Obesity
    View official trial listing →
  • Completed NCT NCT01715324

    Adjuvant Growth Therapy in in Vitro Fertilization

    Not yet reported Clinique Ovo 288 participants Est. completion 2021-08 1 site
    Other conditions: Infertility
    View official trial listing →
  • Completed NCT NCT01718041

    Versartis Trial in Children to Assess Long-Acting Growth Hormone

    Not yet reported, Not yet reported Versartis Inc. 64 participants Est. completion 2014-07 23 sites
    Other conditions: Pediatric Growth Hormone Deficiency
    View official trial listing →
  • Completed NCT NCT01723748

    Somatostatin Analogue Treatment of Acromegaly: Molecular Aspects

    Not yet reported University of Aarhus 18 participants Est. completion 2015-05 1 site
    Other conditions: Acromegaly, Metabolic Diseases
    View official trial listing →
  • Completed NCT NCT01724489

    Study of Growth Hormone and Bone in Obesity

    Not yet reported Massachusetts General Hospital 77 participants Est. completion 2019-04-01 1 site
    Other conditions: Obesity, Osteopenia
    View official trial listing →
  • Completed NCT NCT01732406

    Acromegaly Treatment Quality of Life Study

    Massachusetts General Hospital 126 participants Est. completion 2016-12-19 1 site
    Other conditions: Acromegaly
    View official trial listing →
  • Completed NCT NCT01734447

    Long Term Effect of Somatropin in Subjects With Intrauterine Growth Retardation

    Not yet reported Novo Nordisk A/S 57 participants Est. completion 2003-04-30 1 site
    Other conditions: Foetal Growth Problem, Small for Gestational Age
    View official trial listing →
  • Completed NCT NCT01734486

    Growth Response in Girls With Turner Syndrome

    Not yet reported Novo Nordisk A/S 31 participants Est. completion 2003-05-21 15 sites
    Other conditions: Genetic Disorder, Turner Syndrome
    View official trial listing →
  • Completed NCT NCT01746862

    A Phase 3 Study to Evaluate the Safety and Efficacy of Saizen® in Children With Idiopathic Short Stature (ISS)

    Not yet reported Merck KGaA, Darmstadt, Germany 90 participants Est. completion 2015-03 1 site
    Other conditions: Idiopathic Short Stature
    View official trial listing →
  • Completed NCT NCT01778023

    Efficacy and Safety of Recombinant Human Growth Hormone on Height Velocity in Subjects With Idiopathic Short Stature

    Not yet reported Novo Nordisk A/S 54 participants Est. completion 2014-12-17 8 sites
    Other conditions: Growth Disorder, Idiopathic Short Stature
    View official trial listing →
  • Completed NCT NCT01786902

    Efficacy and Safety of DA-3002 in Children With Idiopathic Short Stature

    Not yet reported Dong-A ST Co., Ltd. 70 participants Est. completion 2014-04
    Other conditions: Idiopathic Short Stature
    View official trial listing →
  • Status unknown NCT NCT01795235

    Study of Glucagon, Ghrelin and Growth Hormone as Counterregulatory Hormones

    Not yet reported University of Virginia 6 participants Est. completion 2014-07 1 site
    Other conditions: Healthy
    View official trial listing →
  • Status unknown NCT NCT01804413

    Pegvisomant With Glucagon Test to Assess for Adult Growth Hormone Deficiency

    Not yet reported Oregon Health and Science University 10 participants Est. completion 2013-12 1 site
    Other conditions: Adults Growth Hormone Deficiency.
    View official trial listing →
  • Completed NCT NCT01806298

    An Open-label Phase 4 Study to Explore Immunogenicity of the Liquid Formulation of Saizen® in Subjects With Adult Growth Hormone Deficiency (AGHD)

    Not yet reported Merck KGaA, Darmstadt, Germany 78 participants Est. completion 2016-03 19 sites
    Other conditions: Adult Growth Hormone Deficiency
    View official trial listing →
  • Completed NCT NCT01809808

    A Prospective Study of Outcome After Therapy for Acromegaly

    Columbia University 280 participants Est. completion 2025-08 1 site
    Other conditions: Acromegaly
    View official trial listing →
  • Completed NCT NCT01813630

    A Clinical Study to Assess the Efficacy and Safety of DA-3002

    Not yet reported Dong-A ST Co., Ltd. 58 participants Est. completion 2018-05 1 site
    Other conditions: Turner's Syndrome
    View official trial listing →
  • Completed NCT NCT01853566

    Effects of Growth Hormone Administration on Muscle Strength and Body Composition in Men Over 50 Years Old

    Not yet reported Universidade Federal do Rio de Janeiro 13 participants Est. completion 2013-06 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT01859949

    Long Term Study of Genotropin (Somatropin) for Short Children Born Small for Gestational Age (SGA)

    Not yet reported Pfizer 62 participants Est. completion 2015-08 19 sites
    Other conditions: Short Stature Born Small for Gestational Age (SGA)
    View official trial listing →
  • Terminated NCT NCT01861717

    A Pilot Study of Pre- and Post-operative Use of Somatuline Depot.

    Not yet reported Saint John's Cancer Institute 4 participants Est. completion 2016-01 1 site
    Other conditions: Acromegaly
    View official trial listing →
  • Completed NCT NCT01877512

    GH and Cardiovascular Risk Factors

    Not yet reported Amsterdam UMC, location VUmc 32 participants Est. completion 2014-04 1 site
    Cardiovascular diseaseMetabolic syndrome Other conditions: Growth Hormone Deficiency, Cognition, Physical Activity
    View official trial listing →
  • Completed NCT NCT01897324

    IVF/ICSI Protocols in Poor Responders With Growth Hormone

    Not yet reported Woman's Health University Hospital, Egypt 287 participants Est. completion 2015-01 1 site
    Other conditions: Female Infertility Due to Diminished Ovarian Reserve
    View official trial listing →
  • Completed NCT NCT01897753

    Retrospective Study Of The Influence Of Age At Start Of Growth Hormone Treatment On Height Gain In Children Born Small for Gestational Age

    Pfizer 264 participants Est. completion 2013-09 12 sites
    Other conditions: Small For Gestational Age (SGA)
    View official trial listing →
  • Completed NCT NCT01897766

    Special Investigation Of Genotropin Long Follow-Up For Patients With A Small For Gestational Age "Scoped for Japanese"

    Pfizer 482 participants Est. completion 2017-06-07
    Other conditions: Small for Gestational Age (SGA)
    View official trial listing →
  • Status unknown NCT NCT01902420

    Aryl Hydrocarbon Receptor Interacting Protein (AIP) Gene Mutations in Acromegaly

    TC Erciyes University 80 participants Est. completion 2014-08 1 site
    Other conditions: Acromegaly
    View official trial listing →
  • Terminated NCT NCT01909479

    A Phase 3, Multicenter Study To Evaluate The Efficacy And Safety Of MOD-4023 In Adults With Growth Hormone Deficiency

    Not yet reported OPKO Health, Inc. 202 participants Est. completion 2018-08 1 site
    Other conditions: Adult Growth Hormone Deficiency
    View official trial listing →
  • Completed NCT NCT01927861

    Investigating the Long-term Efficacy and Safety of Two Doses of NN-220 (Somatropin) in Short Stature Due to Noonan Syndrome

    Not yet reported Novo Nordisk A/S 51 participants Est. completion 2018-07-12 27 sites
    Other conditions: Genetic Disorder, Noonan Syndrome
    View official trial listing →
  • Status unknown NCT NCT01934270

    Growth Hormone Secretion Following the Anaerobic Exercise

    Not yet reported Meir Medical Center 100 participants Est. completion 2020-03-01 1 site
    Other conditions: Short Stature, Obesity, Childhood
    View official trial listing →
  • Completed NCT NCT01943084

    A Trial to Investigate the Bioequivalence of Norditropin® (Somatropin) Versus Genotropin® (Somatropin) in Healthy Adult Subjects

    Not yet reported Novo Nordisk A/S 32 participants Est. completion 2013-10 1 site
    Other conditions: Growth Disorder, Healthy
    View official trial listing →
  • Completed NCT NCT01947894

    A Prospective Non-Interventional Study Protocol With Primary Data Collection - Assessment Of The Long Term Treatment Outcomes Of Genotropin Treatment In Growth Hormone Deficiency (GHD) Patients

    Pfizer 377 participants Est. completion 2018-10-31 12 sites
    Other conditions: Growth Hormone Deficiency
    View official trial listing →
  • Completed NCT NCT01947907

    Safety, PK/PD (Pharmacokinetics/Pharmacodynamics) and Efficacy of ACP-001 Weekly Versus Daily hGH in Children With Growth Hormone Deficiency (GHD)

    Not yet reported Ascendis Pharma A/S 53 participants Est. completion 2015-09 36 sites
    Other conditions: Growth Hormone Deficiency (GHD)
    View official trial listing →
  • Withdrawn NCT NCT01970800

    The Role of Igf-1 Generation Test in Diagnosis and Treatment of Short Stature

    Not yet reported Maimonides Medical Center Est. completion 2014-12 1 site
    Other conditions: Short Stature
    View official trial listing →
  • Completed NCT NCT01973244

    A Trial Investigating Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of a Single Dose of Long-acting Growth Hormone (Somapacitan) Compared to Daily Dosing of Norditropin® SimpleXx® in Children With Growth Hormone Deficiency

    Not yet reported Novo Nordisk A/S 32 participants Est. completion 2014-11-04 22 sites
    Other conditions: Growth Hormone Disorder, Growth Hormone Deficiency in Children
    View official trial listing →
  • Completed NCT NCT02005198

    Assessing the Minimal Important Difference (MID) of the Treatment Related Impact Measure-Adult Growth Hormone Deficiency (TRIM-AGHD)

    Novo Nordisk A/S 98 participants Est. completion 2015-12 1 site
    Other conditions: Growth Hormone Disorder, Adult Growth Hormone Deficiency
    View official trial listing →
  • Completed NCT NCT02012556

    Pharmacokinetic and Pharmacodynamic Study of TH9507, a Growth Hormone-Releasing Factor Analog, in HIV Positive Patients

    Not yet reported Theratechnologies 18 participants Est. completion 2008-07 1 site
    Other conditions: HIV
    View official trial listing →
  • Completed NCT NCT02015273

    To Assess the Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ (ECOS Taiwan, Indonesia, Singapore)

    Merck KGaA, Darmstadt, Germany 82 participants Est. completion 2015-12-31 6 sites
    Other conditions: Growth Disorders
    View official trial listing →
  • Completed NCT NCT02015286

    To Assess the Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ in Middle East

    Merck KGaA, Darmstadt, Germany 7 participants Est. completion 2015-12-31 1 site
    Other conditions: Growth Disorders
    View official trial listing →
  • Terminated NCT NCT02018172

    Evaluation of the Adherence and the Patient Acceptability of Zomacton® Treatment With the Zomajet® Vision X Device

    Ferring Pharmaceuticals 3 participants Est. completion 2015-02 1 site
    Other conditions: Growth Hormone Deficiency, Turner's Syndrome
    View official trial listing →
  • Completed NCT NCT02023918

    Role of Growth Hormone Antagonism in Modulating Insulin Sensitivity in Subjects With Pre-diabetes

    Not yet reported University of California, San Francisco 6 participants Est. completion 2015-12 1 site
    Metabolic syndrome Other conditions: Diabetes, Insulin Resistance
    View official trial listing →
  • Completed NCT NCT02026973

    Impact of Endogenous E2 on SSI and GH Rebound

    Not yet reported Mayo Clinic 62 participants Est. completion 2015-11 1 site
    Other conditions: Normal Healthy Volunteers
    View official trial listing →
  • Completed NCT NCT02042170

    Efficacy and Safety Study of Sr-hGH in Comparison With Daily hGH in ISS Patients

    Not yet reported LG Life Sciences 46 participants Est. completion 2015-03 1 site
    Other conditions: Establishing Dose of Sr-hGH in ISS Patients
    View official trial listing →
  • Status unknown NCT NCT02049671

    Elucidation of the Effects of Growth Hormone (GH) Deficiency and GH Replacement on Clot and Platelet

    The Leeds Teaching Hospitals NHS Trust 150 participants Est. completion 2020-07-30 1 site
    Other conditions: Hypopituitary Adults
    View official trial listing →
  • Terminated NCT NCT02068521

    Versartis Long-Term Safety Study of Somavaratan

    Not yet reported, Not yet reported Versartis Inc. 385 participants Est. completion 2017-11-17
    Other conditions: Pediatric Growth Hormone Deficiency
    View official trial listing →
  • Completed NCT NCT02077348

    Metabolic Signalling in Muscle- and Adipose-tissue Following Insulin Withdrawal and Growth Hormone Injection.

    Not yet reported University of Aarhus 9 participants Est. completion 2015-09 1 site
    Other conditions: Diabetes Mellitus Type I, Ketoacidosis
    View official trial listing →
  • Terminated NCT NCT02092077

    A Phase 2, Safety and Dose-Finding Study in Treatment-Naive, Pre-Pubertal, Growth Hormone-Deficient Children

    Not yet reported Teva Pharmaceutical Industries, Ltd. 65 participants Est. completion 2016-08-31 34 sites
    Other conditions: Growth Hormone-Deficiency
    View official trial listing →
  • Completed NCT NCT02092779

    Growth Hormone Deficiency and Empty Sella Cardio-Metabolic Risk Factors in Obesity: a Cross-Sectional Study

    University of Roma La Sapienza 447 participants Est. completion 2014-03
    Other conditions: Obesity
    View official trial listing →
  • Completed NCT NCT02114775

    Growth Hormone or Sildenafil as Therapies for Fatigue in Mild- Traumatic-brain-injury (MTBI)

    Not yet reported The University of Texas Medical Branch, Galveston 34 participants Est. completion 2017-11-10 1 site
    Other conditions: Traumatic Brain Injury
    View official trial listing →
  • Status unknown NCT NCT02115906

    Assessment of Changes in Metabolic Activity in Liver & Skeletal Muscle in Patients Suffering From Acromegaly

    Medical University of Vienna 24 participants Est. completion 2018-05 1 site
    Other conditions: Acromegaly
    View official trial listing →
  • Completed NCT NCT02122380

    The Effect of Dipeptidyl Peptidase 4 Inhibition on Growth Hormone Secretion in Women With Polycystic Ovarian Syndrome

    Not yet reported Vanderbilt University 23 participants Est. completion 2019-08-01 1 site
    Other conditions: Polycystic Ovary Syndrome
    View official trial listing →
  • Withdrawn NCT NCT02124070

    Therapeutic Effect of Recombinant Human Growth Hormone (rhGH) on the Myopathy of Cystinosis

    Not yet reported, Not yet reported National Human Genome Research Institute (NHGRI) Est. completion 2015-11-06
    Other conditions: Cystinosis, Myopathy
    View official trial listing →
  • Completed NCT NCT02152124

    Growth Hormone, IGF-1 and Medical Treatment in Acromegaly: Are There Effects on Gut Hormone Physiology and Postprandial Substrate Metabolism?

    University Hospital, Ghent 21 participants Est. completion 2017-08-31 1 site
    Other conditions: Acromegaly
    View official trial listing →
  • Completed NCT NCT02173821

    A Follow-up Study to Examine the Presence of Anti-human Growth Hormone Antibodies Following a Study (FE 999905 CS07) of Zomacton in Children With Growth Hormone Deficiency

    Not yet reported Ferring Pharmaceuticals 23 participants Est. completion 2015-04 7 sites
    Other conditions: Idiopathic Growth Hormone Deficiency
    View official trial listing →
  • Status unknown NCT NCT02179255

    Human Growth Hormone Pre-treatment for 6 Weeks Prior to Ovulation Induction for IVF

    Not yet reported, Not yet reported Center for Human Reproduction 30 participants Est. completion 2022-06 1 site
    Other conditions: Female Infertility Due to Diminished Ovarian Reserve
    View official trial listing →
  • Completed NCT NCT02196831

    Tesamorelin Effects on Liver Fat and Histology in HIV

    Not yet reported Massachusetts General Hospital 61 participants Est. completion 2019-07-24 2 sites
    MASLDMASH Other conditions: Human Immunodeficiency Virus (HIV)
    View official trial listing →
  • Completed NCT NCT02199587

    The Effect of Medical Clown on the Pain and Anxiety Perception During LRH Analog Treatment or GH Provocation Test

    Not yet reported Meir Medical Center 58 participants Est. completion 2018-08-01 1 site
    Other conditions: Precocious Puberty, Growth Hormone Tests
    View official trial listing →
  • Completed NCT NCT02204163

    Study to Assess the Efficacy and Safety of Eutropin in Prader-Willi Syndrome

    Not yet reported LG Life Sciences 34 participants Est. completion 2017-12 3 sites
    Other conditions: Prader-Willi Syndrome
    View official trial listing →
  • Completed NCT NCT02205450

    Growth Hormone in Children Under 2 Years With Prader-Willi in Hospital of Sabadell

    Corporacion Parc Tauli 16 participants Est. completion 2019-07-29 1 site
    Other conditions: Prader-Willi Syndrome
    View official trial listing →
  • Completed NCT NCT02208076

    To Assess the Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ in Columbia

    Merck KGaA, Darmstadt, Germany 44 participants Est. completion 2015-12-31 1 site
    Other conditions: Growth Disorders
    View official trial listing →
  • Completed NCT NCT02217345

    Growth Hormone and Intrahepatic Lipid Content in Patients With Nonalcoholic Fatty Liver Disease

    Not yet reported Massachusetts General Hospital 131 participants Est. completion 2021-09-13 1 site
    MASLD
    View official trial listing →
  • Completed NCT NCT02217800

    The Effect of Subcutaneous Infusions of 3 Doses of DG3173 on Growth Hormone Levels in Untreated Acromegalics

    Not yet reported Aspireo Pharmaceuticals Limited 8 participants Est. completion 2016-05
    Other conditions: Acromegaly
    View official trial listing →
  • Completed NCT NCT02229851

    Trial to Compare the Efficacy and Safety of NNC0195-0092 (Somapacitan) With Placebo and Norditropin® FlexPro® (Somatropin) in Adults With Growth Hormone Deficiency.

    Not yet reported Novo Nordisk A/S 301 participants Est. completion 2018-05-07 117 sites
    Other conditions: Growth Hormone Disorder, Adult Growth Hormone Deficiency
    View official trial listing →
  • Status unknown NCT NCT02232100

    Attentional Bias Modification Training for People With Chronic Musculoskeletal Pain

    Not yet reported University of Southampton 160 participants Est. completion 2023-11-01 1 site
    Other conditions: Chronic Pain
    View official trial listing →
  • Completed NCT NCT02240043

    Growth Hormone Evaluation in the Elderly People

    Not yet reported Universidade Federal do Rio de Janeiro 48 participants Est. completion 2013-08
    Other conditions: Aging
    View official trial listing →
  • Withdrawn NCT NCT02243852

    Effects of Growth Hormone (GH) Deficiency and Growth Hormone Replacement on Serum Fibroblast Growth Factor 21 (FGF21)

    University of Liverpool Est. completion 2017-06-06 2 sites
    Other conditions: Growth Hormone Deficiency
    View official trial listing →
  • Status unknown NCT NCT02263781

    PREPL in Health and Disease

    Not yet reported Universitaire Ziekenhuizen KU Leuven 125 participants Est. completion 2025-01 1 site
    Other conditions: Hypotonia-Cystinuria Syndrome, Muscle Hypotonia, Healthy Volunteers, Dwarfism, Growth Hormone Deficiency, Obesity, Prader-Willi Syndrome
    View official trial listing →
  • Completed NCT NCT02271282

    Estradiol-Receptor Blockade in Older Men and Women

    Not yet reported Mayo Clinic 40 participants Est. completion 2016-05 1 site
    Other conditions: Normal Healthy Volunteers
    View official trial listing →
  • Completed NCT NCT02272647

    Progesterone Amplifies Estrogen-stimulated Growth Hormone Secretion in Older Women

    Not yet reported Mayo Clinic 47 participants Est. completion 2018-02 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT02311894

    A Post-Marketing Study of the Immunogenicity of Somatropin (Ribosomal Deoxyribo Nucleic Acid [rDNA] Origin) Injection (Nutropin AQ®) in Children With Growth Hormone Deficiency

    Not yet reported Genentech, Inc. 82 participants Est. completion 2017-11-08 33 sites
    Other conditions: Growth Hormone Deficiency
    View official trial listing →
  • Status unknown NCT NCT02314676

    Phase IV Clinical Study of Pegylated Somatropin (PEG Somatropin) to Treat Growth Hormone Deficiency Children

    Not yet reported Changchun GeneScience Pharmaceutical Co., Ltd. 900 participants 2 sites
    Other conditions: Dwarfism, Pituitary
    View official trial listing →
  • Status unknown NCT NCT02322034

    Interval Training and Hormones in Chronic Heart Failure

    Not yet reported Federico II University 80 participants Est. completion 2019-01 1 site
    Heart failure
    View official trial listing →
  • Status unknown NCT NCT02326610

    Early hGH Treatment of SGA Infants to Prevent Irreversible Neurologic and Psychological Damage and Sequelae

    Not yet reported Tel-Aviv Sourasky Medical Center 20 participants Est. completion 2018-12
    Other conditions: Infant, Small for Gestational Age, Growth Hormone Treatment, Infant, Premature, Diseases
    View official trial listing →
  • Status unknown NCT NCT02335801

    The TOSCA Registry: Hormonal and Metabolic Deficiencies in Chronic Heart Failure

    Federico II University 650 participants Est. completion 2019-12-01 17 sites
    Heart failure
    View official trial listing →
  • Completed NCT NCT02338206

    Long Protocol and Growth Hormone in Poor Responders

    Not yet reported Woman's Health University Hospital, Egypt 240 participants Est. completion 2017-11-15 1 site
    Other conditions: Infertility
    View official trial listing →
  • Completed NCT NCT02339090

    Long-Acting Growth Hormone in Children Compared to Daily rhGH

    Not yet reported Versartis Inc. 138 participants Est. completion 2017-08-23
    Other conditions: Growth Disorders
    View official trial listing →
  • Completed NCT NCT02359695

    Low-dose GH Supplementation Increases Clinical Pregnancy Rate

    Not yet reported Centro de Infertilidad y Reproducción Humana 64 participants Est. completion 2017-05 1 site
    Other conditions: Infertility
    View official trial listing →
  • Active, not recruiting NCT NCT02375620

    Clinical Study of Pegylated Somatropin (PEG Somatropin) to Treat SGA Children With Short Stature

    Not yet reported Changchun GeneScience Pharmaceutical Co., Ltd. 96 participants Est. completion 2025-12 9 sites
    Other conditions: Short Stature Children Born Small for Gestational Age (SGA)
    View official trial listing →
  • Status unknown NCT NCT02380235

    Phase IV Clinical Study of Pegylated Somatropin (PEG Somatropin) to Treat Growth Hormone Deficiency Children (Clinical Trial I)

    Not yet reported Changchun GeneScience Pharmaceutical Co., Ltd. 600 participants Est. completion 2017-07 12 sites
    Other conditions: Growth Hormone Deficiency
    View official trial listing →
  • Completed NCT NCT02382939

    A Trial to Compare the Safety of Once Weekly Dosing of Somapacitan With Daily Norditropin® FlexPro® for 26 Weeks in Previously Human Growth Hormone Treated Adults With Growth Hormone Deficiency

    Not yet reported Novo Nordisk A/S 92 participants Est. completion 2016-01-04 28 sites
    Other conditions: Adult Growth Hormone Deficiency, Growth Hormone Disorder
    View official trial listing →
  • Terminated NCT NCT02410343

    Study of TV-1106 in Growth Hormone-Deficient Adults

    Not yet reported Teva Branded Pharmaceutical Products R&D, Inc. 14 participants Est. completion 2015-12-31 33 sites
    Other conditions: Growth Hormone Deficiency
    View official trial listing →
  • Terminated NCT NCT02413138

    Versartis Trial in Pre-pubertal Japanese Children With Growth Hormone Deficiency (GHD) to Assess Long-Acting Growth Hormone (Somavaratan, VRS-317)

    Not yet reported, Not yet reported Versartis Inc. 41 participants Est. completion 2017-11-30 1 site
    Other conditions: Pediatric Growth Hormone Deficiency, Growth Disorders
    View official trial listing →
  • Completed NCT NCT02418767

    Pharmacokinetics and Pharmacodynamics of Long Acting Human Growth Hormone (hGH) Product (MOD-4023) in Healthy Caucasian and Japanese Volunteers

    Not yet reported OPKO Health, Inc. 42 participants Est. completion 2015-06 1 site
    Other conditions: Growth Hormone Deficiency
    View official trial listing →
  • Completed NCT NCT02420353

    Evaluation of rGH Therapy to Prevent Muscle Atrophy in Patients With ACL Tears

    Not yet reported University of Michigan 20 participants Est. completion 2018-10 1 site
    Other conditions: Rupture of Anterior Cruciate Ligament
    View official trial listing →
  • Completed NCT NCT02424240

    Growth Hormone (GH) Deficiency & Insulin Like Growth Factor 1 (IGF-I)/ Insulin Like Growth Factor Binding Protein 3 (IGFBP-3) Ratio

    University of Jordan 134 participants
    Other conditions: Diagnosis of GHD With IGF-I/IGFBP-3 Ratio
    View official trial listing →
  • Status unknown NCT NCT02480985

    The PIT-TBI Pilot Study

    Not yet reported CHU de Quebec-Universite Laval 70 participants Est. completion 2018-03 5 sites
    Other conditions: Pituitary Disorders, Traumatic Brain Injury
    View official trial listing →
  • Completed NCT NCT02500095

    Substrate Metabolism, Growth Hormone Signaling, and Insulin Sensitivity During Fasting

    Not yet reported University of Aarhus 10 participants Est. completion 2016-11 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT02500316

    Long Term Follow up Study of Long-acting hGH (MOD-4023) in Growth Hormone Deficient Children

    Not yet reported OPKO Health, Inc. 48 participants Est. completion 2023-11 13 sites
    Other conditions: Growth Hormone Deficiency (GHD)
    View official trial listing →
  • Completed NCT NCT02507245

    Observational Longitudinal Study in Children Affected by Idiopathic Growth Hormone Deficiency (GHD)

    Stefania La Grutta, MD 48 participants Est. completion 2015-05
    Other conditions: Growth Hormone Deficiency
    View official trial listing →
  • Completed NCT NCT02526420

    Versartis International Trial in Adults With Long-Acting Growth Hormone

    Not yet reported Versartis Inc. 36 participants Est. completion 2016-10 18 sites
    Other conditions: Adult Growth Hormone Deficiency
    View official trial listing →
  • Completed NCT NCT02553603

    The Effect of Growth Hormone Releasing Hormone on Cognitive Function in Individuals With Mild Cognitive Impairment

    Not yet reported The University of Texas Medical Branch, Galveston 22 participants Est. completion 2019-01-17 1 site
    Other conditions: Mild Cognitive Impairment
    View official trial listing →
  • Completed NCT NCT02558829

    Validation of Macimorelin as a Test for Adult Growth Hormone Deficiency

    Not yet reported AEterna Zentaris 157 participants Est. completion 2016-11-29 27 sites
    Other conditions: Growth Hormone Deficiency With Pituitary Anomalies
    View official trial listing →
  • Completed NCT NCT02574793

    Glycemic Fluctuations in Newly Diagnosed Growth Hormone-Secreting Pituitary Adenoma and Cushing Syndrome Subjects

    Huashan Hospital 60 participants Est. completion 2018-01-07 1 site
    Other conditions: Pituitary Adenoma
    View official trial listing →
  • Completed NCT NCT02580032

    Validation of Two Measures for Growth Hormone Deficiency in Children, the Treatment Related Impact Measure of Childhood Growth Hormone Deficiency (TRIM-CGHD) and the Treatment Burden Measure of Childhood Growth Hormone Deficiency (TB-CGHD)

    Novo Nordisk A/S 252 participants Est. completion 2018-05-14 28 sites
    Other conditions: Growth Disorder, Growth Hormone Deficiency in Children
    View official trial listing →
  • Withdrawn NCT NCT02597660

    A Study to Evaluate the Efficacy of Somatropin in the Treatment of Patellar Tendinopathy

    Not yet reported Hospital for Special Surgery, New York Est. completion 2020-12-01 1 site
    Other conditions: Tendinopathy
    View official trial listing →
  • Terminated NCT NCT02599701

    Acute Effects of Gabapentin in Sleep Parameters and Hormonal Release During Sleep in Older Men

    Not yet reported Associação Fundo de Incentivo à Pesquisa 8 participants Est. completion 2015-12 1 site
    Other conditions: Sleep
    View official trial listing →
  • Status unknown NCT NCT02629926

    Transitional Growth Hormone (GH) Use in Growth Hormone Deficient (GHD) Cancer Survivors

    The Leeds Teaching Hospitals NHS Trust 60 participants 1 site
    Other conditions: Metabolic Diseases, Cancer
    View official trial listing →
  • Completed NCT NCT02655263

    Substrate Metabolism, Growth Hormone Signaling (GH), and Insulin Sensitivity During GH and Ketone Bodies Infusion

    Not yet reported University of Aarhus 10 participants Est. completion 2017-10 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT02693522

    Evaluation of Efficacy and Safety of Recombinant Somatroipn in Patients With Growth Hormone Deficiency

    Not yet reported Daewoong Pharmaceutical Co. LTD. 52 participants Est. completion 2004-12 1 site
    Other conditions: Growth Hormone Deficiency
    View official trial listing →
  • Terminated NCT NCT02719990

    Open-label Extension Study to Evaluate the Safety of Long-term Twice-monthly Administration of Somavaratan in Adult Growth Hormone Deficiency (AGHD)

    Not yet reported Versartis Inc. 36 participants Est. completion 2018-01-11
    Other conditions: Adult Growth Hormone Deficiency (AGHD)
    View official trial listing →
  • Completed NCT NCT02720770

    Growth Hormone Treatment in Children With Hypophosphatemic Rickets

    Not yet reported, Not yet reported Bicetre Hospital 19 participants Est. completion 2011-01
    Other conditions: X Linked Hypophosphatemic Rickets
    View official trial listing →
  • Completed NCT NCT02726542

    Augmenting Growth Hormone to Ameliorate Nonalcoholic Fatty Liver Disease in Adolescents

    Not yet reported Massachusetts General Hospital 24 participants Est. completion 2020-04-02 1 site
    MASLD
    View official trial listing →
  • Status unknown NCT NCT02736591

    Dehydroepiandrosterone Versus Growth Hormone in Women Undergoing ICSI With Expected Poor Ovarian Response

    Not yet reported Cairo University 210 participants 2 sites
    Other conditions: Subfertility
    View official trial listing →
  • Status unknown NCT NCT02766764

    Combined Dehydropeiandrosterone and Growth Hormone in Women With Expected Poor Ovarian Response Undergoing ICSI

    Not yet reported Cairo University 230 participants 2 sites
    Other conditions: Subfertility
    View official trial listing →
  • Completed NCT NCT02770157

    Efficacy and Safety of DA-3002 in Short Children Borns SGA.

    Not yet reported Dong-A ST Co., Ltd. 75 participants Est. completion 2019-08-28 1 site
    Other conditions: Infant, Small for Gestational Age
    View official trial listing →
  • Completed NCT NCT02781727

    A Phase 3 Trial of the Safety, Tolerability and Efficacy of TransCon hGH Weekly Versus Daily hGH in Children With Growth Hormone Deficiency (GHD)

    Not yet reported Ascendis Pharma Endocrinology Division A/S 162 participants Est. completion 2019-01-17 53 sites
    Other conditions: Growth Hormone Deficiency, Pediatric, hGH (Human Growth Hormone), Endocrine System Diseases, Hormones, Pituitary Diseases
    View official trial listing →
  • Completed NCT NCT02782221

    Lipolytic Effects of GH in Human Subjects in Vivo

    Not yet reported University of Aarhus 9 participants Est. completion 2017-01-15 1 site
    Other conditions: Metabolic Diseases, Growth Hormone Treatment
    View official trial listing →
  • Status unknown NCT NCT02801591

    Effect of Recombinant Human Growth Hormone Injection on the Clinical Outcome of POR in Patients Undergoing IVF/ET

    Changchun GeneScience Pharmaceutical Co., Ltd. 240 participants 2 sites
    Other conditions: Poor Ovarian Response
    View official trial listing →
  • Completed NCT NCT02879747

    Individualizing Dose of Growth Hormone to Maintain Normal Growth Velocity After Fulfilled Catch up Growth in Children

    Not yet reported, Not yet reported Göteborg University 99 participants Est. completion 2017-12
    Other conditions: Short Stature
    View official trial listing →
  • Status unknown NCT NCT02908958

    Clinical Study of Pegylated Somatropin to Treat Children Growth Hormone Deficiency

    Not yet reported Changchun GeneScience Pharmaceutical Co., Ltd. 900 participants 22 sites
    Other conditions: Growth Hormone Deficiency
    View official trial listing →
  • Status unknown NCT NCT02931591

    Effect of Insulin Sensitization on IGF-1 Response to Growth Hormone in SGA Children

    Not yet reported Cambridge University Hospitals NHS Foundation Trust 24 participants Est. completion 2020-06
    Other conditions: Small for Gestational Age
    View official trial listing →
  • Completed NCT NCT02946606

    A Clinical Study in AGHD to Assess Safety, Tolerability and Efficacy of GX-H9

    Not yet reported Genexine, Inc. 45 participants Est. completion 2016-12-30 1 site
    Other conditions: Adult Growth Hormone Deficiency
    View official trial listing →
  • Completed NCT NCT02968004

    Safety and Efficacy Phase 3 Study of Long-acting hGH (MOD-4023) in Growth Hormone Deficient Children

    Not yet reported OPKO Health, Inc. 224 participants Est. completion 2024-05 81 sites
    Other conditions: Pediatric Growth Hormone Deficiency
    View official trial listing →
  • Status unknown NCT NCT02973061

    The Impact of the Use of Recombinant Human Growth Hormone on ADHD Characteristics in Children and Adolescents

    Assaf-Harofeh Medical Center 100 participants Est. completion 2024-12 1 site
    Other conditions: Growth Hormone Deficiency, Attention Deficit Disorder, Idiopathic Short Stature
    View official trial listing →
  • Status unknown NCT NCT02976675

    Pegylated Somatropin (PEG Somatropin) in the Treatment of Children With Growth Hormone Deficiency

    Not yet reported Changchun GeneScience Pharmaceutical Co., Ltd. 600 participants 24 sites
    Other conditions: Growth Hormone Deficiency
    View official trial listing →
  • Status unknown NCT NCT02977091

    Fitness Level in Short Stature Children and After Growth Hormone Treatment

    Meir Medical Center 50 participants Est. completion 2019-03-01 1 site
    Other conditions: Fitness
    View official trial listing →
  • Completed NCT NCT02987868

    Effects of an Amino Acid-Based hGH Secretagogue on Triiodythyronine

    Not yet reported Pennington Biomedical Research Center 16 participants Est. completion 2012-12
    Other conditions: Growth Hormone Treatment, Aging
    View official trial listing →
  • Completed NCT NCT02988687

    Metabolic and QOL Effects of GH Treatment in Patients With TBI and AGHD

    Garcia, Jose M., MD, PhD 7 participants Est. completion 2022-10 1 site
    Other conditions: Adult-Onset Growth Hormone Deficiency
    View official trial listing →
  • Status unknown NCT NCT03005561

    Detection of Difficulties and Improvement Compliance to Growth Hormone Treatment

    Not yet reported Prof. Eli Hershkovitz 200 participants Est. completion 2018-03
    Other conditions: Growth Hormone Treatment
    View official trial listing →
  • Completed NCT NCT03015909

    Evaluation of the Ease of Use, Preference, and Safety of EutropinPen Inj.

    Not yet reported LG Life Sciences 116 participants Est. completion 2017-12-21 1 site
    Other conditions: Short Stature, Idiopathic, Infant, Small for Gestational Age, Growth Hormone Deficiency, Chronic Renal Failure, Turner Syndrome
    View official trial listing →
  • Status unknown NCT NCT03027843

    The Effect of Growth Hormone in Assisted Reproductive Technology Clinical Outcome of Poor Responder

    Not yet reported Sun Yat-sen University 80 participants Est. completion 2020-04
    Other conditions: Low Ovarian Reserve
    View official trial listing →
  • Completed NCT NCT03031535

    Study of Intranasal Octreotide (DP1038) in Healthy Adult Volunteers

    Not yet reported Dauntless Pharmaceuticals 32 participants Est. completion 2017-03 1 site
    Other conditions: Healthy Volunteer Study
    View official trial listing →
  • Completed NCT NCT03033121

    Three-times-weekly Versus Daily Growth Hormone (GH) Treatment in naïve GH-deficient Children

    Not yet reported University of Palermo 32 participants Est. completion 2017-01-01 1 site
    Other conditions: Growth Hormone Treatment
    View official trial listing →
  • Completed NCT NCT03038594

    Growth Hormone Therapy for Muscle Regeneration in Severely Burned Patients

    Not yet reported, Not yet reported The University of Texas Medical Branch, Galveston 13 participants Est. completion 2021-11-30 1 site
    Other conditions: Burns, Growth Hormone Treatment
    View official trial listing →
  • Completed NCT NCT03075644

    A Trial to Evaluate the Safety of Once Weekly Dosing of Somapacitan (NNC0195-0092) and Daily Norditropin® FlexPro® for 52 Weeks in Previously Human Growth Hormone Treated Japanese Adults With Growth Hormone Deficiency

    Not yet reported Novo Nordisk A/S 62 participants Est. completion 2018-10-04 12 sites
    Other conditions: Growth Hormone Disorder, Adult Growth Hormone Deficiency
    View official trial listing →
  • Completed NCT NCT03091374

    Impact of Recombinant Human Growth Hormone on HIV Persistence

    Not yet reported McGill University Health Centre/Research Institute of the McGill University Health Centre 22 participants Est. completion 2024-12 1 site
    Other conditions: Human Immunodeficiency Virus, Growth Hormone Treatment
    View official trial listing →
  • Terminated NCT NCT03145831

    A Long-Term Safety Study of Somavaratan in Japanese Children With Growth Hormone Deficiency

    Not yet reported Versartis Inc. 21 participants Est. completion 2017-11-30 1 site
    Other conditions: Growth Hormone Deficiency
    View official trial listing →
  • Completed NCT NCT03162172

    Growth Hormone (GH) in Congenital Adrenal Hyperplasia

    Hospices Civils de Lyon 25 participants Est. completion 2016-03-15 1 site
    Other conditions: Adrenal Hyperplasia, Congenital
    View official trial listing →
  • Status unknown NCT NCT03189160

    A Study of PEG-somatropin Injection to Treat Children of Turner Syndrome

    Not yet reported Changchun GeneScience Pharmaceutical Co., Ltd. 180 participants 9 sites
    Other conditions: Turner Syndrome
    View official trial listing →
  • Completed NCT NCT03203356

    Adrenal Function in GHD Children

    University of Palermo 30 participants Est. completion 2017-05-30 1 site
    Other conditions: Growth Hormone Treatment, Adrenal; Functional Disturbance
    View official trial listing →
  • Status unknown NCT NCT03221088

    A Study of PEG-somatropin in the Treatment of Children With Idiopathic Short Stature

    Not yet reported Changchun GeneScience Pharmaceutical Co., Ltd. 360 participants 7 sites
    Other conditions: Dwarfism
    View official trial listing →
  • Completed NCT NCT03223025

    Comparing Efficacy and Safety of CinnaGen Biosimilar Growth Hormone (CinnaTropin®) Versus Nordilet in Children With Idiopathic Growth Hormone Deficiency

    Not yet reported Cinnagen 30 participants Est. completion 2017-02-04
    Other conditions: Idiopathic Growth Hormone Deficiency
    View official trial listing →
  • Completed NCT NCT03225755

    Adipose Tissue and Circulating Markers of Inflammation in GH Deficiency and Changes With GH Therapy

    Columbia University 7 participants Est. completion 2025-04-30 1 site
    Other conditions: Growth Hormone Deficiency
    View official trial listing →
  • Status unknown NCT NCT03237117

    Effect of Growth Hormone on Uterine Receptivity in Women With RIF in an Oocyte Donation Program

    Not yet reported Competence Centre on Health Technologies 105 participants Est. completion 2017-12-31 1 site
    Other conditions: Female Infertility
    View official trial listing →
  • Status unknown NCT NCT03244215

    The Recurrence Study

    Not yet reported Hamad Medical Corporation 300 participants Est. completion 2018-05-17 1 site
    Cardiovascular disease Other conditions: Transient Ischemic Attack
    View official trial listing →
  • Status unknown NCT NCT03245333

    A Study of Recombinant Human Growth Hormone Injection for Short Children With Small for Small for Gestational Age(SGA)

    Not yet reported Changchun GeneScience Pharmaceutical Co., Ltd. 120 participants 5 sites
    Other conditions: Small for Gestational Age Infant
    View official trial listing →
  • Status unknown NCT NCT03249480

    Pegylated Somatropin (PEG Somatropin) in the Treatment of Children With Growth Hormone Deficiency

    Not yet reported Changchun GeneScience Pharmaceutical Co., Ltd. 900 participants 28 sites
    Other conditions: Growth Hormone Deficiency
    View official trial listing →
  • Active, not recruiting NCT NCT03255694

    A Study Extension Period of PEG-somatropin (Pegylated-somatropin) in the Treatment of Children With Idiopathic Short Stature

    Not yet reported Changchun GeneScience Pharmaceutical Co., Ltd. 360 participants Est. completion 2030-06 12 sites
    Other conditions: Dwarfism
    View official trial listing →
  • Terminated NCT NCT03274973

    Study to Assess Long-term Effectiveness of Zomacton® and Treatment Adherence in Patients With Growth Hormone Deficiency or Ullrich-Turner Syndrome

    Ferring Pharmaceuticals 4 participants Est. completion 2018-10-31 1 site
    Other conditions: Growth Disorders
    View official trial listing →
  • Completed NCT NCT03288103

    Growth Hormone Treatment in Patients With Aggrecan (ACAN) Deficiency

    Not yet reported, Not yet reported Children's Hospital Medical Center, Cincinnati 22 participants Est. completion 2023-08-31 1 site
    Other conditions: Short Stature
    View official trial listing →
  • Completed NCT NCT03305016

    A Safety, Tolerability and Efficacy Study of TransCon hGH in Children With Growth Hormone Deficiency

    Not yet reported Ascendis Pharma Endocrinology Division A/S 146 participants Est. completion 2019-03-19 24 sites
    Other conditions: Growth Hormone Deficiency, Pediatric, Endocrine System Diseases, Hormone Deficiency, Pituitary Diseases
    View official trial listing →
  • Completed NCT NCT03309891

    Dose Finding Study of GX-H9 in Paeditaric Patients With Growth Hormone Deficiency

    Not yet reported Genexine, Inc. 56 participants Est. completion 2019-05-15 1 site
    Other conditions: Growth Hormone Deficiency
    View official trial listing →
  • Status unknown NCT NCT03327207

    Exploring Interactions Between Growth Hormone and the Microbiome

    Rambam Health Care Campus 200 participants Est. completion 2021-11 1 site
    Other conditions: Growth Hormone Deficiency
    View official trial listing →
  • Enrolling by invitation NCT NCT03338387

    Co-Feedback Action of Growth Hormone, PP and PYY on Ghrelin in Bulimia

    Not yet reported Charles University, Czech Republic 24 participants Est. completion 2026-12-20
    Obstructive sleep apnea Other conditions: Eating Disorder
    View official trial listing →
  • Completed NCT NCT03344458

    A Long-Term Trial Investigating Safety and Efficacy of TransCon hGH in Children With Growth Hormone Deficiency Who Have Completed a Prior TransCon hGH Clinical Trial

    Not yet reported Ascendis Pharma A/S 298 participants Est. completion 2023-02-21 42 sites
    Other conditions: Growth Hormone Deficiency, Pediatric, Endocrine System Diseases, Hormone Deficiency, Pituitary Diseases
    View official trial listing →
  • Status unknown NCT NCT03373149

    Growth Hormone Co-treatment Within a GnRH Antagonist Protocol in Patients With Poor Ovarian Response

    Not yet reported Riyadh Fertility and Reproductive Health center 228 participants Est. completion 2020-11 1 site
    Other conditions: Infertility, Female
    View official trial listing →
  • Completed NCT NCT03409380

    Supplementation Trial on Arginine With Metabolic Profiling

    Not yet reported Pennington Biomedical Research Center 30 participants Est. completion 2019-07-08 1 site
    Other conditions: Protein, Amino Acid, Arginine
    View official trial listing →
  • Completed NCT NCT03420144

    Growth Hormone Therapy in Liver Cirrhosis

    Not yet reported, Not yet reported Post Graduate Institute of Medical Education and Research, Chandigarh 76 participants Est. completion 2020-06-30 1 site
    Other conditions: Cirrhosis, Liver
    View official trial listing →
  • Completed NCT NCT03422081

    Growth and Asymmetric diMethylArginine

    University Hospital, Lille 23 participants Est. completion 2018-12-31 2 sites
    Other conditions: Growth Hormone Deficiency, Small-for-gestational Age
    View official trial listing →
  • Completed NCT NCT03435627

    Post Marketing Surveillance on Long-term Use With Norditropin® (Short Stature Due to Noonan Syndrome)

    Novo Nordisk A/S 71 participants Est. completion 2022-01-18 22 sites
    Other conditions: Genetic Disorder, Noonan Syndrome
    View official trial listing →
  • Status unknown NCT NCT03439709

    Multicenter Evaluation of the Effect of Upfront Radiosurgery on Residual Growth Hormone-secreting Pituitary Adenoma

    Not yet reported Samsung Medical Center 90 participants Est. completion 2022-12-31 1 site
    Other conditions: Acromegaly Due to Pituitary Adenoma
    View official trial listing →
  • Completed NCT NCT03500913

    Adipose Tissue and Serum Inflammation in GH Deficiency

    Columbia University 19 participants Est. completion 2020-02-20 1 site
    Other conditions: Growth Hormone Deficiency
    View official trial listing →
  • Completed NCT NCT03525171

    Evalutation of Insulin Sensitivity Through Hyperinsulinemic Clamp in Children With GH Deficiency

    Not yet reported University of Palermo 23 participants Est. completion 2015-12-30 1 site
    Other conditions: Growth Hormone Deficiency
    View official trial listing →
  • Completed NCT NCT03525587

    Development and Validation of a Self-assessment System Based on a Mobile App to Manage Adult Growth Hormone Deficiency

    Not yet reported Azienda Ospedaliero-Universitaria di Modena 83 participants Est. completion 2024-12-31 1 site
    Other conditions: Growth Hormone Deficiency
    View official trial listing →
  • Status unknown NCT NCT03535415

    A Study to Evaluate the Efficacy and Safety of Recombinant Human Growth Hormone in Short Stature Children Due to Chronic Kidney Disease Before Transplantation

    Not yet reported Changchun GeneScience Pharmaceutical Co., Ltd. 68 participants Est. completion 2021-09 12 sites
    Other conditions: Dwarfism
    View official trial listing →
  • Completed NCT NCT03548415

    Safety, Tolerability, and Efficacy of IONIS-GHR-LRx in Participants With Acromegaly Being Treated With Long-acting Somatostatin Receptor Ligands

    Not yet reported Ionis Pharmaceuticals, Inc. 43 participants Est. completion 2021-04-02 33 sites
    Other conditions: Acromegaly
    View official trial listing →
  • Status unknown NCT NCT03554031

    A Study to Evaluate the Efficacy and Safety of Recombinant Human Growth Hormone Injection in Patients With Prader-Willi Syndrome

    Not yet reported Changchun GeneScience Pharmaceutical Co., Ltd. 30 participants Est. completion 2020-01-01 6 sites
    Other conditions: Prader-Willi Syndrome
    View official trial listing →
  • Completed NCT NCT03554265

    Brain and Gut Plasticity in Mild TBI or Post-acute COVID Syndrome Following Growth Hormone Therapy

    Not yet reported The University of Texas Medical Branch, Galveston 72 participants Est. completion 2023-10-04 1 site
    Other conditions: Traumatic Brain Injury, Fatigue, Cognitive Impairment, COVID-19
    View official trial listing →
  • Completed NCT NCT03616509

    GH in Adults With PWS, Effect on Hypotonia Evaluated by Functional MRI, Relationship With Strength and Body Composition

    Not yet reported Corporacion Parc Tauli 30 participants Est. completion 2019-07-26 1 site
    Other conditions: Prader-Willi Syndrome
    View official trial listing →
  • Status unknown NCT NCT03634514

    Non-inferiority Evaluation of Pain Intensity After Biomatrop (Somatropin) Application in Relation to Hormotrop (Somatropin), in Healthy Subjects

    Not yet reported Ache Laboratorios Farmaceuticos S.A. 68 participants Est. completion 2018-10 1 site
    Other conditions: Healthy Subjects
    View official trial listing →
  • Completed NCT NCT03658187

    Assessment of the Acute Effect of IP

    Not yet reported Vedic Lifesciences Pvt. Ltd. 32 participants Est. completion 2019-01-25 1 site
    Other conditions: Deficiency Growth Hormone
    View official trial listing →
  • Completed NCT NCT03672617

    Validation of a Questionnaire That Identifies the Reasons for Non-adherence to Existing Growth Hormone Therapy

    Novo Nordisk A/S 321 participants Est. completion 2019-04-25 1 site
    Other conditions: Growth Hormone Deficiency in Children
    View official trial listing →
  • Status unknown NCT NCT03708523

    Next Day Growth Hormone Predicting Pituitary Function After Adenomectomy

    National Taiwan University Hospital 400 participants Est. completion 2019-09 1 site
    Other conditions: Hypopituitarism
    View official trial listing →
  • Completed NCT NCT03717168

    Effects of Growth Hormone on Difficult Ventilator Weaning Patients

    Not yet reported National Cancer Institute, Egypt 60 participants Est. completion 2018-08-30 1 site
    Other conditions: Mechanical Ventilation Complication
    View official trial listing →
  • Completed NCT NCT03759301

    Efficacy of Growth Hormone Supplementation With Gonadotrophins in IVF/ICSI for Poor Responders

    Not yet reported ClinAmygate 156 participants Est. completion 2019-06-05 1 site
    Other conditions: Infertility, Female
    View official trial listing →
  • Status unknown NCT NCT03775993

    Treatment of GHD Associated With CHF

    Not yet reported Federico II University 64 participants Est. completion 2022-03-01
    Heart failure Other conditions: Growth Hormone Deficiency
    View official trial listing →
  • Status unknown NCT NCT03800810

    Implantation of Allogenic Mesenchymal Stem Cell From Umbilical Cord Blood for Osteoarthritis Management

    Not yet reported Indonesia University 9 participants Est. completion 2019-05 1 site
    Osteoarthritis
    View official trial listing →
  • Completed NCT NCT03811535

    A Research Study in Children With a Low Level of Hormone to Grow. Treatment is Somapacitan Once a Week Compared to Norditropin® Once a Day (REAL4)

    Not yet reported Novo Nordisk A/S 200 participants Est. completion 2025-09-30 135 sites
    Other conditions: Growth Hormone Deficiency in Children
    View official trial listing →
  • Completed NCT NCT03812913

    Neuropsychological Assessment of Children and Adolescents With Turner Syndrome

    University Hospital, Angers 70 participants Est. completion 2025-05-27 3 sites
    Other conditions: Turner Syndrome, Isolated Growth Hormone Deficiency, Cognitive Functions, Social Cognition, Pediatrics
    View official trial listing →
  • Completed NCT NCT03826160

    Growth Hormone Dynamics and Cardiac Steatosis in HIV

    Massachusetts General Hospital 23 participants Est. completion 2022-04-19 1 site
    Other conditions: Human Immunodeficiency Virus, Lipodystrophy, Cardiac Disease
    View official trial listing →
  • Completed NCT NCT03831880

    Patient Perception of Treatment Burden in Weekly Versus Daily Growth Hormone Injections in Children With GHD

    Not yet reported Pfizer 87 participants Est. completion 2020-08-28 32 sites
    Other conditions: Growth Hormone Deficiency
    View official trial listing →
  • Status unknown NCT NCT03878992

    Effects of Growth Hormone and IGF-1 on Anabolic Signals and Stem Cell Recruitment in Human Skeletal Muscle

    Not yet reported University of Aarhus 12 participants Est. completion 2021-12-31 1 site
    Other conditions: Growth Hormone Deficiency, Growth Hormone Treatment
    View official trial listing →
  • Completed NCT NCT03882034

    Safety and Efficacy of Pegvisomant in Children With Growth Hormone Excess

    Not yet reported Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) 12 participants Est. completion 2025-09-30 1 site
    Other conditions: Pituitary Disease
    View official trial listing →
  • Completed NCT NCT03921710

    CAPA-IVM Versus STANDARD IVM

    Not yet reported Mỹ Đức Hospital 80 participants Est. completion 2018-10-10 1 site
    Other conditions: Infertility, Female
    View official trial listing →
  • Completed NCT NCT03967249

    Extension Study of IONIS-GHR-LRx Administered to Participants With Acromegaly Being Treated With Long-acting Somatostatin Receptor Ligands

    Not yet reported Ionis Pharmaceuticals, Inc. 39 participants Est. completion 2022-07-07 22 sites
    Other conditions: Acromegaly
    View official trial listing →
  • Enrolling by invitation NCT NCT03972345

    Influence of Adherence to Growth Hormone Therapy (GHT) With Norditropin® on Near Final Height in Patients With Growth Hormone Deficiency (GHD) and Born Small for Gestational Age (SGA)

    Novo Nordisk A/S 750 participants Est. completion 2031-06-30 1 site
    Other conditions: Growth Hormone Deficiency in Children, Born Small for Gestational Age
    View official trial listing →
  • Status unknown NCT NCT03998267

    Qatar Diabetes Mobile Application Trial

    Not yet reported Hamad Medical Corporation 180 participants Est. completion 2020-12-31 1 site
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT04003207

    Growth Hormone Treatment in Children With Phelan McDermid Syndrome

    Not yet reported Swathi Sethuram 6 participants Est. completion 2020-06-05 1 site
    Other conditions: Phelan McDermid Syndrome
    View official trial listing →
  • Completed NCT NCT04020913

    Skeletal Muscle Effects of GH in Boys

    Nemours Children's Clinic 45 participants Est. completion 2025-10-30 1 site
    Other conditions: Growth Hormone Deficiency, Idiopathic Short Stature
    View official trial listing →
  • Completed NCT NCT04042428

    Generation of Biological Samples Positive to Somatropin for Anti-doping Control

    Not yet reported Parc de Salut Mar 6 participants Est. completion 2020-01-08 1 site
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Completed NCT NCT04066569

    Reproducibility and Utility of OGTT in Acromegaly

    Not yet reported Assistance Publique - Hôpitaux de Paris 109 participants Est. completion 2025-03-05 1 site
    Other conditions: Acromegaly
    View official trial listing →
  • Completed NCT NCT04079010

    The Effect of Blood Flow Restriction With and Without Arginine on Physical Performance and Growth Hormone

    Not yet reported University of Mary Hardin-Baylor 30 participants Est. completion 2019-11-25 1 site
    Other conditions: Blood Flow Restriction, Growth Hormone, Strength Outcomes, Arginine
    View official trial listing →
  • Completed NCT NCT04085224

    6x3 Crossover, Bioavailability, Safety and Tolerability Among Different Eutropin Formulations in Healthy Volunteers

    Not yet reported LG Chem 24 participants Est. completion 2020-01-02 1 site
    Other conditions: Bioavailability, Safety and Tolerability Among Different Eutropin Formulations in Healthy Volunteers
    View official trial listing →
  • Status unknown NCT NCT04180657

    Ghrelin Levels in Patients With Protein C Deficiency

    University of Aarhus 60 participants Est. completion 2020-07
    Other conditions: Protein C Deficiency
    View official trial listing →
  • Status unknown NCT NCT04310293

    Novel Therapy for Poor Responders Management

    Not yet reported Al Baraka Fertility Hospital 100 participants Est. completion 2020-08-01 1 site
    Other conditions: Poor Ovarian Response
    View official trial listing →
  • Status unknown NCT NCT04326374

    Safety, Tolerability and Efficacy of TransCon hGH Weekly Versus Daily hGH in Chinese Pediatric Growth Hormone Deficiency

    Not yet reported Visen Pharmaceuticals (Shanghai) Co., Ltd. 150 participants Est. completion 2022-04 1 site
    Other conditions: Growth Hormone Deficiency, Endocrine System Diseases, Hormones, Pituitary Diseases, Pituitary Disease, Anterior
    View official trial listing →
  • Completed NCT NCT04349839

    ACRODAT Prospective Evaluation Study

    University of Aarhus 500 participants Est. completion 2025-03-24 1 site
    Other conditions: Acromegaly
    View official trial listing →
  • Status unknown NCT NCT04352712

    Gene Expression in Monocytes of Growth Hormone Deficient Children

    University of Salerno 40 participants Est. completion 2021-04-15 1 site
    Other conditions: Growth Hormone Deficiency
    View official trial listing →
  • Status unknown NCT NCT04384744

    To Explore the Effect of GH on Outcomes of IVF and Telomerase Activity of Granulosa Cells in Women With POR

    Guangzhou First People's Hospital 40 participants Est. completion 2021-11-30
    Other conditions: GH, Poor Ovarian Reserve Based on POSEIDON
    View official trial listing →
  • Status unknown NCT NCT04384783

    To Explore the Effect of GH Pretreatment on Clinical Outcomes in Patients With Low Ovarian Reserve

    Guangzhou First People's Hospital 114 participants Est. completion 2022-04-30
    Other conditions: GH, Low Ovarian Reserve
    View official trial listing →
  • Completed NCT NCT04420481

    Growth Hormone in Ischemic Heart Failure

    Not yet reported Göteborg University 37 participants Est. completion 2012-02-25
    Heart failure Other conditions: Ischemic Heart Disease Chronic
    View official trial listing →
  • Withdrawn NCT NCT04465565

    Fluids Administration During Combined Clonidine-Arginine Growth Hormone Stimulation Test

    Not yet reported Rabin Medical Center Est. completion 2022-08 1 site
    Other conditions: Growth Hormone Deficiency
    View official trial listing →
  • Not yet recruiting NCT NCT04484051

    Growth Hormone Study in Adults With Prader-Willi Syndrome

    Erasmus Medical Center 25 participants Est. completion 2026-10-01 1 site
    Other conditions: Prader-Willi Syndrome
    View official trial listing →
  • Status unknown NCT NCT04507945

    Stablishment of Prevention and Treatment System for Intestinal Dysfunction

    Not yet reported, Not yet reported Nanjing University School of Medicine 50 participants Est. completion 2023-09-30
    Other conditions: Bowel Dysfunction
    View official trial listing →
  • Completed NCT NCT04508673

    Impact of GH Measurements on GHD Diagnosis

    University Hospital, Montpellier 41 participants Est. completion 2019-11-25 1 site
    Other conditions: Growth Hormone Deficiency
    View official trial listing →
  • Status unknown NCT NCT04510181

    Effect of an Amino-Acid-Based Blend on Human Growth Hormone (hGH) and Fibromyalgia (FM) Symptoms

    Not yet reported Pekarovics, Susan, MD 100 participants Est. completion 2022-07-31 1 site
    Other conditions: Fibromyalgia
    View official trial listing →
  • Completed NCT NCT04513171

    Safety and Efficacy of Y-shape Pegylated Somatropin in Growth Hormone Deficiency Children

    Not yet reported, Not yet reported Xiamen Amoytop Biotech Co., Ltd. 434 participants Est. completion 2023-07-10 1 site
    Other conditions: Growth Hormone Deficiency
    View official trial listing →
  • Status unknown NCT NCT04529356

    The TMS Treatment for Postoperative Headache in GH Tumor

    Not yet reported Huashan Hospital 200 participants Est. completion 2022-09-30
    Other conditions: Headache, Pituitary Tumor, Acromegaly
    View official trial listing →
  • Withdrawn NCT NCT04532554

    Growth Hormone in Obese Cases With Covid-19

    Not yet reported ClinAmygate Est. completion 2020-12-20 1 site
    Other conditions: Covid19
    View official trial listing →
  • Status unknown NCT NCT04588844

    Effect of Growth Hormone Injection on the IVF/ICSI Outcome of Patients With Poor Ovarian Reserve.

    Not yet reported Shandong University 200 participants Est. completion 2023-03-20
    Other conditions: Poor Ovarian Reserve
    View official trial listing →
  • Completed NCT NCT04614337

    Phase 2 Study of LUM-201 in Children With Growth Hormone Deficiency (OraGrowtH210 Trial)

    Not yet reported Lumos Pharma 104 participants Est. completion 2024-09-04 43 sites
    Other conditions: Growth Hormone Deficiency
    View official trial listing →
  • Completed NCT NCT04633057

    A Study to Evaluating the Efficacy and Safety of Recombinant Long-acting Human Growth Hormone (TJ101) in Children With Growth Hormone Deficiency

    Not yet reported TJ Biopharma Co., Ltd. 168 participants Est. completion 2023-07-31 30 sites
    Other conditions: Pediatric Growth Hormone Deficiency
    View official trial listing →
  • Completed NCT NCT04697381

    Study of the Efficacy and Safety of Somatropin in Japanese Participants With PWS

    Not yet reported Pfizer 33 participants Est. completion 2024-04-15 5 sites
    Other conditions: Prader-Willi Syndrome
    View official trial listing →
  • Completed NCT NCT04786873

    A Research Study of How Well Macimorelin Works to Find Out if Children Have a Lack of Growth Hormone and How Safe it is

    Not yet reported AEterna Zentaris 101 participants Est. completion 2024-06-13 45 sites
    Other conditions: Growth Hormone Deficiency
    View official trial listing →
  • Completed NCT NCT04812665

    Digital Health for Caregivers Emotional and Self-management Support

    Adhera Health, Inc. 65 participants Est. completion 2022-08-12 1 site
    Other conditions: Emotional Adjustment, Mood Disturbance
    View official trial listing →
  • Status unknown NCT NCT04860037

    Micromegaly and Discrepancy Between Growth Hormone and IGF1 at the Diagnosis and Follow-up of Acromegalic Patients

    University Hospital, Montpellier 250 participants Est. completion 2022-12-01 1 site
    Other conditions: Acromegaly
    View official trial listing →
  • Completed NCT NCT04938466

    Assessment of Adherence, Quality of Life, Clinical Response and Safety of Daily and Long-Acting Growth Hormone Therapy

    University of Minnesota 19 participants Est. completion 2024-10-30 1 site
    Other conditions: Growth Hormone Deficiency, Growth Hormone Treatment
    View official trial listing →
  • Status unknown NCT NCT04962360

    The Effect of Nutritional Formula Supplementation on Linear Growth of Growth Hormone (GH) Treated Prepubertal Children With Idiopathic Short Stature (ISS) After 2 Years From the Beginning of GH-therapy

    Not yet reported Rabin Medical Center 64 participants Est. completion 2025-10 1 site
    Other conditions: ISS- Idiopathic Short Stature
    View official trial listing →
  • Status unknown NCT NCT04970303

    Endocrine Disrupting Chemicals and Hormones in ADHD

    Chang Gung Memorial Hospital 240 participants Est. completion 2021-12-31 1 site
    Other conditions: Attention Deficit Hyperactivity Disorder
    View official trial listing →
  • Completed NCT NCT04970654

    A Research Study in Chinese Children With a Low Level of Hormone to Grow. Treatment is Somapacitan Once a Week Compared to Norditropin® Once a Day.

    Not yet reported Novo Nordisk A/S 110 participants Est. completion 2023-12-18 32 sites
    Other conditions: Growth Hormone Deficiency in Children
    View official trial listing →
  • Status unknown NCT NCT04998500

    Growth Hormone as a Model for Reversible Activation of Adipose Tissue Fibrosis

    Not yet reported University of Aarhus 10 participants Est. completion 2023-12-31 1 site
    Other conditions: Fibrosis
    View official trial listing →
  • Status unknown NCT NCT05070234

    Genetic Diagnosis and Human Growth Hormone Treatment in Small for Gestational Age Children With Short Stature

    Chunxiu Gong 150 participants Est. completion 2022-08-30
    Other conditions: Small for Gestational Age Infant, Silver-Russell Syndrome, Genetic Diseases, Inborn
    View official trial listing →
  • Status unknown NCT NCT05089344

    Growth Hormone Pretreatment in Poseidon Type IV Undergoing ICSI Using Minimal Induction Protocol: A Randomized Controlled Trial

    Not yet reported Ain Shams Maternity Hospital 132 participants Est. completion 2022-12-30 1 site
    Other conditions: Poor Response to Ovulation Induction Poseidon Type IV
    View official trial listing →
  • Completed NCT NCT05105685

    Effectiveness of Recombinant Human Growth Hormone Therapy for Children With PMS

    Not yet reported, Not yet reported Affiliated Hospital of Jiangnan University 6 participants Est. completion 2021-06-08 1 site
    Other conditions: Phelan-McDermid Syndrome, Growth Hormone Treatment
    View official trial listing →
  • Status unknown NCT NCT05144035

    A Real World Study of the Effect of Early PEG-rhGH Therapy on Cognitive Development of SGA Infants

    Not yet reported Tongji Hospital 138 participants Est. completion 2026-06-30 1 site
    Other conditions: Small for Gestational Age Infant, Growth Hormone Treatment, Cognitive Developmental Disorder
    View official trial listing →
  • Completed NCT NCT05154422

    Effects of Regular Activity on Physiology Between Recreational Athletes of Different Body Fatness

    Florida State University 15 participants Est. completion 2021-06-07 1 site
    Other conditions: Obesity, Insulin Sensitivity
    View official trial listing →
  • Completed NCT NCT05169606

    Effect of Tissue Flossing, AIS, PNF on Hamstring Among Knee OA Patients

    Not yet reported Riphah International University 30 participants Est. completion 2022-01-20 1 site
    Osteoarthritis
    View official trial listing →
  • Completed NCT NCT05171855

    A Trial to Investigate Long Term Efficacy and Safety of Lonapegsomatropin in Adults With Growth Hormone Deficiency

    Not yet reported Ascendis Pharma Endocrinology Division A/S 220 participants Est. completion 2024-12-23 85 sites
    Other conditions: Adult Growth Hormone Deficiency, Endocrine System Diseases, Hormone Deficiency
    View official trial listing →
  • Completed NCT NCT05187377

    A Controlled Trial of Growth Hormone in Phelan-McDermid Syndrome and Idiopathic Autism

    Not yet reported Icahn School of Medicine at Mount Sinai 32 participants Est. completion 2025-02-05 1 site
    Other conditions: Phelan-McDermid Syndrome, Autism Spectrum Disorder (ASD)
    View official trial listing →
  • Completed NCT NCT05195437

    Evolution of the Quality of Life of Short Statured Children Treated With Growth Hormone : Evaluation at Adult Size

    Assistance Publique - Hôpitaux de Paris 36 participants Est. completion 2024-10-12 1 site
    Other conditions: Growth Hormone Treatment
    View official trial listing →
  • Active, not recruiting NCT NCT05230550

    Post-Marketing Surveillance (Special Use-results Surveillance on Long-term Use) With Sogroya®

    Novo Nordisk A/S 200 participants Est. completion 2026-12-31 47 sites
    Other conditions: Adult Growth Hormone Deficiency
    View official trial listing →
  • Completed NCT NCT05250063

    Phase 2 Study of LUM-201 in Children Who Have Previously Completed the LUM-201-01 Trial (OraGrowtH213)

    Not yet reported Lumos Pharma 15 participants Est. completion 2025-01-22 10 sites
    Other conditions: Growth Hormone Deficiency
    View official trial listing →
  • Completed NCT NCT05281341

    Effect of GH Administration in Poor Responders Undergoing Intracytoplasmic Sperm Injection (ICSI)

    Not yet reported Alexandria University 160 participants Est. completion 2022-02-13 1 site
    Other conditions: Female Infertility
    View official trial listing →
  • Enrolling by invitation NCT NCT05308927

    French Registry of Children Treated With Norditropin® for Short Stature Associated With Noonan Syndrome

    Novo Nordisk A/S 221 participants Est. completion 2028-03-17 3 sites
    Other conditions: Noonan Syndrome
    View official trial listing →
  • Active, not recruiting NCT NCT05330325

    A Research Study to Compare Somapacitan Once a Week With Norditropin® Once a Day in Children Who Need Help to Grow

    Not yet reported Novo Nordisk A/S 412 participants Est. completion 2027-10-29 199 sites
    Other conditions: SGA, Turner Syndrome, Noonan Syndrome, ISS
    View official trial listing →
  • Status unknown NCT NCT05338411

    Effect of Exogenous Growth Hormone on Ocular Findings

    Isfahan University of Medical Sciences 90 participants Est. completion 2023-10-22 2 sites
    Other conditions: Precocious Puberty, Early Puberty, Refraction Error
    View official trial listing →
  • Completed NCT NCT05353192

    A Study to Evaluate the Efficacy and Safety of Recombinant Human Growth Hormone in Children With Achondroplasia

    Not yet reported Changchun GeneScience Pharmaceutical Co., Ltd. 39 participants Est. completion 2025-12-12 1 site
    Other conditions: Achondroplasia
    View official trial listing →
  • Active, not recruiting NCT NCT05382637

    Growth Hormone in a Patient With a Dominant-Negative GHR Mutation

    Not yet reported Children's National Research Institute 1 participants Est. completion 2028-09-01 1 site
    Other conditions: Growth Disorders
    View official trial listing →
  • Status unknown NCT NCT05390073

    Growth Hormone in EB

    Cairo University 50 participants Est. completion 2022-06-15
    Obstructive sleep apnea
    View official trial listing →
  • Completed NCT NCT05391620

    The Effect of the 3/7 vs 3X9 Method in Resistance Training on Metabolic Stress in Cardiac Rehabilitation

    Not yet reported Université Libre de Bruxelles 25 participants Est. completion 2022-10-25 1 site
    Heart failureCardiovascular disease Other conditions: Resistance Training
    View official trial listing →
  • Completed NCT NCT05448924

    Isolated Growth Hormone Deficiency and Amennorrhea

    Universitas Padjadjaran 1 participants Est. completion 2022-01-31 1 site
    Other conditions: Growth Hormone Deficiency
    View official trial listing →
  • Active, not recruiting NCT NCT05509894

    Korean Post-marketing Surveillance Ngenla® Pre-filled Pen Injection for the Treatment of Pediatric Patients With Growth Disturbance Due to Insufficient Secretion of Growth Hormone

    Pfizer 565 participants Est. completion 2026-09-23 1 site
    Other conditions: Pediatric Growth Hormone Deficiency
    View official trial listing →
  • Completed NCT NCT05574894

    Effect of GH Supplementation on the Blastocyst Euploid Rate in AMA Patients--A Retrospective Cohort Study

    Not yet reported ShangHai Ji Ai Genetics & IVF Institute 692 participants Est. completion 2022-09-30 1 site
    Other conditions: Growth Hormone, Advanced Maternal Age, PGT-A
    View official trial listing →
  • Status unknown NCT NCT05585177

    Growth Hormone to Improve the Clinical Outcome of Assisted Fertility in Young Patients With Decreased Ovarian Reserve

    Not yet reported Nanjing University 120 participants Est. completion 2025-10-30 1 site
    Other conditions: Infertility
    View official trial listing →
  • Status unknown NCT NCT05602090

    Growth Hormone For Poor Ovarian Reserve Patients in ICSI Trials

    Not yet reported, Not yet reported Beni-Suef University 120 participants Est. completion 2023-10-30 1 site
    Other conditions: Poor Ovarian Reserve
    View official trial listing →
  • Active, not recruiting NCT NCT05602766

    Ngenla Subcutaneous Injection Special Investigation

    Pfizer 1 participants Est. completion 2029-04-06 1 site
    Other conditions: Growth Hormone Deficiency Without Epiphyseal Closure
    View official trial listing →
  • Status unknown NCT NCT05603936

    Adaption and Testing of the Quality of Life in Short Stature Youth (QoLISSY) Questionnaire for Parents With Children From 0-4

    Universitätsklinikum Hamburg-Eppendorf 168 participants Est. completion 2023-12-31 1 site
    Other conditions: Achondroplasia, Small for Gestational Age, Growth Hormone Deficiency
    View official trial listing →
  • Not yet recruiting NCT NCT05645211

    The AgRP and GH/IGF-1 Axis in Children

    Columbia University 156 participants Est. completion 2027-12-31
    Other conditions: Growth Hormone Deficiency
    View official trial listing →
  • Active, not recruiting NCT NCT05690386

    A Trial to Investigate Different Doses of Lonapegsomatropin Compared to Somatropin in Individuals With Turner Syndrome

    Not yet reported Ascendis Pharma Endocrinology Division A/S 48 participants Est. completion 2027-12 19 sites
    Other conditions: Turner Syndrome
    View official trial listing →
  • Enrolling by invitation NCT NCT05718570

    A Study to Follow Patients With Adult Growth Hormone Deficiency (AGHD) Treated With Sogroya® for Long Term Safety Information

    Novo Nordisk A/S 400 participants Est. completion 2032-12-15 55 sites
    Other conditions: Adult Growth Hormone Deficiency
    View official trial listing →
  • Completed NCT NCT05724134

    Pancreatic Clamp in NAFLD

    Not yet reported Columbia University 18 participants Est. completion 2025-09-24 1 site Stand-alone
    Other conditions: Insulin Resistance, Prediabetic State, Hyperinsulinemia, Non-Alcoholic Fatty Liver Disease, Obesity
    View official trial listing →
  • Terminated NCT NCT05759598

    Effect of Respiratory Training Protocols on GH Secretion in Obesity (ALRESPGHOB)

    Not yet reported Istituto Auxologico Italiano 3 participants Est. completion 2022-06-08 1 site
    Other conditions: Obesity
    View official trial listing →
  • Enrolling by invitation NCT NCT05796440

    A Long-Term Safety Trial of LUM-201 in Children With Idiopathic Growth Hormone Deficiency Who Have Previously Completed a LUM-201 Clinical Trial (OraGrowtH211)

    Not yet reported Lumos Pharma 60 participants Est. completion 2028-04 7 sites
    Other conditions: Growth Hormone Deficiency
    View official trial listing →
  • Completed NCT NCT05809947

    Mechanisms of Tissue Repair After Muscle Injury and Tendon Strain

    Not yet reported Bispebjerg Hospital 25 participants Est. completion 2024-01-03 1 site
    Other conditions: Muscle; Injury, Quadriceps (Thigh), Tendon Strain
    View official trial listing →
  • Completed NCT NCT05838885

    A Trial of YPEG-rhGH in Children With Short Stature

    Not yet reported Xiamen Amoytop Biotech Co., Ltd. 78 participants Est. completion 2023-12-19 19 sites
    Other conditions: Idiopathic Short Stature, Small for Gestational Age, Turner Syndrome
    View official trial listing →
  • Terminated NCT NCT05894876

    A Study of the Genetic Basis of Response to Growth Hormone Treatment in Children With Idiopathic Short Stature

    Novo Nordisk A/S 43 participants Est. completion 2025-03-21 4 sites
    Other conditions: Idiopathic Short Stature
    View official trial listing →
  • Completed NCT NCT05958056

    Low Load Resistance Exercises With Blood Flow Restriction Versus High Load Resistance Exercises

    Not yet reported University of Jordan 22 participants Est. completion 2022-07-01 1 site
    Other conditions: Athletes
    View official trial listing →
  • Status unknown NCT NCT05979480

    The Effects of Growth Hormone Treatment Discontinuation in Adults on Metabolic Profile, Body Composition and Quality Of Life (GAMBOL Study)

    University Hospital Birmingham 25 participants Est. completion 2025-11-30 1 site
    Other conditions: Adult Growth Hormone Deficiency
    View official trial listing →
  • Status unknown NCT NCT06007417

    A Study to Investigate Efficacy and Safety of Weekly PEG-somatropin (GenSci004) in Treatment Naive Children With Growth Hormone Deficiency

    Not yet reported Changchun GeneScience Pharmaceutical Co., Ltd. 162 participants Est. completion 2025-08-01 1 site
    Other conditions: GHD
    View official trial listing →
  • Status unknown NCT NCT06014398

    Improving Survivorship and Health-related Quality of Life in Patients With Primary Brain Tumours

    Not yet reported Royal College of Surgeons, Ireland 50 participants Est. completion 2025-09-01 2 sites
    Other conditions: Hypopituitarism, Radiotherapy-Induced Hypopituitarism, Brain Tumor
    View official trial listing →
  • Status unknown NCT NCT06019286

    Novel Predictors of Premature Aging in COPD Patients

    Assiut University 100 participants Est. completion 2024-04-01
    Other conditions: COPD
    View official trial listing →
  • Status unknown NCT NCT06024967

    A Study to Investigate the Safety and Efficacy of Once-weekly PEG-somatropin (GenSci004) in Children With Growth Hormone Deficiency

    Not yet reported Changchun GeneScience Pharmaceutical Co., Ltd. 180 participants Est. completion 2025-09-01
    Other conditions: GHD
    View official trial listing →
  • Completed NCT NCT06094998

    Health Status of Children Born After Assisted Reproductive Technologies

    Kazakhstan's Medical University "KSPH" 252 participants Est. completion 2024-01-22 1 site
    Other conditions: Children Born After Assisted Reproductive Technologies, Health Status, Child Development
    View official trial listing →
  • Status unknown NCT NCT06103513

    Randomized Clinical Trial of Two Different Initial Growth Hormone Doses in Children

    Not yet reported Northwell Health 50 participants Est. completion 2025-12-10 1 site
    Other conditions: Growth Disorders, Growth Failure, Growth Hormone Treatment, Growth
    View official trial listing →
  • Enrolling by invitation NCT NCT06109935

    Special Use-results Surveillance on Long Term Use of Sogroya® in Children With Short Stature Due to Growth Hormone Deficiency Where Epiphysial Discs Are Not Closed

    Novo Nordisk A/S 200 participants Est. completion 2026-12-31 86 sites
    Other conditions: Growth Hormone Deficiency in Children
    View official trial listing →
  • Withdrawn NCT NCT06113952

    A Study to Compare the Experiences of Taking Daily Growth Hormone Injections to Weekly Ngenla in Children With Low Levels of Growth Hormone

    Pfizer Est. completion 2025-10-17
    Other conditions: Pediatric Growth Hormone Deficiency
    View official trial listing →
  • Withdrawn NCT NCT06126354

    Dexamethasone/Pancreatic Clamp P&F

    Not yet reported Columbia University Est. completion 2026-03-31 1 site
    Other conditions: Insulin Resistance, Prediabetic State, Non-Alcoholic Fatty Liver Disease, Overweight and Obesity
    View official trial listing →
  • Completed NCT NCT06135155

    A Clinical Trial to Compare Pharmacokinetics of Two Different PEG-rhGH Preparations

    Not yet reported Changchun GeneScience Pharmaceutical Co., Ltd. 48 participants Est. completion 2024-03-18 1 site
    Other conditions: Pediatric Growth Hormone Deficiency (PGHD)
    View official trial listing →
  • Completed NCT NCT06135168

    A Clinical Trail to Compare Pharmacokinetics of Two PEG-rhGH Injections With Different Preparations

    Not yet reported Changchun GeneScience Pharmaceutical Co., Ltd. 60 participants Est. completion 2024-03-18 1 site
    Other conditions: Pediatric Growth Hormone Deficiency (PGHD)
    View official trial listing →
  • Status unknown NCT NCT06166797

    Elucidating Growth Hormone Dynamics at Stages of Progressive Nonalcoholic Fatty Liver Disease

    Massachusetts General Hospital 60 participants Est. completion 2024-07-31
    MASLD
    View official trial listing →
  • Status unknown NCT NCT06221215

    Clinical Analysis of Early Hormones Between Patients With Traumatic Brain Injury and Cerebral Hemorrhage

    General Hospital of Ningxia Medical University 100 participants Est. completion 2024-12-31 1 site
    Other conditions: Brain Injury Traumatic Diffuse With Loss of Consciousness
    View official trial listing →
  • Completed NCT NCT06295341

    Short Stature and Psychological Well-being

    Istituto Auxologico Italiano 80 participants Est. completion 2024-01-31 1 site
    Other conditions: Short Stature, Short; Stature, Psychosocial
    View official trial listing →
  • Completed NCT NCT06331026

    A Bioequivalence Study of Two Different PEG-rhGH Preparations.

    Not yet reported Changchun GeneScience Pharmaceutical Co., Ltd. 87 participants Est. completion 2024-08-28 1 site
    Other conditions: Pediatric Growth Hormone Deficiency (PGHD)
    View official trial listing →
  • Suspended NCT NCT06354023

    Human Growth Hormone Injections in the Knee Joint to Treat Osteoarthritis

    Not yet reported John Sledge 23 participants Est. completion 2026-02-08 1 site
    Osteoarthritis
    View official trial listing →
  • Completed NCT NCT06379659

    Effectiveness of Intrauterine Growth Hormone Administration as an add-on Therapy to Conventional Hormone Therapy Compared to Placebo in Patients With Thin Endometrium Undergoing Frozen Thawed Embryo Transfer

    Not yet reported, Not yet reported Isfahan University of Medical Sciences 54 participants Est. completion 2024-09-14 1 site
    Other conditions: Thin Endometrium, Infertility Female, Infertility
    View official trial listing →
  • Status unknown NCT NCT06382857

    Effectiveness of a Microbiome-directed Food to Promote Programmatic and Sustained Nutritional Recovery Among Children With Uncomplicated Acute Malnutrition

    Not yet reported Epicentre 7356 participants Est. completion 2026-02-01 1 site
    Other conditions: Malnutrition, Child
    View official trial listing →
  • Completed NCT NCT06385145

    A Bioavailability Study of Two Different PEG-rhGH Preparations.

    Not yet reported Changchun GeneScience Pharmaceutical Co., Ltd. 16 participants Est. completion 2025-03-26 1 site
    Other conditions: Pediatric Growth Hormone Deficiency (PGHD)
    View official trial listing →
  • Completed NCT NCT06433375

    Evaluation of the Efficacy of Growth Hormone, EndoSeal MTA Sealer, and Their Combination on Healing of Periapical Pathosis

    Not yet reported Al-Azhar University 28 participants Est. completion 2025-04-01 1 site
    Other conditions: Growth Hormone, EndoSeal MTA, Periapical Pathosis
    View official trial listing →
  • Active, not recruiting NCT NCT06433557

    A Phase 2 Clinical Trial to Evaluate Efficacy, Safety, and Tolerability of Navepegritide in Combination With Lonapegsomatropin in Children With Achondroplasia

    Not yet reported Ascendis Pharma Growth Disorders A/S 22 participants Est. completion 2027-11 3 sites
    Other conditions: Achondroplasia
    View official trial listing →
  • Status unknown NCT NCT06448195

    Effects of Growth Hormone Therapy on Metabolic Function in Fatty Liver Post-Pituitary Adenoma Surgery

    Not yet reported Shanghai Zhongshan Hospital 40 participants Est. completion 2025-12-31 1 site
    Other conditions: Growth Hormone Treatment
    View official trial listing →
  • Status unknown NCT NCT06455956

    Use of miRNAs in Growth Hormone Deficiency (GHD)

    University of Parma 400 participants Est. completion 2026-03-01 1 site
    Other conditions: Growth Hormone Deficiency
    View official trial listing →
  • Status unknown NCT NCT06542809

    Evaluation of the Propensity of Patients Under rhGH to Envision a Modification of Their Treatment Regimen Toward LAGH

    Not yet reported Cliniques universitaires Saint-Luc- Université Catholique de Louvain 500 participants Est. completion 2026-03-01 1 site
    Other conditions: Growth Hormone Deficiency
    View official trial listing →
  • Not yet recruiting NCT NCT06558422

    Human Models of Selective Insulin Resistance: Pancreatic Clamp

    Not yet reported Columbia University 36 participants Est. completion 2029-02-28 1 site Stand-alone
    MASLD Other conditions: Insulin Resistance, Hyperinsulinemia, Non-Alcoholic Fatty Liver Disease, Prediabetic State, Obesity
    View official trial listing →
  • Completed NCT NCT06564753

    Phase 2 Trials of NA-931 to Study Subjects Who Are Obese With at Least One Weight-related Comorbid Condition

    Not yet reported Biomed Industries, Inc. 126 participants Est. completion 2025-04-18 5 sites
    Other conditions: Weight Loss, Obesity, Body Weight, Body Weight Changes
    View official trial listing →
  • Not yet recruiting NCT NCT06694506

    BELux Children OutcoME During A(@)Dulthood With GHD

    Not yet reported Cliniques universitaires Saint-Luc- Université Catholique de Louvain 200 participants Est. completion 2029-08-01 1 site
    Other conditions: Growth Hormone Deficiency, Adult Growth Hormone Deficiency
    View official trial listing →
  • Completed NCT NCT06743997

    A Study to Compare Eutropin Formulations in Healthy Volunteers for Bioavailability, Safety, and Tolerability

    Not yet reported LG Chem 48 participants Est. completion 2025-04-15 1 site
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Not yet recruiting NCT NCT06768411

    The Dosage Exploration Study of PEG-rhGH for Treating Short Stature in Prepubertal and Pubertal Children

    Not yet reported Second Affiliated Hospital of Wenzhou Medical University 240 participants Est. completion 2027-06-01
    Other conditions: Short Stature
    View official trial listing →
  • Completed NCT NCT06797505

    A Bioequivalence Study of Two Different PEG-rhGH Preparations

    Not yet reported Changchun GeneScience Pharmaceutical Co., Ltd. 87 participants Est. completion 2025-05-30 1 site
    Other conditions: Pediatric Growth Hormone Deficiency (PGHD)
    View official trial listing →
  • Completed NCT NCT06830525

    Development of a Personalized Growth Hormone Treatment Profile (PGTP) Report for Pediatric Endocrinology

    Luis Fernandez Luque 40 participants Est. completion 2025-11-12 1 site
    Other conditions: Growth Hormone Deficiency (GHD)
    View official trial listing →
  • Not yet recruiting NCT NCT06840691

    A Bioequivalence Study of Two Different Processes of PEG-rhGH Preparations

    Not yet reported Changchun GeneScience Pharmaceutical Co., Ltd. 87 participants Est. completion 2025-09 1 site
    Other conditions: Pediatric Growth Hormone Deficiency (PGHD)
    View official trial listing →
  • Completed NCT NCT06900335

    Functional Connectome in Prader-Willi Syndrome: Neuroimaging and AI to Assess Therapeutic Impact

    Corporacion Parc Tauli 101 participants Est. completion 2025-03-15 1 site
    Other conditions: Prader Willi Syndrome, Hyperphagia, Behavior Disorders
    View official trial listing →
  • Not yet recruiting NCT NCT06907121

    Investigation of Growth Hormone and Platelet-Rich Plasma on Joint Health

    Not yet reported, Not yet reported Integrant Pty Ltd 192 participants Est. completion 2027-12 1 site
    Other conditions: Arthritis Ankle, Arthritis Knee
    View official trial listing →
  • Completed NCT NCT07026812

    Impact of Screens on Children's Growth

    University Hospital, Rouen 150 participants Est. completion 2025-06-01 1 site
    Other conditions: Growth Disorders
    View official trial listing →
  • Active, not recruiting NCT NCT07036003

    Recombinant Human Growth Hormone (rHGH) for Knee Osteoarthritis (KORR)

    Not yet reported, Not yet reported Dr. David Wasserstein 34 participants Est. completion 2029-01 1 site
    Osteoarthritis
    View official trial listing →
  • Terminated NCT NCT07037420

    ALXN2420 Versus Placebo in Combination With Somatostatin Analogs in Participants With Acromegaly

    Not yet reported Alexion Pharmaceuticals, Inc. 8 participants Est. completion 2026-06-24 6 sites
    Other conditions: Acromegaly
    View official trial listing →
  • Not yet recruiting NCT NCT07126288

    Evaluating the Efficacy and Safety of GB08 Injection in Pediatric Patients With Growth Hormone Deficiency

    Not yet reported, Not yet reported Shenzhen Kexing Pharmaceutical Co., Ltd. 268 participants Est. completion 2028-12-23 16 sites
    Other conditions: Growth Hormone Deficiency in Children, Growth Hormone Deficiency (GHD), Growth Hormone
    View official trial listing →
  • Not yet recruiting NCT NCT07129759

    Phase 3 Long Term Safety Extension Study of LUM-201 in Children With Growth Hormone Deficiency

    Not yet reported Lumos Pharma 150 participants Est. completion 2030-02
    Other conditions: Growth Hormone Deficiency (GHD)
    View official trial listing →
  • Not yet recruiting NCT NCT07173036

    Evaluation of (Cardio)Metabolic and Auxological Outcomes of GHD Patients Under rhGH or LAGH With Stratification According to IGF-1 Levels

    Not yet reported Cliniques universitaires Saint-Luc- Université Catholique de Louvain 300 participants Est. completion 2031-09-01
    Other conditions: Growth Hormone Deficiency
    View official trial listing →
  • Terminated NCT NCT07259564

    A Study of GS3-007a for Oral Suspension in the Diagnosis of Adult Growth Hormone Deficiency (AGHD)

    Not yet reported Changchun GeneScience Pharmaceutical Co., Ltd. 120 participants Est. completion 2026-05-12 1 site
    Other conditions: Adult Growth Hormone Deficiency (AGHD)
    View official trial listing →
  • Not yet recruiting NCT NCT07264595

    A Study (Phase 1b/2) of GS3-007a Oral Treatment in Children With Growth Hormone Deficiency (PGHD)

    Not yet reported, Not yet reported Changchun GeneScience Pharmaceutical Co., Ltd. 88 participants Est. completion 2030-11 1 site
    Other conditions: Pediatric Growth Hormone Deficiency
    View official trial listing →
  • Completed NCT NCT07339436

    Lower Body Plyometric Training Effects on Upper Body in Basketball Players

    Not yet reported Birjand University of Medical Sciences 50 participants Est. completion 2025-03-20 1 site
    Other conditions: Basketball Performance
    View official trial listing →
  • Not yet recruiting NCT NCT07450001

    A Study of GenSci134 in Children With Growth Hormone Deficiency (PGHD)

    Not yet reported, Not yet reported Changchun GeneScience Pharmaceutical Co., Ltd. 128 participants Est. completion 2028-12-31 1 site
    Other conditions: Pediatric Growth Hormone Deficiency
    View official trial listing →
  • Not yet recruiting NCT NCT07450053

    A Study (Phase 1b/2) of GenSci134 in Children With Idiopathic Short Stature (ISS)

    Not yet reported, Not yet reported Changchun GeneScience Pharmaceutical Co., Ltd. 128 participants Est. completion 2028-12-31 1 site
    Other conditions: Idiopathic Short Stature
    View official trial listing →
  • Not yet recruiting NCT NCT07481656

    Effects of Recombinant Human Growth Hormone in Elderly Patients With Moderate to Severe Acute Brain Injury (GH-ABI-RCT)

    Not yet reported Anhui Provincial Hospital 160 participants Est. completion 2028-10-30 1 site
    Other conditions: Acute Brain Injuries, Moderate to Severe Traumatic Brain Injury
    View official trial listing →
  • Completed NCT NCT07542886

    A Study to Learn How Different Injector Pens Affect the Study Medicine Called Genotropin (Somatropin) Delivery and Taken up Into the Blood in Healthy Adults

    Not yet reported Pfizer 27 participants Est. completion 2026-07-24 1 site
    Other conditions: Healthy
    View official trial listing →
  • Enrolling by invitation NCT NCT07568574

    Impact of Medically Supervised Performance-Enhancing Substances (PES) on Elite Athletes

    Not yet reported Enhanced Emirates Limited 60 participants Est. completion 2033-03-01 1 site
    Other conditions: Safety and Impact of Medically Supervised Performance Enhancing Substance Usage in Healthy Elite Athletes
    View official trial listing →
  • Not yet recruiting NCT NCT07581860

    Growth Hormone Resistance of Beta-cells

    University of Missouri-Columbia 10 participants Est. completion 2030-09-01 1 site
    Prediabetes Other conditions: Healthy, Obesity & Overweight
    View official trial listing →
  • Not yet recruiting NCT NCT07659912

    Direct Versus Video Laryngoscopy in Patients With Acromegaly

    Muzaffer GENCER 40 participants Est. completion 2026-08-31
    Other conditions: Acromegaly, Nonfunctioning Pituitary Adenoma
    View official trial listing →
Efficacy history

Not yet reported.

Safety

Not yet reported.

Sources
Related On The Pen coverage

No related coverage yet.

This drug may be investigational and not yet approved for any use. Whether someone can join a clinical trial is determined only by that trial's own study team — On The Pen does not determine eligibility. Information here can change; always confirm current details on the official ClinicalTrials.gov listing or with the sponsor.